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Abstract. 
Neuroblastoma is a common pediatric cancer, the prognosis for which is 
markedly dependent upon the progression of the disease at the time of diagnosis. It 
has been argued that a mass screening programme for all infants would aid early 
detection of neuroblastoma and reduce mortality. Neuroblastoma is unusual 
amongst childhood cancers since the basis for such a test exsists - otherwise 
asymptomatic patients excrete abnormal amounts of specific phenolic compounds in 
their urine. The presence of these metabolites at elevated levels is taken as 
diagnostic of the disease. A number of pilot screeninglrogrammes in different parts 
of the world have shown that a quick, inexpensive an reliable method of screening 
is needed. One candidate for this is a test based upon the responses of 
Agrobacterium tumefaciens to compounds with structures similar to those produced 
as a result of tumour metabolism. 
This bacterium responds to such phenolic ligands chemotactically and by 
induction of virulence gene expression. Data presented in this work shows that 
phenolics secreted by neuroblastoma tumours are incapable of inducing virulence 
gene expression but are capable of acting as chemoattractants. The role of 
phosphorylation in VirA/G mediated phenolic chemotaxis is investigated. Evidence 
is presented that phosphorylation of Vir and G is required for chemotaxis. A novel, 
highly reproducible and comparible measure rif bacterial chemotaxis, the 
chemotactic index is derived and applied. 
The copyright of this thesis rests with the author. 
No quotation from it should be published without 
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1. Introduction. 
1.1 Neuroblastoma. 
Neuroblastoma was probably first described by Virchow in 1864, the present 
name being ascribed in 1910 by Wright. It is one of the most interesting paediatric 
malignant neoplasms, with a wide spectrum of possible outcomes, including 
complete spontaneous remission, maturation to benign ganglioneuroma and death of 
the patient (Smith and Castleberry, 1990). The disease is usually congenital (Carlsen, 
1988), arising in utero as a result of loss of regulation of cell division (Sutow, 1958, 
Rubin, 1968, Wilson & Draper, 1974, Birch et al, 1980, Carlsen, 1988). 
Neuroblastoma is the most common malignant neoplasm of infancy and the most 
frequent extracranial solid tumour of childhood (Garvin et al, 1990). Prognosis is 
markedly dependent on a variety of factors (Evans et al, 1987), becoming poorer 
with increasing tumour burden and dissemination (Carlsen, 1992). 
1.1.1 Origin Of Neuroblastomas. 
Primary neuroblastomas appear at many sites in the body. The presence of 
histopathologic features such as rosettes and fibrils with similarity to developing 
adrenal tissue led Wright to propose in 1910 that the tumour arose from the 
primitive neural crest (Wright, 1910). There is a wide spectrum of cell types in 
tumours described as neuroblastoma, some tumours being composed of small round 
cells almost indistinguishable from other so called small, round cell tumours cells 
such as Ewing's sarcoma and rhabdomysarcoma, whilst other tumours are so well 
differentiated as to be called ganglioneuroma, ganglion cells comprising the majority 
of the tumour (Evans et al, 1980). The disease is classified as a subgroup of 
peripheral primitive neuroectodermal tumours (PNET) (Denher, 1986, Shimada, 
1992). 
12 
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The anatomic sites of neuroblastoma origin and biologic growth are well 
explained by the embryology of neuroblast development (Smith and Castleberry, 
1990). The Neurocristopathy concept (Schummacher, 1992, Schmike, 1980) asserts 
that certain diseases originate from an aberration of the development, maturation 
and migration of neural crest cells. 
The nervous system develops from pluripotent stem cells (Smith and 
Castleberry, 1990) in the embryo and cell differentiation continues into puberty 
(Carlsen, 1992) . The embyonal ectoderm thickens to form the neural plate. This 
invaginates to establish the neural groove, which closes along the midline, forming a 
tube and eventually giving rise to the central nervous system. The neural crest 
separates from the neural tube, giving a plate from which sensory ganglia, autonomic 
ganglia, melanocytes, Schwann cells, the chromaffin system and the leptomeninges 
arise. Neuroblasts migrate from the neural crest to the central ganglia flanking the 
spinal column, the thoracic and abdominal prevertebral ganglia and the 
postganglionic cells of the adrenal medulla. Here they synapse with sympathetic 
preganglion fibres. In the 8mm embryo, primitive sympathetic cells can be found in 
the aortic regions. The differentiation of neuroblastoma cells mirrors that of 
neuroblasts. The undifferentiated embryonal cells with a large nucleus and almost 
no cytoplasm have a dispersed chromatin pattern and no nucleolus. Cells are tightly 
packed and arranged diffusely. As neuroblasts develop to form processes, rosettes 
and pseudorosettes arise. Finally as the cells become recognisable as mature ganglia 
dendrites appear, the cytoplasm coalesces, Nissl substance becomes visible and a 
nucleolus becomes visible in the now vesicular nucleus (Smith and Castleberry, 
1990). Embryonic neuroblasts, some with mitotic capability, and cells at all stages of 
differentiation may be found in the maturing nervous system (Carlsen, 1992). The 
distribution of the sympathetic nervous system mirrors the sites of primary tumours, 
most commonly in the adrenal glands (over 50% of cases) and less frequently in 
other endocrine glands, the peritoneum, retroperitoneum, thymus, heart, 
13 
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mediastinium, abdominal connective and soft tissue, and other sites in the brain, 
head, neck, thorax, abdomen and pelvis (Smith and Castleberry, 1990, Hanawa et al, 
1990). On rare occasions a case is encountered with more than one primary tumour 
(Felici et al, 1990). Tumours can appear concurrently or in sequence. When tumours 
arise in relatively rapid succession metastasis is expected. True multiple primary 
tumours more frequently arise together or at intervals of several years (Evans, 
1980). 
Neuroblastoma is thought to anse according to the Knudson 2 stage 
mutational model (Knudson and Strong, 1972, Moolgavkar & Knudson, 1981, 
Knudson, 1985, Knudson, 1989) due to its age distribution (Carlsen, 1992). This 
model proposes emancipation from regulation of cell division due to single 
mutations in several groups of genes, division promoting oncogenes and tumour 
suppressing (anti-oncogenes) genes. N-myc (Schwab et al, 1983) has been proposed 
as the neuroblastoma oncogene, whilst the as yet unidentified tumour suppressor is 
thought to map to 1p36.1-2 (Weith et al, 1989). The ret proto-oncogene is also 
specifically expressed in neuroblastoma cell lines and thought to play a role in 
tumour biology (Ikeda et al, 1990). For carcinogenesis to occur, mutation is required 
in both genetic groups in the same cell. Mutations need not arise at the same time, 
and if such a mutation is received by a cell early in development and passed on to 
many daughters, the change of a cell receiving a second "hit" greatly increases 
(Marshall, 1991). Non malignant and regressing cancers are explained as arising due 
to one "hit" in this model (Knudson and Meadows, 1980, Carlsen, 1992). In 
hereditary cancers, the first mutation is always germinal (Knudson and Meadows, 
1980). Knudson (1980) estimates that 20% of neuroblastomas arise from an 
inherited predisposition. Gilbert and Balaban-Malenbaum (1980) note that such 
inherited mutations are dominant but Brodeur (1990) estimates inheritance to be 
important in only 1% of neuroblastomas. 
14 
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1.1.2 Incidence & Epidemiology. 
Neuroblastoma is the most common malignant tumour of infancy and the 
most frequent extracranial solid tumour of childhood (Garvin et al, 1990). The 
disease accounts for 8-10% of all cancers within the first 14 years of life (Evans et al, 
1987, Sawada et al, 1991), Hirayama (1981) noting a slightly higher incidence in l! 
Japan (9.8% malignant disorders of childhood) compared to the West (7.7% in USA 
(Young and Miller, 1975), 6.6% England (Jones, 1981). 80% of cases are detected 
within the first 5 years (Bigotti and Coli, 1990) and it is very rare in adults and 
indeed in the over 7's (Cropper, 1989) though Mackay et al (1976) diagnose 9 adult 
patients as having neuroblastoma. However, the percentage of childhood deaths 
attributable to neuroblastoma is much higher (15%) (Craft and Pearson, 1989). 
Weinblatt (1988) states that 1 in 39 infant mortalities are found to have 
neuroblastoma on post mortem examination, but that this may not always be the 
cause of death. Parkin et al, estimate incidence to be 1 in 6000 to 10000 births, whilst 
Scriver et al (1987) arrive at a figure of 1 in 10330. Christiansen et al (1990) and 
Sawada et al (1990) calculate frequencies of 8 and 8.2 per million under IS's 
respectively whilst Delattre et al (1991) estimate 13.5 per million per year. Grosfeld 
points out that the disease is marginally more common in boys. Muir et al (1990) 
support Miller's claims in 1989 and 1990 that neuroblastoma is less frequent in 
people of African descent, whilst this is disputed by Lucas and Fischer (1990). This 
difference may provide some important pointers to tumour biology (Miller, 1990, 
Muir et al, 1990) and to apparently higher incidence in Japanese studies. 
To aid comparison of the data, Dr Parker constructed the following table at 
the Second International Symposium on Neuroblastoma Screening in Minnesota, 
zznd_z4th May 1991. 
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Area (time). 
Quebec (77-86) 
Denmark (70-80) 
Great Delaware 
Valley (77-86) 
Lyon 
Brazil (80's) 
U.K. (80's) 
Incidence of Neuroblastoma/M 
Year 
11.3 
11.0 
Sapporo (pre-screening) 
Sapporo (post-screening) 
10.6 
8.9 
7.7 
7.5 
13.6 
14.1 
Introduction. 
Mortality. 
Year 
4.8 
5.6 
5.0 
4-5 
6.2 
4.0 
10.8 
4.1 
Mortality is defined as number of neuroblastoma deaths per year/population size. 
There is an association between parental participation in occupations that 
lead to increased exposure to electromagnetic fields (Spitz & Johnson, 1985, Wilkins 
& Hundley, 1990) though this is debated by Bunin et al (1990). No other significant 
association between parental occupation and neuroblastoma incidence is noted by 
these groups of authors. 
Furthermore, White et al report an association between increased chance of 
neuroblastoma following in vitro fertilization and ovulation induction and Kobayashi 
et al (1991) make the same findings for ovulation induction alone. Toren et al (1992) 
reinforce the importance of extrinsic factors during embryogenesis in congenital 
disease. 
1.1.3 Pathology. 
The macroscopic appearance of a tumour varies with its position in the body, 
the degree of development and the extent of necrosis and haemorrhage. The tumour 
may be smooth or irregular, and generally becomes more nodular upon treatment. 
At first the mass is red/grey, vascular and friable. Although initially contained with 
in a capsule, tumours invade into surrounding tissue at an early stage, especially if 
found on the midline. Extension is generally along tissue planes and perineural 
pathways. Tumours vary widely in size from a few centimetres to structures of 
considerable volume. Haemorrhage and necrosis are often associated with larger 
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tumours, and this tends to lead to calcification. Major organs and vessels, the gut and 
ureters are often surrounded but rarely invaded by the cancer. This can lead to 
complications due to pressure upon and constriction of such bodies (Smith and 
Castleberry, 1990). 
Microscopically neuroblastoma is difficult to differentiate from other "small 
blue round cell" tumours such as Ewing's sarcoma, acute lymphoblastic 
leukemia/lymphoma, Rhabdomyosarcoma and Wilm's tumour. The appearance of 
cells varies with degree of differentiation from uniform spreads to nests of very 
primitive cells. The presence of rosettes of cells around a pink centre, chromosome 
abnormalities such as deletions and double minutes (DM's) and dense 
neurosecretory core granules and microtubules in neural processes when viewed 
under electron microscopy give neuroblastomas a more distinctive appearance 
(Smith and Castleberry, 1990). Accurate diagnosis is now aided by immunoreactivity 
studies using a number of antibodies raised to different antigens (Wirnsberger et al, 
1992, Roald & Brandtzaeg, 1991, Sugimoto et al, 1988). The value of chromosome 
aberrations in distinguishing these tumours is recognised by Sainati and colleagues in 
their 1992 paper. 
1.1.4 Diagnosis. 
Neuroblastoma has a wide range of symptoms, the subset of which are 
presented being related to the primary site, development and spread of the disease. 
The symptoms include pain, respiratory problems, swellings, masses under the skin, 
fever, weight loss, weakness, paralysis, blindness, watery diarrhoea, nausea, 
abdominal distension, stiffness and reluctance to walk. Older children may present 
with a feeling of general unwellness. The most common first symptom is a palpable 
tumour (Jereb, 1984, Smith and Castleberry, 1990, Evans, 1980). Some symptoms 
such as diarrhoea are related to vasoactive intestinal peptide production, whilst 
opsoclonus, darting eye movements (Carlsen, 1991, Smith and Castleberry, 1990), 
17 
Chapter 1. 1 ntroduction. 
and myoclonus (Pranzatelli & Balletti, 1992), jerks and ataxia of the trunk is often 
noted in patients and can provide an initial pointer to a diagnosis of neuroblastoma. 
Boney metastasis is associated with "bruising" around the orbit and some 
metastasized patients exhibit "blueberry muffin" marks under their skin (Smith and 
Castleberry, 1990, Evans, 1980). A minimum set of requirements for a diagnosis of 
neuroblastoma was proposed by Brodeur et al, 1988: 
A diagnosis of neuroblastoma is established if: 
Unequivocal pathologic diagnosis is made from tumour 
methods, including electron microscopy if necessary; or 
tissue by standard 
Bone marrow contains unequivocal tumour cells ( eg. synfctia) and urine contains 
increased urinary catecholamine metabolites (VMA and or VMA > 3 SD above 
the mean per mg creatinine for age). 
This m1mmum could be modified to include more recently evaluated 
biological markers such as N-myc amplification, ferritin production and DNA ploidy. 
Prenatal diagnoses of neuroblastoma have been made on the basis of ultrasound 
scans. The neuroblastoma! alterations in catecholamine metabolism of the foetus 
can have an adverse effect on the mother. Headache, sweating, paleness, tingling 
sensations in the toes and fingers and paroxysmal hypertension are all described as 
being associated with this syndrome and HV A and VMA level determination of the 
mothers urine and the amniotic fluid as well as examination of placental cells for 
signs of metastasis are recommended (Hosoda et al, 1992). Congenital cases can 
present with paraplegia, the outcome of these cases is frequently good, but 
neurological damage is often sustained (Munro et al, 1991). 
Schummacher and colleagues note the raised incidence of rib anomalies, 
including bifurcation in children with neuroblastoma and malignancies in general 
when subjected to roentogenic analysis (Schummacher et al, 1992). The authors 
contend such features can act as pointers to disease since in neuroblastoma and 4 
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other paediatric cancers, the association is statistically significant (Schummacher et 
al, 1992). These diagnostic factors do not aid early clinical diagnosis and it is thought 
that 2/3 of a tumours life is subclinical (Abelson, 1987). 
1.1.5 Staging of Neuroblastoma. 
To allow accurate evaluation of clinical trials and patient monitoring, to 
provide prognostic information and to contribute information for the basis of 
appropriate therapeutic decisions, neuroblastoma has been divided into several 
stages. At least four staging systems have been widely considered, all of which have 
some incompatibilities, some being based upon the stage of disease at the time of 
diagnosis, for example that used by the Children's Cancer Study Group (CCSG) and 
others (Evans et al, 1971,) and some upon the resectability of the tumour, eg those 
used by St Jude's Children's Research Hospital and the Paediatric Oncology Group 
(Hayes et al, 1983, Nitschke et al, 1988) and systems based on the Tumour Node 
Metastasis (TNM) system proposed by the International Union Against Cancer 
(UICC) (Lippincott, 1983). 
Although these systems all largely succeeded in distinguishing low stage good 
prognosis patients from those more advanced with poor outlook, comparison of 
individual cases is difficult. Points of disagreement include emphasis on the 
importance of tumour resectability, the prognostic significance of crossing the 
midline, the importance of lymph node involvement and the classification of stage 4 
special ( 4S) cases (Brodeur et al, 1988). Most recently workers have been 
encouraged to use the International Staging System for Neuroblastoma (ISNN) 
proposed by Brodeur et al in 1988 (and the adaption of this by Nagahara et al, 1990) 
which attempt to incorporate these discrepancies. For addition comparison of 
staging systems, the reader is also referred to Evans et al (1990), Evans and D'Angio 
(1991), Carlsen et al (1986) and Halperin & Cox (1986), who favour the 
CCSG/Evans system, Rata et al who prefer the postsurgical version of the 
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UICC/TNM system. Fleming (1992), and Haase (1991) favour a blend of the two 
major divisions of staging systems (ISNN). 
ISNN Staging. 
Stage 1: Localized tumour confined to the area of origin; complete gross 
excision, with or without microscopic residual disease; identifiable ipsilateral and 
contralateral lymph nodes negative microscopically. 
Stage 2A: Unilateral tumour with incomplete gross excision; identifiable 
ipsilateral and contralateral lymph nodes negative microscopically. 
Stage 2B: Unilateral tumour with complete or incomplete gross excision; with 
positive ipsilateral regional lymph nodes; identifiable contralateral lymph nodes 
negative microscopically. 
Stage 3: Tumour infiltrating across the midline with or without regional 
lymph node involvement; or, unilateral tumour with contralateral regional lymph 
node involvement. 
Stage 4: Dissemination of tumour to distant lymph nodes, bone marrow, liver, 
and/ or other organs (except as described in stage 4S). 
Stage 4S: Localized primary tumour as defined for stage 1 or 2 with 
dissemination limited to liver, skin, and/ or bone marrow. 
Nagahara et al introduce the further prognostic subdivisions 4A and 4B with 
bone-cortex and bone marrow metastases respectively. 
(ISNN staging will be used unless otherwise stated). 
1.1.6 Management of Neuroblastoma. 
1.1.6.1 Evaluation. 
The minimal evaluation for clinical staging of neuroblastoma is described by 
Lippincott (1989) as being as follows: Complete blood count, (differential platelets), 
liver and kidney function studies, urinary catecholamine excretion study, bone 
marrow aspirate and diagnostic imaging. 
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Petrus et al summarised the current usage of radiological tests for studying 
suspected adrenal neoplasm in 1992 (Petrus et al, 1992). Here it is recommended 
that initial investigations should be performed using ultrasound and that NMR 
rather than CAT should provide more detailed information. This assessment is based 
upon the quality of information provided and the former techniques ability to 
function without administration of contrast enhancers or ionizing radiation, although 
GD-DTPA can be useful (Kornreich et al, 1991). NMR has the addition advantage 
of providing data on spinal canal extension without resorting to myelography, thus 
sparing the patient intrathecal injection (Petrus et al, 1992). 
Moss and Sanders (1990) recommend monitoring of patients for relapse by 
immunological detection of neuroblasts in the patients blood. They commend this 
technique as being cost effective, non-distressing to the child and not requiring the 
use of ionising radiation. Detected relapse can be further evaluated with imaging 
studies. 
1.1.6.2 Treatment. 
The treatment of neuroblastoma has benefited disappointingly from the 
development of chemotherapy techniques (Craft and Pearson, 1989). Other 
paediatric solid tumours such as Wilms' tumour, nephroblastoma, teratocarcinoma 
and rhabdomyosarcoma have been found to respond well to this form of 
management, Wilms' tumour having a long term survival of 70-90% (Evans et al, 
1992). The prognosis for older patients with advanced disease is still extremely poor 
(Smith and Castleberry, 1990, Sawaguchi et al, 1990, Ikeda et al, 1989). Despite this 
Thiery Philip identifies a subgroup of patients "curable" with "Megatherapy" (Philip 
et al, 1991, Philip, 1992). There are however problems in translating improved 
response to treatment into improved long term survival and aggressive treatment can 
have deleterious effects later in life (Craft and Pearson, 1989). The prognosis for less 
advanced cases is however somewhat better (Evans et al, 1987). 
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In general terms the strategy for treatment of neuroblastoma is surgical 
resection of as much of the primary tumour as possible, followed by chemotherapy 
to irradicate residual and metastatic disease (Tsuchida et al, 1992, Haase et al, 1989). 
For stage I tumours, surgery may prove sufficient (Pritchard and Kemshead, 1983). 
Whilst tumours are sensitive to ionizing radiation, administration of these techniques 
was generally superceded by chemotherapy except for pain control, diminishing 
problematic metastases and emergencies such as optic nerve compression (Pritchard 
and Kemshead, 1983, Smith and Castleberry, 1990). Radiotherapy is however being 
used again during autologous bone marrow rescue (August et al, 1984) to obviate 
complications of marrow toxicity when treating advanced cases with marrow 
involvement. Cure rate is however not improved on a long term basis by this 
technique (reviewed by Vossen in 1990). Silber and colleagues however report bone 
marrow therapy as the only treatment to alter the prognosis of advanced patients 
(Silber et al, 1991). Castleberry and co-workers argued in 1989 and 1991 that 
children older than 1 year with regional lymph node metastases have statistically 
significantly better response rates if chemotherapy is used in conjunction with 
radiotherapy. This is however debated by D' Angio et al (1991). 
Chemotherapeutic agents seem most effective when used in multiple drug 
regimens which take advantage of drug synergism, differing mechanisms of 
cytotoxicity (esp cell cycle disruption), and vary side effects (Ikeda et al, 1989, 
Sawaguchi, et al, 1990). These protocols designed with reference to single agent 
approaches have achieved success in treating unresectable localized advanced 
disease, but there has been little improvement for over 30 years in the prognosis of 
older patients with more advanced disease (Vossen, 1990). Chemotherapy can be 
used to improve the operability of a large vascular, friable primary tumour, judged 
to be unresectable on a surgical "first look" by inducing shrinkage and a change to a 
fibrous less vascular nature (Smith and Castleberry, 1990). 
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Imashuku et al (1991) recommend the monitoring of initial response to 
chemotherapy by reference to biological markers such as catecholamine metabolite 
excretion and NSE levels, allowing tailoring of treatment to the individual. Novel 
treatments for advanced disease are actively sought in an attempt to improve the 
prognosis for this group of patients. One potentially promising technique, using 
radiolabelled 1-MIBG is described by Sisson and colleagues, but benefits have only 
lasted a few months (Sisson et al, 1990, Pinkerton, 1990, Evans et al, 1992.). Yang et 
al, describe a technique for using high intensity focussed ultrasound to limit the 
growth of unresectable tumours, but this has not been thoroughly researched yet 
(Yang et al, 1992). Indicine N-oxide was tested in phase II trials with relapsed 
neuroblastoma patients, but to no effect (Miser et al, 1991). Evans and co-authors 
describe other novel treatments under development in 1992, as did Smith and 
Castleberry (1990). 
Surgery is both diagnostic and therapeutic, the procedure can provide 
valuable information for the accurate diagnosis and staging of disease ( esp. in 
illucidating lymph node involvement) as well as cure. The histologic nature of 
tumours is assessed from biopsy specimens, needle biopsy being used with increasing 
frequency (Roald & Brandtzaeg, 1991, Smith and Castleberry, 1990,). Hedborg et al 
(1992) whilst recomending this technique report problems in obtaining enough 
material for analysis and contaminmation of tumour cells with non cancerous tissue. 
Primary and metastatic disease can be operated upon and such procedures are 
classified as primary (exploration, prior to treatment), delayed primary (operation 
on primary tumour after initial therapy), secondary, tertiary, etc after primary 
surgery and/or treatment. Delayed and repeat operations allow for assessment of 
treatment and diagnosis or metastatic and recurrent disease without significantly 
influencing prognosis (Smith and Castleberry, 1990). 
Primary tumours should be removed where ever possible (Tsuchida et al, 
1992). Major organs, vessels and nerves should however not be compromised in 
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good prognosis cases in order to achieve removal of the mass. Resectability is judged 
in terms of mobility of the mass, position, relation to other important structures, 
friability, encapsulation, encasement of structures and vessel involvement (Smith 
and Castleberry, 1990). Surgical complications especially associated with 
neuroblastoma include uncontrolable haemorrhage, injury to renal vessels and 
neurological complaints. Younger children are more prone to complications, but are 
more able to overcome them (Azizkjan et al, 1985). 
1.1.6.3 Risk Related Therapy. 
The nature of treatment given is based upon a particular patients prognostic 
variables. Of these the most important are age and stage. Stage 1 and 2 tumours with 
a generally good prognosis are treated by solely by surgery (Stage 1 only, Jereb et al, 
1984) and mild chemotherapy to ensure complete destruction a cancerous cells 
(Jereb et al, 1984, Smith and Castleberry, 1990). Stages 3 and especially 4 have a 
poorer prognosis, and require more aggressive chemotherapy following surgery 
(Ikeda, et al, 1989, Bigotti and Coli, 1990, Philip et al, 1991, Sawaguchi et al, 1990, 
Tsuchida et al, 1992). There is however, a subgroup, 4S (originally reported by 
D' Angio et al, 1970) of stage 4 disease which has a good prognosis and requires less 
(removal of primary tumour and mild chemotherapy, (Smith and Castleberry, 1990)) 
or no treatment (Evans et al, 1981). Haas et al dismissed surgery and advocated no 
treatment unless careful monitoring of disease warranted chemotherapy to preserve 
organ function. These authors preferred to hope for spontaneous 4S regression 
(Haas et al, 1988). Nitschke et al also refute the use of chemotherapy, claiming 
100% success in the treatment of stage 4S disease without resort to cytotoxic drugs 
(Nitschke et al, 1983). Jereb and colleagues however warn that stage 4S disease is 
capable of progression to stage 4 with fatal outcome (1984). Paul et al propose that 
the dismal prognosis for stage 4 patients is somewhat less dire in children younger 
than 1 year if treated intensively with multiple chemotherapeutic agents (Jereb et al, 
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1984, Paul et al, 1991). Philip et al similarly identify a stage 4 subgroup responding 
better to therapy (Philip, 1991). Nakagawara et al advise aggressive therapy in all N-
myc amplified patients regardless of other features (1988). Cervera et al (1990) 
point out the possibility of recurrent disease despite remission for many years and 
recommend rigourous follow up. 
1.1. 7 Regression. 
Spontaneous regression of neuroblastoma is occasionally observed in young 
infants, but is extremely rare in older children (Carlsen, 1990). Neuroblastoma 
remission however accounts for around 17% of all human remissions from cancer 
(Everson & Cole, 1966). Dutch records show regression occurring in less than 2% of 
cases, but the actual incidence may be higher since some cases may have been 
recorded as malignant tumours, and some asymptomatic tumours may regress before 
diagnosis (Carlsen, 1992). Evans et al estimate regression in 8% of cases (Evans et 
al, 1976), whilst Pritchard and Kemshead agree with the Dutch estimate (Pritchard 
& Kemshead, 1983). Smith and Castleberry (1990) not that neuroblastoma has the 
highest remmission rate of all human cancers. All stages are capable of regression, 
with stage 2 and 4S comprising the majority (Evans et al, 1976). Both primary and 
metastatic lesions can regress (Evans, 1980). 
Matsumura et al (1991) report a regressing stage 1 tumours that shrank in size 
and whose catecholamine metabolism gradually normalized. Over 18 months 
observation the tumour reduced by 90% in volume before surgical removal. No 
other treatment was given. 
Knudson and Meadows proposed in 1980 that regressmg stage 4S 
neuroblastoma was not in fact malignant since it lacked a second "hit" or genetic 
tumour activation. They furthermore suggest that the mutation is in the parent's 
germ line, newly arising in non-hereditary cases. It is proposed that stage 4S lesions 
arise from neural crest cells with a mutation affecting their normal developmental 
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pattern, and not as metastases of primary tumours (Knudson and Meadows, 1980, 
D' Angio, 1980,). The cells have the possibility to develop a malignant nature if a 
second mutation arises and this is taken as an argument against the administration of 
treatment with possible mutagenic side-effects (Knudson and Meadows, 1980). 4S 
lesions which eventually regress often do not respond to therapy (Evans et al, 1976). 
The lesion cells are thought to have arrested development, allowing cell 
proliferation. If no further mutagenic event occurs, the lesions cells should 
eventually complete benign differentiation to gangioneuromas or neurofibromas. 
The mechanism of tumour regression is still not ellucidated with any certainty (Haas 
et al, 1988). 
1.1.8 Maturation. 
Another favourable outcome for neuroblastoma patients is maturation of the 
tumour to benign ganglioneuroma (Dyke and Mulkey, 1967, Evans et al, 1976, 
Uchino et al, 1978, Garvin et al, 1984) and/or neurofibroma (Griffin and Eolande, 
1969, Rangecroft et al, 1978). In these cases, malignant neuroblastoma cells 
differentiate to benign ganglia, either spontaneously or as a result of treatment 
(Evans, 1980). Maturation is a possible outcome for both localized and metastatic 
disease (Evans et al, 1976). Favourable biological markers (section 1.1.10) are 
associated with this rarely documented event (5 cases in 18 years) (Haas et al, 1988). 
Shimada et al reported in 1984 that patients with good prognosis showed signs of 
tumour maturation along and age dependant sequence. The recorded incidence of 
both spontaneous regression and maturation is perhaps somewhat lower than it 
might be due to the reluctance of pediatricians not to treat ill patients. 
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1.1.9 Prognosis for Neuroblastoma Patients. 
In the early 1930's neuroblastoma was considered almost universaly fatal, 
aside from a few tumours which spontaneously regressed or matured. The 
application of surgery in the late 1920's and radiation therapy 10 years later 
increased overall survival rate to 20-30%. Chemotherapy has improved the 
prognosis for certain groups to greater than 80% survival (Carlsen, 1991). Prognosis 
for patients with advanced disease remains poor despite vigorous efforts, but 
complete remission rates and prolonged disease free survival have been improved 
(Evans et a/, 1987). August et a/ recommend bone marrow therapy for improving the 
prognosis of advanced patients (1984 ). 
1.1.10 Prognostic Factors in Neuroblastoma. 
The evaluation of factors which relate to the eventual outcome and course of 
a disease is important in determining the most suitable treatment. By considering 
many such factors which are correlated with the prognosis, more accurate decisions 
can be made (Carlsen, 1991) and administration of treatment with undesirable side 
effects minimized (Evans et al, 1987). Correct treatment is also necessary to avoid 
complications of residual tumour resistance (Silber et al, 1991). Recognition of 
prognostic factors also aids comparison of different treatment modalities. The 
choice of system for diagnosis and staging may have an effect upon incidence, time 
of detection and prognosis (Carlsen, 1991). 
1.1.10.1 Symptomology and Diagnosis. 
The association of watery diarrhoea, and Dancing Eye Syndrome with 
neuroblastoma generally lead to an early diagnosis, improving prognosis. 
Incidentally discovered tumours generally have a good prognosis (Carlsen, 1990) as 
do ones detected by mass screening ((87.5% survival) Nishi, et a/1988). Conversely 
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symptoms associated with metastatic disease such as bone pain, rheumatic 
symptoms, preorbital ecchymoses and proptosis, malaise, irritability, anaemia and 
unexplainable fever indicate a poorer outlook (Carlsen, 1991). 
1.1.10.2 General Prognostic Factors. 
Age and stage are related to the outcome of a case (Breslow & McCann, 
1971, Evans et al, 1987). Traditionally age at the time of diagnosis was considered to 
be the most important single prognostic factor, children under 1 year having the best 
prognosis (Kajanti & Holsti, 1986, Ninane, 1992). Furthermore Evans stage II, III 
and IV (Evans et al 1971), children under 1 year of age at time of diagnosis have a 
better prognosis than older children of the same stage (Jereb et al 1984, Philip, 
1992). This indicates that the better prognosis for younger children is not because of 
a lower bias in the stage spectrum. These authors state that the ability of young 
patients' tumours to mature may be significant however, as a greater proportion of 
mature tumours (ganglioneuroblastomas) are found in older children. It is proposed 
that neuroblastic tumours progress along a maturational sequence with age and that 
only tumours overdeveloped for their age are truly malignant (Shimada et al, 1984, 
Cooper et al, 1991). 
Evans stage (Evans et al, 1971) is an independent prognostic factor (Jereb et 
al, 1984, Evans et al, 1987). Patient treated at the Children's' Hospital of 
Philadelphia have the following 2 year survivals: 
Evans Stage I II III IV IVS 
Survival(%) 100 82 42 30 100 
Whilst the table above relates the general picture, it must be remembered 
that different staging systems will show different effects on prognosis. (It is therefore 
possible that different staging systems are more useful in evaluating different types 
of neuroblastoma). However, disease extent, the basis of several staging systems, 
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including Evans (Smith and Castleberry, 1990), is shown to be of great prognostic 
significance (Carlsen et al, 1986, Wilson and Draper, 1974, Breslow & McCann, 
1971, Jaffe, 1976, Coldman et al, 1980), many authors attributing greatest import to 
this factor (Kajanti & Holsti, 1986, Delattre et al, 1991). 
The site of the primary tumour is important m determining outcome. 
Retroperitioneal and especially adrenal neuroblastoma are associated with the 
poorest prognosis, whilst a mediastinal site indicates a better course of disease 
(Ninane, 1992). 
In localised disease, lymph node involvement is indicative of poor prognosis 
(Hays et al, 1983, Ninane et al, 1982). The same has also be found to hold true in 
metastatic disease, and more surprisingly the prognosis of patients with distant 
lymph node metastasis is better than that of patients with regional involvement 
(Yamada et al, 1992). 
The pattern of urinary catecholamine metabolite excretion is correlated to 
outcome, a high ratio of VMA to HV A production being favourable, indicating the 
maturity of the tumour (Laug et al, 1978). Sex and race are not of prognostic 
significance (Evans et al, 1987). 
1.1.10.3 Tumour Markers with Prognostic Significance. 
Ferritin is an iron binding proteinaceous component of normal and diseased 
serum (Hann et al, 1980a, Blatt et al, 1990). Increase in serum ferritin above 
142ng/rnl was shown by Hann et al (1980b) to be a indicator of poor prognosis. 
Prognostic value of ferritin levels is confirmed by Evans et al, 1987. The level of 
serum ferritin correlates approximately with tumour size (Carlsen, 1991). Tumour 
cells contain (Arioso et al, 1976) and secrete (Watanabe et al, 1979, Hann et al, 1984) 
ferritin. The work of Blatt and colleagues (1990) demonstrates that neuroblastoma 
cell synthesize ferritin de novo under regulation of iron levels. The role of the 
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protein in tumour biology is still unclear (Blatt et al, 1990) however, Blatt & 
Wharton (1992) report that ferritin stimulates mitosis in cultured neuroblastoma cell 
lines. The prognostic significance of ferritin levels is independent of age, stage, 
histology and etiology (Evans et al, 1987) and a 90% accurate model predicting 
outcome from ferritin levels, age, stage and histology was devised by Silber and 
colleagues (1991). Laboratory measurement of serum ferritin is routine and, coupled 
to age of accurate prognostic importance (Evans et al, 1987). 
Serum neuron specific enolase (NSE) levels above lOOmg/ml have been 
correlated with stage and dissemination of disease by Zeiter and co-workers (Zeiter 
et al, 1980, Zeiter et al, 1983). NSE levels can be used to separate advanced patients 
into good and poor prognosis groups (Evans et al, 1987, Zeiter et al, 1986). 
In stage IVS (Evans et al, 1971) patients serum levels of lactose 
dehydrogenase correlate with prognosis and N-myc amplification (Nakagawara et al, 
1990b). 
1.1.10.4 Histopathologic Factors. 
The Shimada classification (Shimada et al, 1984) divides patients into stroma-
poor and stroma-rich subgroups on the basis of stromal development, organization 
and number of Schwann cells, stroma or "background" cells being a product of the 
tumour and also arising from the neural crest. The stroma poor group is further 
subdivided into favourable (84% survival) and unfavourable (4.5% survival groups) 
according to the patients age at diagnosis, tumour maturity and nuclear pathology 
(mitosis-karyorrhexis index (MKI)). Similarly, the stroma rich group is subdivided 
into well differentiated (100% survival), intermixed (92% survival) and nodular 
(18% survival) groups, solely on the basis of tumour morphology (Shimada et al, 
1984). The authors make the interesting prediction that the tumours they classify as 
having good prognosis will eventually mature to benign masses, whilst poor 
prognosis tumours are essentially more aggressive and malignant in nature, requiring 
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more exhaustive management. In 1992 Shimada et al note a correlation between 
stroma poor undiferentiated tumours with a high MKI and amplification of theN-
myc oncogene (Schwab et al, 1983). This they propose is because the DNA binding 
protein product of this gene can act upon Schwann cells, arresting development and 
neuroblast differentiation thus leading to a certain morphology. Carlsen (1991) 
extends the prognostic value of the Shimada classification by linking it to age. 
Bigotti and Coli reported evidence that supported the validity of Shimada 
classification. These authors further add to the classification, reporting that in good 
prognosis cases, anti S-100 protein anti sera reacts with slender satellite cells in the 
stromal septa of neuroblasts. The use of NSE antisera is recommended to aid cell 
identification. Similarly Wirnsberger et al evaluated a panel of commercially 
available antibodies for diagnosis and gauging of tumour maturity (Wirnsberger et 
al, 1992). 
1.1.10.5 Cellular Factors. 
P-Glycoprotein is a conserved 170Kd plasma membrane protein with 
homology to bacterial active transport proteins. It is thought to be responsible for 
ATP dependent export of many chemotherapeutic drugs from the cell, thus causing 
multiple resistance. This protein is only detected using immunological methods in 
patients with non-localized aggressive disease, and is associated with poor prognosis. 
Pre-treatment levels of P-Glycoprotein levels correlate with the success of 
chemotherapeutic treatment in metastatic disease. It is thought treatment of patients 
with agents that block the action of this transport protein before chemotherapy may 
be beneficial (Chan et al, 1992). White however contends that the predictive value of 
P-Glycoprotein expression may be somewhat more complicated. The alkylating 
agent type drugs, most effective in the treatment of the neuroblastoma are not 
thought to be subject to P-Glycoprotein export and this author suggests that 
increased expression may be a marker for as yet undetected factors (White, 1992). 
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1.1.10.5.1 Genetic Abnormalities. 
The study of genetic alterations is important in determining both prognosis 
and the underlying mechanisms of carcinogenesis. 
Flow cytometric analysis has revealed a non random bimodal DNA index 
distribution. Approximately 1/3 of tumours have a near diploid genome, the 
remainder being hyperdiploid, most commonly near triploid. Tumour DNA content 
is a stable marker and does not vary with disease progression or maturation or 
therapy (Taylor et al, 1988). Hypodiploidy is rare in neuroblastoma (Delattre et al, 
1991). Naito et al report a somewhat smaller proportion (around half) of aneuploid 
tumours but associate hyperdiploidy with a good prognosis-58.8% of patients older 
than 1 year surviving, compared to 28.6% of diploid tumour children of similar age. 
Furthermore, in the same study of patients with advanced disease, stage III and IV 
(Evans et al, 1971) 63.2% of aneuploid tumour patients survived, compared to 
30.4% of children with diploid tumours. This is surprising in that in the majority of 
other tumours higher DNA content is associated with aggressive, behaviour and poor 
prognosis (Naito et al, 1991). 73.3% of these authors' patients who had aneuploid 
tumours survived, whilst 66.7% of the group with diploid lesions succumbed to 
disease. This is a statistically significant difference. DNA ploidy is an independent 
prognostic factor (Naito et al, 1991, Carlsen, 1991), possibly because aneuploid 
tumours have a better response to chemotherapy (Look et al, 1984 ). There is 
however, a marked association between diploidy and advanced disease, whilst 
aneuploid tumours are found at all stages of tumour development (Naito et al, 1991). 
Cohn et al report a statistically significant association between DNA diploidy and 
unfavourable histology and between ploidy and high proliferative activity (Cohn et 
al, 1990). Furthermore DNA content of tumours seems strongly correlated with age 
and stage (Carlsen, 1991). N-myc amplification is restricted to tumours with an 
unfavourable DNA content (Dominci et al, 1992), whilst Cohn et al found in 1990 
32 
Chapter 1. 1 ntroduction. 
that there was a non-statistically significant trend between N-myc amplification and 
DNA ploidy. The reason for increase in genetic material is unclear at present 
(Carlsen, 1991) and in hyperdiploid tumours a population of normal diploid cells is 
always found (Hayashi et al, 1986). 
Cytogenetic signs of gene amplification such as homogeniously staining 
regions (HSR's) and extra chromosomal elements, double minutes (DM's) are 
associated with poor prognosis (Schwab et al, 1983, Franke et al, 1986). These 
structures develop during tumour evolution, largely due to amplification of theN-
myc oncogene (Schwab et al, 1983) and surrounding sequences from 2p24 (Carlsen 
1991). The number of copies of amplified sequence varies from lO's to thousands 
and usually consists of repeats of a few hundred Kb. HSR's are found on many 
different chromosomes (Franke et al, 1986). The elements are found in about 1/3 of 
all primary tumours and in most cell lines (Delattre et al 1991). The ability of a 
tumour to establish cell lines is itself a marker of poor prognosis (Evans et al, 1987). 
The features are associated only with advanced disease (Franke et al, 1986). These 
authors also report that whilst HSR's and DM's may both be present in the same 
tumour cell population, they are never found in the same metaphase. Brodeur et al 
point out in 1984 that more tumours may show signs of amplification when studied 
with molecular biology techniques giving a higher resolution that the 106-5*106 bp 
of light microscopy. 
Aberrations of the short arm of chromosome 1 are associated with poor 
prognosis (Franke et al, 1986). At least 70% of human neuroblastomas display 
cytogenetically visible anomalies of this type. Analysis using molecular biology 
techniques shows the frequency to be nearer 90% (possibly 100%) in advanced cases 
(Weith at al, 1989). Allelic loss (loss of heterozygosity (LOH) (Carlsen, 1991)) is 
associated with these aberrations, the consensus deletion mapping to 1p36.1-2 
(Weith et al, 1989). This 10 megabase segment (Weith et al, 1989) is thought to be 
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the location of the putative neuroblastoma tumour suppressor (Carlsen, 1991, Weith 
et al 1989, White et al, 1991). There is no correlation between putative suppressor 
loss and N-myc oncogene overexpression, suggesting different mechanisms of 
acquisition (Weith et al, 1989). This is however debated by Brodeur (1990) who's 
colleagues find strong association. LOH for chromosomes 14 and 13 may also be 
informative and provides evidence of neuroblastoma's genetic heterogeneity 
(Brodeur and Nakagawara, 1992). 
Genomic amplification of the N-myc oncogene is closely related to the 
proliferation of neuroblastoma cells (Schwab et al, 1983). N-myc is part of a family 
of myc genes (DePinho et al, 1987). Only a patient's tumour cells are amplified 
implying somatic rather than germinal multiplication (Schwab et al, 1984 ). Closely 
regulated (unamplified) N-myc expression plays a role in human foetal brain 
development (Grady et al, 1987). Amplification is thought to occur after 1p deletion 
(Christiansen and Lampert, 1988) and is related to increased gene expression (Nisen 
et al, 1988) due to increases in 4kb mRNA transcript numbers (Seeger et al, 1985) 
though the link between overexpression and amplification is not inevitable (Schwab 
et al, 1984 ). The gene can be amplified from 3 to several hundred times (Brodeur et 
al, 1984) and copy number is temporally and spatially stable (Brodeur et al, 1987). 
Of neurological tissue, only primitive neuroblasts and not differentiated ganglia 
express N-myc RNA (Schwab et al 1984, Grady-Leopardi et al, 1986). Clinically this 
amplification is associated with poor prognosis, progressing Stage ill and Stage IV 
(Evans et al, 1971) disease (Brodeur et al, 1984, Seeger et al, 1985, Nakagawara et al, 
1987a). 65% of Stage III cases and 47.5% Stage IV are amplified for the oncogene, 
Stage II and particularly Stage I (Evans et al, 1971) tumours are however much less 
likely to show increased copy numbers (Brodeur et al, 1985). Nakagawara et al 
(1987b) extend the prognostic significance of N-myc amplification to Stage II and 
IVS (Evans et al, 1971) tumours, normally associated with a good prognosis, unless 
amplification is observed. Shimada et al have found that patients of any stage have a 
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worse outlook if their tumour is amplified when compared to similar non amplified 
cases (1992) and this argument is supported by Brodeur (1990). Tonini et al adopt 
report a less inevitable prognosis in 1990 however, and Cornaglia-Ferraris et al 
(1990) report that a highly tumourigenic cell line they studied had undetectable N-
myc expression. Despite strong correlation with stage and primary site (Nakagawara 
et al, 1987a), amplification is however age independent (Brodeur et al, 1985). 
Although disputed by several authors, including Nakagawara et al (1987a) this 
suggests a strong role for N-myc in tumour biology, which few authors deny. Nerve 
growth factor receptor expression is inversely correlated to N-myc expression, and 
the ability to respond to this signal may play a role in determining outcome 
(Christiansen et al, 1990). Nakagawara and colleagues reported in 1990 
(Nakagawara et al, 1990a,b) that even correcting for variables such as tumour 
volume, stage and prognosis, N-myc amplified tumours excreted more HV A and 
VMA and at a different ratio than their non-amplified counterparts. This links to 
Laug et als' 1978 correlation of tumour catecholamine metabolism immaturity and 
prognosis. N-myc gene is also amplified in retinoblastoma (Schwab et al, 1984, Lee 
et al, 1984) and astrocytoma (Garson et al, 1985) as well as Wilm's tumour and 
heptoblastoma, tumours not derived from the neuroectoderm (Nissen et al, 1986). 
The protein product of the oncogene is localised in the nucleus, so it is here that it is 
presumed to have its effect (Slamon et al, 1986, Ikegaki et al, 1986, Ikegaki et al, 
1988) and would be expected to function in concert with a Max partner (Cole, 1991). 
In summary N-myc seems to have a key role in determining the aggressiveness of 
neuroblastoma tumours (Seeger et al, 1983), however, in some cases this has been 
shown not to be so (Seeger, et al, 1988, Cornaglia-Ferraris et al, 1990) and Cohn et al 
(1990) report that in some tumours a biologic factor other than N-myc plays a part in 
this determination. Recently Sansone and co-workers have found that N-myc 
amplification does not seem to have an effect on prognosis in older children though 
the sample they studied was small (Sansone et al, 1991). In stage IVS (Evans et al, 
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1971) tumour regression is independent of oncogene amplification and expression 
does not correlate with prognosis (Nakagawara et al, 1990b). Garvin and colleagues 
suggested in 1990 that N-myc expression may be a factor in tumourigenesis whilst 
amplification may be a later event, correlating with progression. Furthermore 
overexpression from a single copy N-myc gene is not a marker of poor prognosis 
(Brodeur, 1990). 
Telomeres are the physical ends of eukaryotic chromosomes. Shortening of 
the G-rich repeated sequences forming these structures is associated with aging and 
a number of malignancies (Hiyama et al, 1992). The structures exist to prevent 
chromosomes fusion and degradation (Zaikan, 1989, Blackburn, 1991). Compared to 
average values, aggressive neuroblastomas with a poor prognosis show significant 
reduction in telomere length (Hiyama et al, 1992). It is also noted by these authors 
that similar observations can be made in stage IVS (Evans et al, 1971) cases which 
have favourable outcomes. This can not be adequately explained at present, though 
may relate to cell senescence before regression. It is reported in the same paper that 
a few older advanced patients had telomeres extended above the average length. 
This however could be an artefact of the study as there is a degree of individual 
variation in this characteristic, and the authors do not compare tumour to non lesion 
data on a personal basis. 
1.1.10.6 Additional Factors. 
Eckschlager concludes that increased peripheral lymphocyte count is 
associated with good prognosis in neuroblastoma patients. He however notes that 
lowered counts do not indicate poor prognosis. It is proposed that the lymphocyte 
count is raised due to the antigenic nature of the tumour. (Eckschlager, 1992). 
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1.1.10.7 Summary. 
1 ntroduction. 
Studies of tumour biology have lead to the proposal of 2 models explaining 
neuroblastoma behaviour. Firstly all neuroblastoma could begin as benign disease 
with favourable prognosis and if untreated, evolve into more benign, aggressive 
disease with poor prognosis. Alternatively, there could be sub-populations of 
disease, the more favourable group being detected early and being more readily 
cured, the second, more aggressive with poor prognosis (Mauer, 1988, Brodeur, 
1991). The former rarely if ever would progress to the latter, though Knudson thinks 
it theoretically possible (Woods et al, 1992). This would be consistent with the idea 
of single and double "hits" in the Knudson model of disease development although 
there is apparent scope for intermediates. 
Clinical/Genetic Types of Neuroblastoma. 
Feature Type 1. Type 2. Type 3. 
Age <12mo Any age Any age 
Stage 1,2,4S 3,4 Any stage 
Ploidy Hyper diploid Near diploid Near diploid 
Near tetraploid Near tetraploid Near tetraploid 
LOH No No Yes 
DM/HSR No No Yes 
N-myc Amp. No No Yes 
Prognosis. Good Intermediate Poor 
The above table, adapted from Brodeur's 1991 paper and his submission to the 
Second International Symposium on Neuroblastoma Screening in Minnesota, May 
1991 lists characteristics of the proposed subgroups. Similar findings are made by 
Hayashi et al (1988) and Woods et al (1992). It is debatable which is the more useful 
model, Shimada, Cooper and their colleagues having observed disease progression 
(Shimada et al, 1984, Cooper, et al, 1991) and Brodeur and co-workers being able to 
accurately predict prognosis by reference to subgroupings. 
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1.1.11 Screening for Neuroblastoma. 
Neuroblastoma is associated with a distinctive urine chemical phenotype 
(Scriver et al, 1987). In 1957 Mason and co-workers in Newcastle first reported that 
a patient with neuroblastoma secreted adrenalin and noradrenaline in her urine 
(Mason et al, 1957). The presence of elevated levels of the catecholamine 
metabolites (Voorhess and Gardiner, 1960, 1961) HVA and VMA is now taken as 
diagnostic of the disease (Gitlow et al, 1960, 1970), 92% of patients excreting one or 
both compounds at raised levels (Tuchman et al, 1987b ). Catecholamines are 
· synthesized from tyrosine (Candito et al, 1992). The dopaminergic pathway which 
leads tp HV A is often present in neuroblastoma cells, but lacks the enzyme 
dopamine-B-hydroxylase, responsible for the conversion of dopamine to 
norepinephrine. Conversely cells rich in this enzyme have the capacity for 
generating norepinephrine and its metabolite VMA (Laug et al, 1978, Woods et al, 
1992). Serum and urine catecholamine metabolite levels are strongly correlated 
(Dugaw et al, 1990). Biochemically immature neuroblastomas lacking dopamine-B-
hydroxylase are associated with a poor prognosis (Laug et al, 1978). Mastrangelo et 
al present evidence that both cell types could be present in the same tumour (1991). 
Neuroblastoma is the first paediatric cancer to be screened for (Hammond, 1988). 
The general current methodology for screening is as follows: Mothers are 
provided with a neuroblastoma screening kit which explains the programme and 
contains an absorbent piece of filter paper. A sample of the child's urine is collected 
on the filter paper by the mother, air dried and returned for analysis. Random 
sample timing is thought to be adequate (Tuchman et al, 1985) though Weetman et 
al (1976) and Winkel and Slob (1973) report a diurnal variation in catecholamine 
metabolite excretion. At the screening centre the sample is eluted in aqueous 
solution (Seviour et al, 1988), checked for contamination by faeces or other 
compounds such as nappy creams and the phenolic acids extracted from it by 
differential solubility in organic solvent (Seviour et al, 1988, Lemieux et al, 1988). 
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This sample is derivitised if necessary (Dale et al, 1988) and screened for the 
presence of HV A and VMA with concentrations elevated above normal levels as 
determined by screening large numbers of healthy patients. Each group of workers 
has ascribed its own diagnostic cutoffs, usually 2-3 standard deviations above the 
mean excretion values sometimes with bias for age, sex and other factors (Cropper, 
1989, Huddart & Mann, 1991 Henderson et al, 1992, Parker et al, 1992). Because the 
patients urine excretion pattern will vary the apparent concentration of compounds 
in the sample, HV A and VMA concentrations are expressed relative to creatinine 
concentration measured by the Jaffe reaction (Falin & Wu, 1947, Chasson et al, 
1961, Kuroda et al, 1990). Creatinine is excreted at a roughly constant level 
throughout a 24 hour period and so provides a suitable standard (Tuchman et al, 
1989). However, caution is advised when calculating urinary compound 
concentrations relative to creatinine from an untimed measurement (Di Ferrante & 
Lipscomb, 1970, Henderson et al, 1992). Positive samples are retested from a second 
paper or liquid sample before medical work up begins. Some screening techniques 
do not require extraction of phenolics from the resuspended aqueous urine solution 
(Kinoshita, 1988, Sawada 1988) whilst some require the use of fresh urine (Kodama 
& Nakata 1984 ). There is a strong correlation between HV A and VMA levels from 
dried filter paper and fresh urine samples, even when paper samples are stored for 
several days (Tuchman et al, 1987a). 
1.1.11.1 Rationale for Screening. 
"The early detection of cancer, whether in children or adults has long been 
viewed as a worthwhile public health goal" (Prorok, 1992). 
When neuroblastoma screening was initially discussed, it was held to be true 
that in neuroblastoma patient populations, age is strongly correlated to progression 
to a more malignant phenotype, suggesting that advanced patients have passed 
undetected through lower stage disease (with better prognosis). The 2 year survival 
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for patients under 1 year at the time of diagnosis is 75%, compared to 17% for 
patients whose disease is detected later, regardless of stage (Scriver et al, 1987). 
This would suggest early diagnosis is desirable. It is difficult to detect neuroblastoma 
clinically while in infancy or early stages due to lack of chraracteristic symptoms 
(Sawada et al, 1991, Berthold et al, 1991) and it was assumed that presymptomatic 
patients would have a better prognosis and require less treatment, with fewer side 
effects (Draper, 1988). However this author points out that some cases will be 
missed by a test (false negatives) and some detected cases will spontaneously 
regress, without the need for treatment that may be administered (Pastore et al, 
1984), even "cautious" therapy being toxic (Carlsen, 1992). Furthermore it is 
assumed that the neuroblastoma that clinically manifests itself later in life is present 
during infancy to be detected. This is probably a safe supposition (Carlsen, 1988) but 
the tumour may be too small to produce detectable levels of catecholamine 
metabolites (Norman et al, 1987, Ishimoto et al, 1990) or initially quiescent 
(Weinblatt, 1988, Cropper, 1989). False positives cause excess parental anxiety and 
are equally undesirable (Sawada et al, 1991 ). 
Aside from the medical and ethical reasons for screening, there is also an 
economic incentive. Whilst the cost of mass screening would be relatively small 
(Hillson et al, 1988, Sato et al, 1988, Nishi, et al, 1991, Berthold et al, 1991) the cost 
of suitable chemotherapy can be £400 per day per patient, up to £40000 for a full 
course despite the poor prognosis (Cropper, 1989). Woods & Tuchman report 
expenditure of $144256 on advanced patients and $24650 on early stage disease 
( 1987). Cost of screening an entire population is roughly equal to treating the 
expected number of patients within it and there may be a small saving provided the 
test is reliable and accurate (Hillson et al, 1988, Nishi, et al, 1991, Berthold et al, 
1991). Increased sensitivity improves cost benefit, although rescreening is performed 
at additional expense. (Nishi et al). 
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Thus there is an putative advantage in spending money on screening to detect 
early asymptomatic neuroblastomas in the hope of being able to cure a greater 
proportion of children and at lower cost. 
1.1.11.2 History of Neuroblastoma Screening. 
Large scale screening of infants for neuroblastoma was first instigated in the 
Kyoto Prefecture, Japan. Dr Sawada and colleagues employed the LaBrosse spot 
test method, based upon a purple colourmetric reaction of VMA with alkaline 
diazotized p-nitroaniline (LaBrosse, 1968). This method is only 75% accurate, 
missing tumours that do not secrete VMA, and prone to false positives due to 
reaction with other compounds in the patients urine (McKendrick and Edwards, 
1965, LaBrosse, 1968). From 1972 the programme concentrated on 3 year old 
children, the only child detected dying from Evans Stage IT progression, but attention 
was switched to 6 month old infants in 1974 in the hope of detecting more readily 
cured children. This proved more successful, 4 asymptomatic children being detected 
and cured after surgery in the 6 years up to 1979 (Sawada et al, 1991). This 
demonstrates the need for careful consideration of time of screening. Unlike 
phenylketonuria, cretinism and galactosemia neuroblastoma can not be detected at 
any age, as tumours may not be large enough to secrete sufficient catecholamine 
metabolites to detect (Norman et al, 1987, Ishimoto et al, 1990) as the number of 
false negatives in the Newcastle screening programme testifies. 30g is thought to be 
the borderline weight of a detectable tumour (Nishi et al, 1990b ). This argues in 
favour of late testing as does early imbalance in catecholamine and creatinine 
metabolism (Tuchman et al, 1989), however the possibility of progression demands 
screening to be as soon as possible. Ideally each child should be screened at several 
stages during childhood, but this may be prohibitively expensive. Ishimoto et al 
(1990) report that screening at 6 months detects mainly triploid non N-myc 
amplified tumours (good prognosis) and that late occurring diploid and/or N-myc 
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amplified {poor prognosis) cases with immature catecholamine metabolism are more 
amenable to detection around the first birthday. This is supported by Woods et al 
(1992) and Kaneko et al (1988). Berthold et al argue in 1991 for screening between 
10 and 12 months after birth whilst Ishimoto et al (1990) would prefer 18 months. 
Thus the efforts so far, typically screening at 6 months may only detect patients who 
could have been cured anyway and this seems to be reflected in the rise in incidence 
but no decrease in death rate (Weinblatt, 1988). 
All recent mothers in the Kyoto prefecture were provided with a VMA 
screening kit during routine health checks and asked to return a urine soaked filter 
paper for analysis when their child reached 6-7 months. The spot test was adapted to 
ease assay and employed in Nagoya, Japan from 1977. Osaka started spot tests in 
1980 (Sawada et al, 1991). Positive tests are confirmed (Takeda, 1989) and followed 
up by hospital visits, examination and tumour imaging (Sawada et al, 1991). 
Mass screening started in Sapporo City in 1981, initially based upon spot 
testing for VMA and determination of HV A concentration by TLC, simultaneous 
detection being called for by McKendrick and Edwards (1965), Yoshiura et al (1987) 
and Nishi et al (1990a) due to the large number of non VMA secreting tumours 
(LaBrosse, 1968). HVA is a more useful diagnostic indicator as its excretion is not 
stress related (Cropper, 1989), but VMA is more sensitive at an early age (Nishi et 
al, 1990a, Tuchman & Woods, 1992). Candito et al, recommend additional 
consideration of methylated catecholamine metabolites (1992). Tuchman and 
Stoeckler (1988) note that conjugated HVA and VMA may have diagnostic 
importance in "borderline" cases with slightly abnormal urine composition. In 1984 
the system was replaced by automated sampling and simultaneous VMA and HV A 
determination using HPLC and electrochemical detection (Takeda, 1989). Unlike 
the LaBrosse spot test, HPLC is not sensitive to false positive results due to dietary 
constituents, although certain drugs can alter the result (Sawada et al, 1992, 
Weetman et al, 1976) and therefore is not subject to Saito et al's recommendation 
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for a test diet when spot and dip testing (Saito et al, 1990). Despite initial problems 
of bacterial contamination in the wet paper samples leading to an apparently lower 
creatinine and VMA concentration (Mizuta, & Umisa, 1988), accuracy improved 
after drying of filter papers before return (Sato et al, 1988). Following Welfare 
Ministry advice, many Japanese self governing regions started to employ spot testing 
and TLC after 1985, and after 1988 financial support was extended to HPLC 
techniques (Takeda, 1989), 49 of 57 administrations using this technique in 1989 with 
4 fold higher sensitivity and lower false positive rates, leading to less parental 
anxiety (Sawada et al, 1991). 
In about 90% of the Japanese cases detected by screemng, no clinical 
symptoms had been observed and tumour could not be detected during the first visit 
to hospital in 30%, despite screening evidence (Takeda, 1989). Patients typically 
range in age from 7-9 months when diagnosed as time is required for testing and 
retesting and due to late return of samples (Sawada et al, 1989). This is younger that 
the average age for clinical diagnosis 65% of children have stage I and II (Evans et 
al, 1971) tumours, whilst 10% have stage IVS disease (Evans et al, 1971), 11% of 
children are stage III (Evans et al, 1971) and 13% stage IV (Evans et al, 1971) 
(Tsunoda, 1987) and this supported by other studies (Sawada et al, 1991). The 
proportion of advanced stage disease is much the same in screened and clinically 
diagnosed groups (Gutjahr, 1988) and this argues against screening. Primary sites are 
much the same as for clinically diagnosed patients (Takeda, 1989). 5 year survival is 
96% and 95% of Evans stage III and IV cases have responded well to treatment 
(Sawada et al, 1991). 
Workers in Newcastle-upon-Tyne sponsored by the North of England 
Children's Cancer Research Fund and the Neuroblastoma Society initially evaluated 
HPLC for the purpose of neuroblastoma screening (Dale 1989). This however 
proved too slow for their requirements and results were difficult to interpret due to 
signals from other compounds present in urine. Similar contamination problems 
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(Matsumoto et al, 1985) were found with GCFID (Dale et al, 1988) though GCMS 
has yielded far better results. Screening takes place at 6 months of age (Seviour et al, 
1988). Presenting their results at the Second International Symposium on 
Neuroblastoma Screening in Minneapolis, 22nd_24th May 1991, Drs Dale and Craft 
stated that from 20816 infants screened up to 1990, 2 patients had been correctly 
diagnosed along with 7 false positives. 3 neuroblastomas had been missed and were 
identified clinically. 1 case of congenital muscular dystrophy was also diagnosed , 
having elevated urinary catecholamine metabolite concentrations when compared to 
suppressed creatinine excretion 
Workers in Quebec have used various thin layer chromatographic, chemical 
and spectrophotometric methods for neuroblastoma screening (Lemiuex et al, 1988). 
Screening began in 1971 and consists of a primary TLC screen followed by a 
secondary screen for accurate quantification of HV A and VMA levels in samples 
found to be positive on the first screen. A variety of secondary screens have been 
employed, GC-MS being used since 1989 (Tuchman et al, 1987a, Tuchman et al, 
1991b) in collaboration with workers in Minneapolis who had previously run their 
own small pilot programme (Tuchman et al, 1989). Screening has been performed at 
various ages, 5, 14 and 21 days. The earliest screen gave poor compliance, the 14 day 
test high false positive incidence (Lemieux, 1988) and a 3 week screen is now 
employed followed by a 6 month check (Tuchman et al, 1991b). The TLC test has 
the benefit of being able to detect many organic acidurias (Lemieux et al, 1988), with 
the potential benefit of preventing death, mental retardation and developmental 
anomalies (Tuchman et al, 1991a) this advantage is extended to GC-MS by Tuchman 
et al, 1991a. The project is of especial interest since it provides a population based 
comparison between a screened and 4 similar but unscreened cohorts, thus allowing 
accurate analysis of the benefits of screening. This is a significant analytical 
advantage over the Japanese study. 
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The Canadian project has correctly detected 7 neuroblastomas and 2 
additional cases of possible regression. Concurrently 12 additional patients have 
been diagnosed clinically, 6 prior to screening, 1 who missed testing and 5 false 
negatives due to non excreting tumours at time of testing. VMA seems to be a more 
sensitive marker in these early cases, being raised in all the secreting patients, whilst 
HV A was normal in 3. The tumours studied had biologic markers consistent with 
good prognosis (Tuchman et al, 1991b ). 
In 1989 Mellor et al succeeded in raising specific antibodies to VMA in sheep 
using derivitised antigen. This improved reproducibility and facility of assay over the 
technique of Yoshioka et al (1987) and previous workers. They considered their 
product to be the first basis of a possible practical immunological catecholamine 
metabolite screening test although Y okomori et al published the results of a pilot 
study, based upon the earlier work of their Japanese colleagues (1989), finding a 
strong correlation between immunological assay and HPLC techniques. This work 
was explained in greater technical detail by Kuroda et al (1990). These works report 
the increased speed of this methodology over physical techniques while stressing its 
accuracy. Most recently antibodies and immunological testing kits have become 
commercially available. These have been evaluated by a number of workers 
including Saito Wiedemann et al (1990) and McGill et al who reported their 
findings at the Second International Symposium on Neuroblastoma Screening in 
Minneapolis between zznd and 24th May, 1991. 
1.1.11.3 Compliance. 
Unlike screening for diseases such as phenylketonuria, hypothyroidism and 
galactosemia, neuroblastoma screening can not be conducted before neonates are 
discharged from hospital after birth. This is because tumours may be too small to 
produce enough catecholamine metabolites to detect (Normal et al, 1987, Ishimoto 
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et al, 1990) and because catecholamine and creatinine metabolism seems to be 
initially prone to maternal influence (Tuchman et al, 1989). Samples thus have to be 
collected by health visitors (Newcastle Programme) or more commonly returned 
voluntarily by parents. Compliance with Japanese screening was 59% in 1985, rising 
to 79% in 1988 (Hanawa et al, 1990, Sawada et al (1990). As expected, return rates 
are good in Newcastle, 96% according to Cropper (1989) and Tuchman et al report 
95% compliance in Canada (1990a). However Tuchman and Woods report only 15% 
return by a largely unprompted US population in their 1990 paper and correlate 
compliance with support and public awareness and education regarding screening. 
1.1.11.4 Summary. 
Due to its diagnostic urine phenotype, neuroblastoma provides a rare 
opportunity for the early detection of childhood cancer by mass screening 
(Hammond, 1988). The detection of phenolic acids has been shown to be amenable 
to mass screening by several groups using physical techniques (Sawada, et al, 1991, 
Dale, 1988, Tuchman, 1989). However, financial constraints argue for a cheaper 
primary screen followed by more accurate physical testing in positive cases 
(Tuchman & Woods, 1992). 
One alternative strategy could be the use of ELISA techniques, another a 
biological test based upon the common soil prokaryote Agrobacterium tumefaciens. 
This bacterium is capable of detecting and responding to phenolic compounds with 
marked structural similarity to HV A and VMA as part of its normal biology 
(Melchers et al, 1989). The Guthrie test for PKU provides a precident for routine 
infant screening for disease by a bacterial method. Neuroblastoma screening and its 
ramifications screening will be evaluated in Chapter 6 (Discussion). 
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1.2 Agrobacterium. 
1.2.1 The Genus Agrobacterium. 
Taxonomically the genus Agrobacterium is a member of the family 
Rhizobiaceae and is closely related to the genus Rhizobium (Kersters and DeLey, 
1984 ). Agrobacteria are a common component of the soil microflora (Melchers and 
Hooykaas, 1987) and are most commonly found in close proximity to plant roots, 
where their numbers can be up to a thousand times higher than in the nearby soil 
(New and Kerr, 1972). Microscopically they appear as short parallel sided rods with 
rounded ends. They are 0.6-l.O,um wide and 1.5-3.0,um long giving a modal 
equivalent spherical volume of around 0.8,um3. There are 1-6 flagella, typically 4-5 
times the length of the cell and these are arranged along the sides of the cell and in a 
polar tuft (Shaw et al, 1991). When stained, the bacteria are Gram negative 
(Melchers and Hooykaas, 1987). 
The genus has traditionally been classified into four species, based upon 
pathogenic subdivisions (Melchers and Hookyaas, 1987). Agrobacterium tumefaciens 
causes crown gall disease in many species of monocotyledenous and dicotyledenous 
plants (Smith and Townsend, 1907) and the pathogenic nature of other members of 
the genus is detailed in the table below. 
Species 
A.rhizogenes 
A. rubi 
A. radiobacter 
Disesase 
'hairy root disease' 
aerial cane gall 
non-pathogenic 
Reference 
(Riker, 1930). 
(Melchers and Hookyaas, 1987). 
(Nester and Kosuge, 1981). 
The pathogenic nature of each species is determined by the presence of either 
a tumour inducing (Ti) or root inducing (Ri) plasmid (Van Larebeke et al, 1974, 
Zaenen et al, 1974, Watson et al, 1975, Moore et al, 1979). These plasmids are 
capable of being transferred interspecifically (Kerr et al, 1977, Genetallo et al, 1977) 
rendering this classification controversial and subject to constant change. Van 
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Larabeke et al (1975) and Thomashow et al (1980) report that the pathogenic nature 
of each plasmid is unaltered by its host's background, implying that the only 
functional difference between the Agrobacterium species is the plasmid they carry. 
Alternative classifications based upon metabolic, physiological, phage 
resistance and DNA hybridization studies have been proposed by Kerr and 
Panagopoulos (1977), and Kersters and DeLey (1982). These are perhaps 
taxonomically safer divisions, as being based upon chromasomally encoded 
characteristics they should be more stable. In accordance with common parlance 
"Agrobacterium" will be taken to mean Agrobacterium tumefaciens unless otherwise 
stated. 
1.2.2 Crown Gall Disease. 
Crown gall is a neoplastic over proliferation of plant cells caused by 
Agrobacterium tumefaciens (Smith and Townsend, 1907, Melchers and Hooykaas, 
1987). It is of economic importance as it causes commercial losses in several crops 
including grapes, stone fruits and ornamental plants (Kerr and Panagopoulos, 1977, 
Sule, 1978, Bernearts & De Ley, 1963). It is almost geographically ubiquitous and is 
to be found in Africa, Asia, Australasia, Europe and the Americas (Elliot, 1951). The 
species can be isolated from both cultivated and non agricultural land (Binns and 
Thomashow, 1988). Although the disease itself was recognised in Classical times by 
the Greeks, the causative role of the bacterial pathogen was not established until 
1907 (Smith and Townsend, 1907). This discovery has lead to intensive study of the 
field since it is fascinating in its own right and also a possible model system for 
processes underlying cell growth and animal tumours. The implications for plant 
transformation have also been addressed (Hoekema et al, 1983, An et al, 1985, 
Hooykaas and Schilperoort, 1992). 
In 1942 it was demonstrated that crown gall tumours could be maintained and 
grown without the continued presence of inducing bacteria (White and Braun, 1942). 
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Whilst normal plant cells require cytokinin and auxin supplemented media for 
cultured growth, crown gall tissue grows rapidly without exogenous additions (White 
and Braun, 1942). Six years later Braun and Mandie proposed a "tumour inducing 
principle" whereby Agrobacterium modified or added to the plant cell such that it 
acquired a capacity for autonomous growth (Braun and Mandie, 1948). 
Agrobacterium further modifies the plant cell such that it synthesizes novel 
sugar amino acid conjugates that would not normally be produced (reviewed Tempe 
and Goldman, 1982). These conjugates are termed opines, and the type of opine 
synthesized .is determined not by the host plant cell, but by the strain of inciting 
bacteria (Petit et al, 1970). Secreted by the plant cell, opines can be utilised by 
rhizosphere Agrobacteria as a source of energy, carbon and nitrogen (Bomhoff et al, 
1976, Montoya et al, 1977). Bomhoff et al (1976) demonstrated that only 
Agrobacterium strains carrying a Ti-plasmid capable of inciting the induction of a 
particular opine could metabolize that specific conjugate - other micro-organisms 
and Agrobacterium strains are unable to catabolise it (Melchers and Hooykaas, 
1987) (although this is no longer held as universaly true (Binns and Thomashow, 
1988). This modification of the plant cell to cause a proliferation of tissue secreting 
opines is thought to confer a selective advantage on the organism causing it (Schell 
et al, 1979) though it may not be particulary large (Ream, 1989). 
It has been further demonstrated that large extrachromosomal elements, the 
200Kb (approx) Ti Plasmids (Van Larabeke et al, 1974, Watson et al, 1975) are 
essential for tumourigenesis. By means of DNA hybridization experiments, it has 
been shown that a small discrete segment of the Ti plasmid is transferred and stably 
maintained in the plant cell (Chilton et al, 1977, 1980, Willmitzer et al, 1980). This 
small element, called the transfer or T DNA is responsible for the altered 
morphological and biochemical phenotype of crown gall cells. This is the only 
generally excepted example of genetic exchange between the prokaryotic and 
eukaryotic kingdoms (Winans et al, 1988). The proportion of virulent Agrobacterium 
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in the soil is however small. Even in areas where the incidence of crown gall is high, 
Ti plasmids are to be found in only 1-10% of the population (Binns and Thomashow, 
1988). 
1.2.3 Bacterial-Plant Interaction. 
Plant wounding is a prerequisite of tumour formation (Binns and 
Thomashow, 1988). Wounded plants produce a variety of compounds to defend 
themselves against pathogenic attack (Stachel et al, 1985, De Clenne, 1988, 
Dharmatilake and Bauer, 1992, Song et al, 1991a). Amongst the spectrum of 
molecules exuded are sugars, phenolics and acid metabolites (Winans 1991, Mantis 
& Winans, 1992). The Agrobacterium - plant cell interaction is a two way chemical 
signalling process (Winans, 1992). Molecules released by the plant (Hawes et al, 
1988) and wound conditions (Winans, 1991) act upon the bacterium to ellicit 
chemotaxis (Loake et al, 1988, Ashby et al, 1988,) and induction of virulence genes 
(Stachel et al, 1986a). These genes then act in concert to catalyse the transfer of the 
T DNA from the bacterium to the plant cell. 
1.2.3.1 Chemotaxis. 
Chemotaxis in bacteria involves the directed movement of motile cells in 
response to a chemical gradient of attractant or repellant (Adler, 1966). 
Agrobacterium is envisaged to be chemotactically attracted towards plants by wound 
exudates, where due to higher concentrations of biologically active molecules 
expression of the virulence genes is induced (Ashby et al, 1987, Loake et al, 1988). A 
similar scenario is proposed by Dharmatilake and Bauer (1992) who report that 
Rhizobium meliloti, a root nodule inducing organism is attracted towards target 
alfalfa roots by flavonoid root exudates. The Agrobacterium hypothesis is supported 
by the observation that for some exudate components, most notably phenolic lignin 
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precursors and breakdown products ( esp. acetosyringone ), the concentration 
threshold of positive chemotaxis is 1000 fold lower than for gene induction (Ashby et 
al, 1987, Stachel et al, 1985). Whilst Ashby et al used purified chemical attractants in 
their assays, Hawes et al (1988) were able to demonstrate positive Agrobacterium 
chemotaxis to as few as 300 excised living plant cells. 
In 1989 Hawes and Smith demonstrated that in certain open matrix soil types 
non-chemotactic mutants of Agrobacterium were less virulent than their wild type 
counterparts. This dependence on soil type suggests that chemotaxis may be of 
greater significance in some environments than others. Loake et al's results (1988) 
suggest that sugars and amino acids may be the predominant root chemoattractants 
whilst attraction by phenolics may be important on a micrometre scale (Shaw et al, 
1989, Shaw, 1991) an estimate in keeping with the calculations of Dharmatilake and 
Bauer (1992). Furthermore the work of Parke et al (1987) suggests that phenolic 
chemotaxis may only be of ecological importance in the most highly motile 
Agrobacterium strains. Phenolic chemotaxis is mediated by the interaction of a 
multifunctional chemoreceptor/effector system with more general chromosomal 
chemotaxis functions (Shaw, 1991) encoded by as many as 60 genes (MacNab, 
1987a,b). 
Wounding is possibly of further importance in making the plant susceptible to 
infection. Following wounding cell division takes place to repair damage. The 
consequent local increase in DNA replication is possibly important in allowing 
integration of bacterial DNA (Binns and Thomashow, 1988). Furthermore, once a 
tumour has been incited and opines are being produced, these compounds induce the 
conjugative transfer of the Ti plasmid amongst rhizosphere Agrobacteria, ensuring 
they are capable of benefiting from the available energy, carbon and nitrogen source 
(Binns and Thomashow, 1988). 
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1.2.3.2 Attachment of Agrobacterium to Plant Cells. 
Having arrived at a suitable specific site for infection, Agrobacteria attach 
themselves to the plant. This step is essential for virulence (Lippincott and 
Lippincott, 1969). At first individuals congregate to form polar chains, but this is 
followed by a massive aggregation at the plant surface (Matthysse et al, 1981). 
Cellulose fibrils help to maintain the aggregation and attachment to the host 
(Matthysse, 1983, Matthysse et al, 1981) but only one virulent Agrobacterium 
interacts with each wound site to induce tumour formation (Lippincott and 
Lippincott, 1969). The cellulose fibrils are synthesized by the bacterium (Matthysse 
et al, 1981). Ti plasmid presence is a prerequisite for bacterial attachment 
(Matthysse et al, 1978). Bacterial aggregation by chemotaxis and cell division may 
provide enough bacteria secreting lytic enzymes to enable digestion of the plant cell 
wall (Matthysse et al, 1981), aiding T DNA transfer. 
Binding involves both specific plant cell and bacterial receptors (Binns and 
Thomashow, 1988). The plant saturable bacterial receptor appears to be a cell wall 
component (Binns and Thomashow, 1988), possibly a protein (Gurlitz et al, 1987). 
The bacterial recognition factor is probably a lipopolysaccharide (Matthysse et al, 
1978, Whately et al, 1976) although this is not incontrovertible (Binns and 
Thomashow, 1988). Three bacterial genetic loci are also involved, chvA, chvB 
(Douglas et al, 1986) and pscA (Cangelosi et al, 1987) and are thought to facilitate B-
1,2-D-glucan production and export (Binns and Thomashow, 1988) aiding tight 
binding (Ream, 1989). 
1.2.3.3 Structure of the Ti-Plasmid. 
The 2 best studied types of Ti plasmid, encoding the production and 
catabolism of the opines octopine (eg pTiAch5 and pTiA6) or nopaline (eg pTiC58 
and pTiT37). Whilst there are specific difference in the organisation of these 
elements, in general terms, Ti plasmids have 5 functional regions, namely: The T 
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region and functions for virulence, conjugative transfer, replication and opine 
catabolism & uptake (Melchers and Hooykaas, 1987). Octopine plasmids tend to 
have single T DNA elements whereas several mobile elements are common in 
nopaline encoding systems (Zambryski, 1992). 
The T region, which is bounded by almost identical 25bp direct repeats is 
transferred to the host plant cell (see figure 1.2.3.3.A, reproduced by kind permission 
of Mark Levesley). This region contains the T DNA which, on expression in the 
plant, encodes functions for auxin and cytokinin production and opine 
synthesis/ export (Melchers and Hooykaas, 1987). Any DNA bounded by the cis 
acting 25bp repeats will be exported from the bacteria cell to the plant nucleus and 
expressed (Stachel and Zambryski, 1986b, Zambryski, 1992), and this phenomenon 
has been widely exploited for plant transformation (Hoekema et al, 1983, An et al, 
1985, Hooykaas and Schilperoort, 1992). 
The virulence or vir regulon is essential for the catalysis of the transfer 
process. Acting in concert the products of these genes work in trans but are not 
themselves transferred (Hille et al, 1982, Klee et al, 1982, Hoekema et al, 1983, 
Melchers and Hooykaas, 1987). There are 8 vir operons named A-H in clockwise 
direction towards the T region, together comprising approximately 30Kb (Rogowsky 
et al, 1990). Several of these genes are poly-cistronic and each gene in a cistron is 
designated numerically along similar lines. 
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Incompatibility 
ONC OPS 
Ti 
Introduction. 
Conjugation 
Opine 
Catabolism 
Figure 1.2.3.3.A - Ti plasmid (octo pine type) showing 
location, size and polarity of the vir loci trasncripts, the 
location and general functions of the T -DNA and border 
elements and the approximate locations encoding plasmid 
replication, bacterial comjugation and opine catabolism. 
BR =Border Repeat, OD =Overdrive sequence, ONC = 
Oncogenes, OPS =Opine synthesis genes. 
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Functions. 
Signal transduction -
response to pH, sugars, phenolics. 
Transmembrane pore proteins 
/transport functions 
Overdrive functions ? 
T strand production specific 
DNA binding/pilot protein 
Non specific single stranded 
DNA binding. 
Not known 
Two component regulator system 
effector and chemotaxis mediator 
H Formerly 2 Cytochrome P-450 monooxygenases 
pinF 
(Adapted from Melchers and Hooykaas (1987), Rogowsky et al (1990) and other 
sources). 
Expression of the vir genes is closely regulated (Stachel et al, 1986a). 
Transcription of vir A, B, C, D, E, F and H is under the control of the vir AI G system 
(Stachel and Zambryski, 1986a). This system is part of a family of bacterial genes 
known as two component regulators (Winans et al, 1986, Leroux et al, 1986). virA 
acts a signal transducer responding to pH and temperature (Melchers et al, 1989), 
sugars (in conjunction with the periplasmic chvE sugar binding protein (Cangelosi et 
al, 1990)) and phenolics (Stachel et al, 1985, 1986a, Stachel and Zambryski, 1986a). 
Under inducing conditions, autophoshorylated virA transfers phosphate from 
histidine 474 (Huang et al, 1990, Jin et al, 1990b) to aspartate 52 on virG (Jin et al, 
1990a,b). Phosphorylated effector acts as a sequence specific DNA binding protein 
and transcriptional activator (Jin et al, 1990c, Pazour and Das, 1990a). Inducible 
virulence genes all have a consensus cis acting 'vir-box' regulatory element in their 
promotors (Das et al, 1986,). virG expression is autoregulated although subject to 
phosphate starvation and pH regulation (Mantis and Winans, 1992, Winans et al, 
1986). Since the 'pool size' of virG is thought to be the limiting factor on induction 
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(Mantis and Winans, 1992) it is envisaged that a non induced Agrobacterium has 
residual levels of vir A and low levels of virG, if prevailing conditions alter however, 
the effector pool size increases and as a result more receptor is produced, conferring 
greater ability to induce vir expression if necessary. 
Ti plasmid genes also encode for the metabolism of opines (Bomhoff et al, 
1976) and their specific uptake (Klapwijk et al, 1977). The plasmid also has functions 
for plasmid replication and incompatibility. There are 3 incompatibility groups 
incRh-1 to incRh-3 and entry inhibition operates though conjugative transfer is 
possible (Melchers and Hooykaas, 1987). 
1.2.3.4 Generation of aT DNA Copy. 
As a result of vir gene expression, the products of these coding regions act 
upon the T DNA of the Ti plasmid to produce a DNA element capable of being 
transferred to its target. The initial step is a endonucleolytic cleavage between the 
3rd and 4th bases of the 25bp Ti plasmid direct repeats. These nicks, formed only in 
the bottom strand, once detected are used as the initiation and termination sites for 
the liberation of the bottom strand of the T DNA between them. This DNA, 
designated the T strand is displaced in right to left direction leaving a 3' end at the 
right border which acts as a primer for resynthesis of the second plasmid DNA 
strand (Albright et al, 1987, Stachel, et al, 1986b, Wang et al, 1987, Zambryski et al, 
1992). 
The protein products of virDl and virD2 have been shown to be required for 
T strand production (Stachel et al, 1987, Yanofsky et al, 1986). As mutations in these 
genes cause loss of nicking ability and T strand synthesis these proteins are 
implicated as having site specific endonuclease activity (Zambryski, 1992). in vitro 
studies support this conclusion and also demonstrate topisomerase activity for 
VirD1, suggesting that prior to nicking by VirD2 the DNA is specifically relaxed by 
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VirD1 (Zambryski, 1992, Ghai and Das, 1989). VirD2 is clearly a multifunctional 
molecule and will be further discussed below. Only the N terminal 50% of the 
protein is required for 25 bp repeat recognition and binding (De Vos and Zambryski, 
1989, Yanofsky et al, 1986). 
In octopine Ti plasmids border nicking is thought to be enhanced by 
"overdrive" (Peralta et al, 1986) functions (Toro et al, 1988, 1989, Zambryski, 1992). 
The effect of overdrive, a 24bp sequence (Peralta et al, 1986) active either up or 
downstream of the border repeats (Van Haaren et al, 1987) is thought to only be 
important when VirD1 and VirD2 would otherwise be limiting (De Vos and 
Zambryski, 1989). VirC1 has been shown to interact with this sequence (Toro et al, 
1989), though how the subsequent increase in nicking activity (Toro et al, 1988) is 
mediated is not clear. The function of the second protein product of the virC operon 
is even more uncertain. 
T strand production would be expected to require helicase, polymerase and 
unwindase functions. These are thought to be provided by constitutive bacterial 
enzymes or induced under conditions preceding virulence gene expression 
(Zambryski, 1992). These enzymes are not Agrobacterium specific since T strands 
can be produced by E.coli harbouring T DNA substrate and virDl and virD2 
functions (DeVos and Zambryski, 1989). 
1.2.3.5 Formation of aT Strand/ Protein Complex. 
During its transit from the bacterial cytoplasm through the bacterial and plant 
membranes and cell walls, the plant cytoplasm and nuclear membrane the T strand 
must withstand degradation by nucleases. This is effected by the formation of a T 
strand/protein complex which both protects and guides the invading genetic material 
(Howard and Citovsky, 1990). 
VirE2 is a sequence aspecific single stranded DNA binding protein (Christie 
et al, 1988, Citovsky et al, 1988, Das, 1988, Gietl et al, 1987), which binds co-
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operatively to render single stranded DNA nuclease resistant (Citovsky et al, 1989, 
Sen et al, 1989). This molecule is the most highly expressed vir inducible product and 
accounts for 0.05% total cell protein (Citovsky et al, 1988), sufficient to totally cover 
and protect the entire T strand (Zambryski, 1992). A further function of VirE2 may 
be to ensure that the linear T strand maintains an unfolded morphology aiding 
transfer (Zambryski, 1992). 
In addition to VirE2, VirD2 is also tightly bound to the T complex. Localised 
at the 5' end of the T strand by possible covalent bonding (Herrera-Estrella et al, 
1988) this protein is thought to provide targeting information guiding the T complex 
to specific bacterial and plant structures (Zambryski, 1992). 
1.2.3.6 Movement of the Complex From the Bacterium Towards the Plant Nucleus. 
This is a multi step process involving the transfer of the T complex through 
the bacterial membranes and cell wall, the plant cell wall and membranes, the plant 
cytoplasm and eventually the plant nuclear envelope. It is clear that the T complex 
itself is insufficient to provide the functions and a number of bacterial and plant 
encoded functions are also required. 
The 11 open reading frames of the virB locus specify trans-bacterial-
membrane and membrane associated proteins thought to create a pore or channel 
structure. This conclusion is based on the presence of membrane targeting leader 
sequences and considerable hydrophobic domains in these proteins. The pore is 
thought to adopt an "I" shape in the membrane with a hollow channel in the 
downward stoke and the crossways strokes lying parallel to and in association with 
the membranes (see figure 1.2.3.6.A). 
As yet little is known about the uptake of the T complex by the plant cell 
though the role of bacterial enzymes in lysing cell wall components has already been 
mentioned. Targeting of the complex towards the nucleus has however been 
investigated in some detail and is most likely to involve specific uptake through 
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nuclear pores (Zambryski, 1992). VirD2, the protein covalently bound at the 5' end 
of the T strand contains a nuclear localisation signal functional in eukaryotic cells. 
This sequence of amino acids is found at the extreme C terminus of the protein and 
shows wide variation between Ti plasmid subgroups (Zambryski, 1992). Nuclear 
pores are thought to be 9-lOnm in diameter (Gerace & Burke, 1988) and 60nm long 
(Reichelt et al, 1990), more than large enough to accommodate the 2nm wide T 
complex (Zambryski, 1992). 
The calculated length of the T complex (3600nm) and its proposed molecular 
weight of 5 * 10 7 Daltons suggest however that the VirD2 nuclear localisation signal 
alone would be insufficient to deliver the complex to the nucleus (Zambryski, 1992). 
The VirE2 single stranded DNA binding protein has also been demonstrated to have 
similar though somewhat weaker targeting properties (Hirooka et al, 1987, Winans et 
al, 1987, Zambryski, 1992). Zambryski (1992) envisages that VirD2 ensures that the 
5' end of the T complex is presented to the pore to aid transport, similar to 
threading a piece of cotton through a needle. Transport through the pore is then 
facilitated by the targeting information of VirE2 and its ability to keep the T strand 
straight. 
1.2.3.7 Integration of Invading DNA into Host Genome. 
In general T DNA integration can occur on any of the hosts plants 
chromosomes (Ambros et a!, 1986, Chyi et a!, 1986) and transcriptionally active 
regions are preferred (Herman et al, 1990, Koncz et a!, 1989), presumably as their 
unravelled structure eases access. In general large rearrangements of the host 
genome are not induced by T DNA insertion, though small deletions of up to 80bp 
are often found at the target. In addition "filler" DNA stretches up to 33bp in length 
are frequently associated with the T DNA/plant chromosome junctions. This filler is 
composed of sequence homologous to plant DNA found close to the junction 
however there is no target sequence preference, other than for AT rich regions 
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(Gheysen et al, 1987, Zambryski, 1988). 5-10 base regions of homology between the 
T DNA ends and plant genetic material may however be influential in insertion 
(Matsumoto et al, 1990, Zambryski, 1992) by promoting homologous recombination, 
an idea supported by the work of Venkateswarlu and Nazar (1991) who used this 
principle to promote T DNA integration in the chloroplastic genome of tobacco 
plants. The inserted T DNA endpoints are usually within the first few bases of the 
left and right 25bp borders (Gheysen et al, 1991, Wang et al, 1987) and the high 
accuracy of 5' end insertion suggests a role for the bound VirD2 protein, perhaps in 
initiating DNA repair (Zambryski, 1992). 
Single insertions ofT DNA per cell are common, but the mean number is 3 
(Zambryski, 1988). Copy numbers as high as 20-50 per cell have been observed 
(Barton et al, 1983). Multiple copies can be found in clusters or separate locations 
(Zambryski, 1989). Although several models have been proposed (Gheysen et al, 
1987) and its similarity to bacterial conjugation and viral infection noted (Stachel 
and Zambryski, 1986b, Zambryski, 1992, Howard and Citovsky, 1990), precise 
details of T DNA insertion into the host genome are unclear. Zambryski (1988, 
1989) and Gheysen et al (1987) however summarise the known facts as follows: 
Having gained access to the plant nucleus, a protein at the 5' of the T complex 
interacts with a nicked sequence in the plant DNA. Following Attachment of the 2 
DNA's at this site, the local torsional strain on the plant DNA is relieved by the 
production of a nick on the other strand opposite to the target site. The T DNA is 
then ligated into the plant chromosome at the insertion site and its homologous 
strand copied by plant encoded enzymes. The staggered nicks in the plant DNA are 
replicated and repaired as a consequence of which, the repeated and filler DNA 
sequences are generated at the ends of the inserted DNA. Occasionally such large 
scale manipulation of the plant genome can cause errors in replication and repair of 
DNA, leading to the observed direct and inverted repeats of the invading material. 
Binns and Thomashow (1988) note the lack of requirement for bacterial enzymes in 
61 
Chapter 1. Introduction. 
catalysing these processes and discount the possibility of a transposition like 
insertion event. 
1.2.3.8 T DNA Expression. 
T DNA encoded genes fall into 2 groups: those concerned with oncogenicity 
and those encoding opine related functions. Genes tmsl (a.k.a. genel, iaaM), tms2 
(gene2, iaaH) and tmr (gene4, ipt) code for the synthesis of auxin and cytokinin, 
potent plant growth regulators, responsible for the uncontrolled over-production of 
crown gall cells leading to a tumour (Binns and Thomashow, 1988). tmsl is 
responsible for the catalysis of the conversion tryptophan to indole-3-acetamide 
(Thomashow et al, 1986, Van Onckelen et al, 1984) whilst tms2 promotes the 
conversion of this to indole-3-acetic acid (Inze et al, 1984, Schroder et al, 1984, 
Thomashow et al, 1984 ), the primary plant auxin (Binns and Thomashow, 1988). tmr 
encodes the production of the cytokinin iso-pentenyladenosine 5' -monophosphate 
from dimethylallyl-pyrophosphate and 5'-AMP (Akiyoshi et al, 1984, Barry et al, 
1984, Buchmann et al, 1985). 
Opine related genes fall into 2 subgroups: those related to opine biosynthesis 
and those concerned with export of the conjugates from the plant cell. On octopine 
plasmids, gene ocs (a.k.a. gene3) encodes octopine synthase, which catalyses the 
condensation of pyruvate and arginine, similarly on nopaline plasmids a gene 
encodes the condensation of arginine and a-ketoglutarate (Kemp, 1982, Tempe and 
Goldman, 1982). ons (gene6a) encodes a protein responsible for transport of 
octopine across the plant membranes, ensuring its availability to rhizosphere 
Agrobacteria (Messens et al, 1985). It should be noted that the octopine plasmid also 
has functions leading to the production of the opines mannopine and agropine and 
that nopaline type plasmids encode enzymes responsible for the catalysis of 
agrocinopine. There are at least 20 opine produced as a result of Agrobacterial 
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action (Ream, 1989). There are also additional transcribed regions of Ti plasmids 
whose functions are unknown (Binns and Thomashow, 1988). 
1.3 The Basis for an Agrobacterial Neuroblastoma Screening Test. 
1.3.1 vir Gene Regulation. 
The induction of pathogenesis related genes is a recurring theme in 
microbiology (Mekalanos, 1992, Winans et al, 1989). The stimulation of a system 
such as that involved in Agrobacterium I plant infection must be a considerable 
metabolic drain. It would clearly be a selective advantage to a cell to express these 
genes only under appropriate circumstances, such as when in proximity of a 
wounded plant cell. Agrobacterium has developed a chemosensory ability that under 
these conditions acts to induce the transfer of genetic material to the host plant cell. 
As already mentioned, the expression of the majority of the vir genes is 
regulated by a the VirA/G protein pair (Stachel and Zambryski, 1986a). Together, 
these proteins are part of a family known as two component regulators (see section 
5.2), capable of sensing and responding to environmental stimuli. virA/G show 
strong homology to this conserved group of proteins (Stachel et al, 1986, Leroux et 
al, 1986). Other members of this family include NtrB/C, PhoR/B and EnvZ/OmpR 
(Albright et al, 1989). 
VirA is a 92KDa transmembrane protein (Winans et al, 1989) and forms the 
sensor part of the 2 component system, VirG is a 30Kda cytoplasmic transcriptional 
regulator (Winans et al, 1986) These proteins are additionally required for the 
mediation of phenolic chemotaxis (Shaw et al, 1988). According to hydropathy 
predictions and molecular biology studies, VirA has 2 trans-cytoplasmic membrane 
regions (Winans et al, 1989) joined by a 221 residue periplasmic convoluted loop 
(Melchers et al, 1989), thought to be involved in pH, temperature and sugar sensing 
(Melchers et al, 1989, Cangelosi et al, 1990). In addition there is 550 residue 
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(Melchers et al, 1989) cytoplasmic domain with carboxy terminal protein kinase 
activity (Winans et al, 1989). Phenolic sensing is thought to be associated with the 
second transmembrane region (Melchers et al, 1989) although more recent evidence 
suggests reasons to doubt this as will be discussed later. The carboxy terminus of 
VirA can be autophosphorylated at histidine residue 474 (Huang at al, 1990, Jin et 
al, 1990b) and when in receipt of a suitable signal can transfer this phosphate to 
aspartate 52 of VirG (Jin et al, 1990a,b). Intramolecular signalling within the VirA 
molecule is thought to be brought about by conformational changes induced by 
ligand binding (Ames and Parkinson, 1988). Phosphorylation of VirG by Vir A 
renders the effector capable of sequence specific DNA binding, recognising the vir-
box (Jin et al, 1990c, Pazour and Das, 1990a, Powell et al, 1989). The vir-box is a 
conserved regulatory element found upstream of vir genes. Binding of 
phosphorylated VirG through its carboxy terminal domain to the vir box (Powell and 
Kado, 1990) induces transcription of the coding region and consequently expression 
of the gene (Winans et al, 1986). In addition VirA interacts through its periplasmic 
domain with the protein ChvE (Cangelosi et al, 1990). ChvE shows strong homology 
to E.coli periplasmic sugar binding proteins (Cangelosi et al1990) and is implicated 
in induction and chemotactic responses to sugars. 
1.3.1.1 vir Inducing Stimuli. 
There are essentially 3 influences which lead to vir gene induction, namely: 
phenolic compounds, sugars and acidic pH. Of these, greatest research emphasis has 
been placed upon phenolic compounds such as acetosyringone. This is perhaps a 
false bias. 
Stachel et al (1985) isolated 2 monocylic aromatic hydrocarbons with vir 
inducing properties from tobacco roots and cells. These phenolics, acetosyringone 
and hydroxyacetosyringone have been the basis of a great deal of fruitful research. 
However, these are only found in a few species of plant and not always in 
64 
Chapter 1. Introduction. 
appreciable quantities (Spencer and Towers, 1989). There are additional compounds 
with vir inducing activity with equal or greater potency (Spencer et al, 1990, Delay 
and Delmotte, 1990, Delmotte et al, 1991, Song et al, 1991b ). By studying 
compounds with similar structures to acetosyringone, Bolton et al (1986), noted the 
structural requirements for efficient vir inducing activity as follows: the presence of 
a substituted aromatic ring, with 1' polar, 4' hydroxyl and 3' methoxyl groups. For 
maximal efficiency a 5' methoxyl residue was also required. This work was 
continued in 1988 by Spencer and Towers who found conditions for induction 
including: guaiacyl or syringyl substitution on a benzene ring, with certain 
exceptions, a carbonyl group on a substituent para to the hydroxyl group. 5' 
hydroxylation was found to decrease effectiveness although aromatic rings could be 
linked to give far more complex inducing structures. 
Cangelosi et al (1990) and Shimoda et al (1990) report that specific 
monosaccharides such as glucose, galactose, fucose and 6-deoxy-D-glucose may play 
a synergistic role in increasing phenolic induction as well as being inducers in their 
own right. There is no requirement for metabolism of the carbohydrate in this 
interaction (Shimoda et al, 1990). All inducing sugars are aldoses and none ketoses. 
Song et al (1991a) discuss one non metabolically active synergistic monosaccharide, 
inositol as relieving some unknown inhibition to phenolic induction. 
The third environmental condition for vir induction is acidic pH. Induction is 
dependent upon acidic pH with an optimum of pH 5.25 and does not occur under 
neutral conditions (Stachel et al, 1986a, Rogowsky et al, 1987). It is striking that the 
three requirements for vir gene induction are met by the conditions to be found in a 
plant wound site. As already mentioned, phenolics will be present as they are 
produced as an inducible defense response by the plant and are lignin precursors and 
breakdown products and so likely to be found at sites of cell wall growth and repair. 
Furthermore monosaccharides will be common components of plant cytoplasm and 
sap, likely to be lost when damage occurs on a cellular or macroscopic scale. Wound 
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pH is likely to be acidic due to lysis of damaged vacuoles which are generally acidic 
and spillage of sap, also of lower than neutral pH (Winans, 1991). 
1.3.2 Agrobacterium and Catecholamine Metabolites. 
Comparison of the 'ball and stick' (figures 1.3.2.A) molecular models for AS, 
ASOH, HV A and VMA shows distinct structural similarities between the 
catecholamine metabolites taken as diagnostic of neuroblastoma and the potent vir 
gene inducer. These models and the 3 dimensional space filling models (figures 
1.3.2.B) were generated by the procedure described in section 2.19. 
Furthermore the catecholamine metabolites HV A and VMA fulfil many of 
the structural requirements (Bolton et al, 1986, Spencer and Towers, 1988) for 
interaction with the Agrobacterium 2 component regulatory system. HV A and VMA 
are both substituted phenolic compounds. A polar group is found in ortho position to 
the 4' hydroxyl group. Both compounds have 3' methoxyl groups, and although they 
lack similar functional substitution at the 5' position, neither is hydroxylated at this 
site. HV A and VMA were thus thought to be candidate vir inducers and 
chemoattractants. Based upon this premise, this project aimed to research the 
feasibility and nature of a possible neuroblastoma screening test based upon the 
responses of the bacterium Agrobacterium tumefaciens to the catecholamine 
metabolites, HV A and VMA which are taken as diagnostic of the disease when 
found at elevated levels in a patients urine. 
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2. Materials and Methods. 
2.1 Materials. 
Except for the following, all chemicals and biological reagents were 
purchased from Sigma Chemical Company Ltd or BDH Ltd: 
Restriction endonucleases, DNA modifying enzymes, X-gal and IPTG were from 
Northumbria Biologicals Ltd and Boehringer Mannheim. 
Agarose and low melting point agarose were from Bethesda Research Laboratories 
(UK) Ltd. 
Bacteriological agar and yeast extract were from Oxoid Ltd. 
Typticase peptone was from Becton Dickinson Microbiology Systems, Cockeysville, 
USA. 
Sodium chloride was from Reidel de Haen. 
The digoxigenin DNA labelling and detection kit was from Boehringer Mannheim. 
The FLASH chemiluminescent DNA labelling and detection kit and accompanying 
membranes were from Stratagene. 
Electroporation cuvettes and Bradford Reagent were from Bio-Rad Laboratories, 
Herts, UK. 
LAB M nutrient broth, nutrient agar and nitrocellulose filters were from Amersham 
International plc. 
Qiagen columns were from Diagen. 
Petri dishes and Nuclepore polycarbonate membranes and blood dilution vials were 
from Sterilin. 
The Coulter Multisizer II and Isoton II were from Coulter Electronics Ltd. 
Microtitre plates were from Falcon or Nunc. 
Phage plates were from Nunc. 
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2.2 Bacterial Strains. 
The strains of bacteria used in this study are described in the following tables: 
2.2.1 Escherichia coli. 
Strain Characteristics 
BM2KNaiR. 
C2110 polA, rha, his, NaiR. 
DH5a F_, endA1, hsdR17,supE44, 
thi-1, recA1, gyrA96, relA1, 
•( lacZYA-argF ), U169,<1>80, 
dlacZ•M15. 
HB101 p-, hsdS20(r-,m-), recA113, 
proA2, leu-6, thi-1, rps L20, (StrR ), 
arl-14, gal K2, lac Y1, xyl-5, 
mtll-1, sup E44. 
W3110 thy, p-, thy A36, lambda-
Nal, nalidixic acid; Str, streptomycin, R resistant. 
BRL, Bethesda Research Laboratories. 
2.2.2 Agrobacterium tumefaciens. 
Strain Characteristics 
A348 W.t. strain pTiA6NC Ti-plasmid 
C58 W.t. strain pAtC58 Ti-plasmid 
C58C1Rif RifR, Ti-plasmid cured. 
C58ClEryCm EryR, CmR, Ti-plasmid cured. 
GMI9023 RifR, StrpR, Ti-plasmid cured. 
A1030 KmR, virA::Tn5, pAtC58 Ti-plasmid 
Reference. 
(Prince & Borlam, 
1985). 
(BRL). 
(BRL). 
(Bachmann, 1972). 
Reference. 
(Stachel et al, 
1986). 
(van Larebeke 
et al, 1974 ). 
(van Larebeke 
et al, 1974 ). 
(van Larebeke 
et al, 1974 ). 
(Rosenberg et al, 
1984). 
(Garfinkel & 
Nester, 1980). 
Cm, chloramphenicol; Ery, erythromycin; Km, kanamycin; Rif, rifampicin; Str, 
streptomycin, R resistant. 
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2.3 Plasmids. 
Materials and Methods. 
The plasmids used in this study are described in the following tables: 
Plasmid Characteristics Reference. 
pVK 219 KmR, virAB, Inc P (Knauf & Nester, 
1982). 
pVK225 KmR, virGCDE, Inc P (Knauf & Nester, 
1982). 
pVK257 KmR, virABGC, Inc P (Knauf & Nester, 
1982). 
pSG687 KmR, SpR, virGD52N, Inc W (Jin et al, 1990a). 
pSG689 KmR, SpR, virG, Inc W (Jin et al, 1990a). 
pTB108 CbR, TcR, vir A, Inc W (Jin et al, 1990b). 
pRS0824 CbR, TcR, virAH474Q, Inc W (Jinetal, 1990b). 
piB50 KmR, virB::lacZ, virE::cat, IncP (Ankenbauer et al, 
1991). 
piBlOO CbR, virA,G, Inc W (Ankenbauer et al, 
1991). 
piB415 CbR, TcR, virA•63/240, virB::lacZ, IncP (Cangelosi et al, 
1990). 
V21 virB promotor in pUCD derivative (Lilley). 
piJ3100 StrpR, InQ, promotorless cat (Osbourn et al, 
1987). 
pRN3 SpR, StrpR, SuR, TcR, HgR, 
Co-integrate forming. 
pRK2013 KmR, Helper plasmid (An et al, 1985). 
pSM30 KmR, CbR, virB::lacZ (Stachel et al, 
1986). 
pDUB1003•31 NmR, GmR, Nopaline Ti-plasmid Shaw et al, 1984 
pUCD1187 KmR, virB::lux, oripSa, oripBR322 (Rogowsky 
1987). 
et al, 
pUCD1194 KmR, virE::lux, oripSa, oripBR322 (Rogowsky et al, 
1987). 
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Plasmid Characteristics Reference. 
RPI-85 AmpR, TcR, HgR, IncP (Stanisich & 
Bennett, 1976). 
211MxCb CbR, vir A Tn3HoHo Insert Stachel et al, 1985 
226MxCb CbR, vir A Tn3HoHo Insert Stachel et al, 1985 
19MxCb CbR, virG Tn3HoHo Insert Stachel et al, 1985 
Amp, ampicillin; Cb, carbenicillin; Gm, gentamycin; Hg; mercury ion; Km, 
kanamycin; Nm:R neomycin; Sp, spectinomycin; Strp, streptomycin; Su, succinic acid; 
Tc, tetracyclin; resistant. 
The generous gift of numerous plasmids from Professor E.W.Nester is gratefully 
acknowledged. Similarly C.J.Lilley is thanked for the donation of V21. The donation 
of p1J3100 was also much appreciated. 
2.4 Methods. 
Sterile reagents and aseptic technique were employed as appropriaate. 
2.5 Media and Growth Conditions. 
Liquid cultures of bacteria were routinely grown in Luria-Bertani medium, L-
broth (Sambrook et al, 1989) or Lab M nutrient broth number 2. Liquid cultures 
were agitated during growth unless otherwise stated. Solid media consisted of L-agar 
(Sambrook et al, 1989) or Lab M nutrient agar unless alternately indicated. Culture 
density and growth phase were estimated where necessary by determining 
O.D.600nm using a Phillips PU8700 Series UV /Visible Spectrophotometer, 108 
cells/ml giving a reading of approximately 1. For long term preservation strains were 
stored at -80 a C in sterile 40% glcerol. 
L-broth. Tryptone lOg/L L-agar. As L-broth but 
Yeast Extract 5g/L including lOg agar 
NaCl 5g/L 
LabMBroth. Lab M broth 25g/L 
Lab MAgar. Lab Magar 28g/L 
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Swarm plates (for selection of motile bacteria) consisted of L-broth, 
supplemented with 0.17% agar. 
The media were autoclaved after mixing. 
Agrobacterium tumefaciens was grown at 27 C, Escherichia coli at 37 C. 
Minimal Media (Min A) consisted of : 1 OOml 5 *Min A salts 
(Miller, 1972) 0.5 mllM MgS04 
ddH2o to 500ml 
Min A + glucose consisted of Min A supplemented with lOml/L 20% glucose 
(Miller, 1972). 
5*Min A salts: 52.5g~P04 (Miller, 1972) 22.5g }£P04 
l.Og (N 4hS04 
2.5g Na Citrate 
ddH20 to 11 
Media were prepared by adding sterile constituents to autoclaved water. 
YEP (Ebert et al, 1987). Yeast Extract 
Peptone 
NaCl 
to 11 
Media was adjusted to pH 4.5 and autoclaved after mixing. 
Lactose Agar (for the Agrobacterium plate test) : 
(Bernaerts & De Ley, 1963). 
Extract 
lOg 
lg 
Lactose 
Yeast 
20g Agar 
ddH2o to 11. 
Media was autoclaved after mixing. 
M9 Media. (Miller, 1972). 
Autoclaved prior to the addition of: 
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lOg 
768ml 
200ml 
2ml 
lOO,ul 
20ml 
Agar 
ddH20 
5*M9 salts 
1M MgS04 
lMCaCl 
lmg/ ml ttuamine 
Chapter 2. 
5*M9 salts. (Miller, 1972). 
Induction Media. 
Materials and Methods. 
30g 
15g 
2.5g 
5g 
ddH20 
~~zHP04 
KH2P04 Nacl 
NHfCl 
to 1 
(Rogowsky et al, 1987): Murashige Minimal Organics Media, 12.5mM 
potassium phosphate, antibiotics as appropriate. 
(Vernade et al, 1988): Dissolve 12.5g sorbitol and 2.5g sucrose in 400ml ddH2o. Autoclave. Add 100ml5*salts. pH to 5.6. 
(Winans et al, 1988): 1 * AB salts, 2.5mM phosphate, 3% sucrose, 20mM Mes. 
5*Salts (Vernade eta/, 1988). 2.5g (NH4)z S04 
1.25g sodium citrate 
2.5g KN03 
4.4g KH2Po4 0.8g Mes 
Dissolve in ddH20, add 6ml 10% MgS04, 2.5mll% thiamine, make up to 500m1, 
pH to 5.45. 
AB Salts (PNAS, 71, 3672-3676). 
Octo pine Assay Plates (to confirm presence 
of Ti-plasmid in Agrobacterium 
tumefaciens ). 
3g/l 
lg/1 
lg/1 
0.3g/l 
0.15g/l 
O.Olg/1 
2.5mg/l 
0.5% 
K_2HP04S 
NaHzP04 
NH4Cl 
MgS04.7H20 KCl 
CaC12 
FeSG4.7H20 glucose 
760ml 2% Agar 
200ml 5*NO,O Salts 
2.8ml 1M MgSO~ 
4ml 22mM Ca l2 
lOml 20% Glucose 
20ml 5mg/ml Octopine 
Components autoclaved separately and mixed when cool. 
5*NO.O Salts (Miller, 1972). ~P04 51.3g 
CP04 61.75g Na 1 0.75g 
ddH20 to 11 
Adjusted to pH7.5 with lON NaOH and autoclaved. 
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2.5.1 Antibiotics. 
When antibiotic selection was required, stock solutions were prepared, filter 
sterilized and the appropriate volume added to cooled media as detailed in the 
following table (Leemans et al, 1981, Sambrook et al, 1989): 
Antibiotic [Stock] (mg/ml) Solvent [Final] (,ug/ml) 
Ampicillin 25 HzO 50 
Carbenicillin 50 HzO 100 
Chloramphenicol 12.5 EtOH 50(A.t.)/25(E.c.)* 
Erythromycin 50 EtOH 100 
Gentamycin 12.5 HzO 100(A.t.)/25(E.c.)"' 
Kanamycin 12.5 HzO 25(A.t.)/50(E.c.)* 
Neomycin 25 HzO 100 
Rifampicin 50 DMSO 100 
Spectinomycin 50 H2o 100(A. t. )/50(E.c.)"' 
Streptomycin 20 HzO 300( A. t.) I 50(E.c. )"' 
Tetracyclin 12.5 EtOH/HzO 10(A.t. )/15(E.c. )* 
1:1 
* When two figures are shown different final concentration were used for 
Agrobacterium tumefaciens (A.t.) and Escherichia coli (E.c.) 
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2.6 Isolation of DNA. 
2.6.1 Plasmid Mini-Prep. 
Small amounts of plasmid DNA were routinely prepared by the following method, 
essentially as described by Sam brook et al, 1989. 
Solution 1: Sterile 1% Glucose, 10mM EDTA, 25mM Tris-HCL, pH 8.0. 
Solution 2: 0.2N NaOH, 1% SDS. 
Solution 3: Sterile 11.5ml Glacial acetic acid, 28.5ml ddH20, 60ml 5M Potassium 
acetate, pH 4.8. 
TE Buffer: Sterile 10mM Tris-HCL, 1mM EDTA, pH 8.0. 
Phenol/ Chloroform: 25 volumes twice TE saturated phenol, 24 volumes 
chloroform, 1 volume iso-amyl alchohol. 
DNAse Free Pancreatic RNase: Pancreatic RNase was dissolved to a 
concentration of 10mg/ml in lOmM Tris-HCl, pH7.5, 15mM NaCl and boiled for 
15 minutes in a water bath. The mixture was then allowed to cool slowly before 
use. 
A single colony was grown overnight in 5ml L-broth with appropriate 
antibiotic selection. 1.5ml of culture were transferred to a sterile Eppendorf tube 
and spun for 1 minute in an MSE Microcentaur microfuge. The supernatant was 
removed and the pellet lightly dried. The cells were resuspended in lOO.ul ice cold 
solution 1 using a Fisons vortex mixer. The contents of the tube were left to stand for 
5 minutes at RTP. 200.ul of freshly prepared solution 2 were added and mixed in by 
repeated inversion. The bacterial suspension was cooled on ice for 5 minutes to 
allow cell lysis, before the addition of 150.ul solution 3. After vortexing the mixture 
was kept on ice for 5 minutes and then centrifuged for 5 minutes to remove cellular 
debris. 400.ul of the resulting supernatant were transferred to a fresh Eppendorf and 
an equal volume of phenol/ chloroform added. The contents of the tube were 
vortexed before centrifugation at 12000rpm for 2 minutes in an MSE Microcentaur. 
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The aqueous phase of the preparation was transferred to a fresh tube and mixed 
with 2 volumes of 100% ethanol at room temperature. After vortexing the tube was 
incubated at RTP for 2 minutes before centrifugation for 5 minutes to pellet plasmid 
DNA. The supernatant was poured off and contaminating salt dissolved away by the 
addition of 1ml 70% ethanol. A further 2 minutes centrifugation in an MSE 
Microcentaur were followed by removal of the ethanol and the DNA dried under 
vacuum. The preparation was taken up in 50,ul TE supplemented with RNase to a 
final concentration of 20,ug/ml. 
2.6.2 Plasmid Midi-Prep (Alkaline Lysis/Glass Fines Method). 
Nal solution: 90.8g Nal and 2.0g Na2S03 were dissolved in 100ml ddH20 and 
autoclaved. 
This method was used when more DNA was required. A 5ml culture was 
grown overnight with appropriate plasmid selection. 1ml of this was used to 
inoculate 50ml of fresh L-broth supplemented with antibiotic for growth overnight. 
Cells were harvested by spinning for 10 minutes at 4000g in an MSE 18 High Speed 
centrifuge. The supernatant was discarded and the bacterial pellet drained. Cells 
were resuspended by pipetting in 3.0ml ice cold solution 1. After 10 minutes 
incubation at RTP, 6.0ml fresh solution 2 were mixed in by inversion. Cell lysis was 
visually confirmed by the increased viscosity of the preparation after 10 minutes 
incubation on ice. 4.5ml of solution 3 were added and vortexed in before chilling the 
preparation for 15 minutes on ice. The supernatant resulting from centrifugation at 
7000g, 4 o C for 15 minutes was removed to a fresh tube and 5.0ml phenol chloroform 
mixed in. The mixture was spun at 6000g, 4 o C for 15 minutes and the resulting 
aqueous phase pipetted to a fresh tube. Two volumes of isopropanol were vortexed 
in and the contents of the tube left for 5 minutes at RTP. DNA was pelleted by 
centrifugation at 6000g for 10 minutes, the resulting supernatant being discarded. 
The DNA pellet was resuspended in 200,ul TE and transferred to an Eppendorf tube 
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containing l.Oml Nal solution. 30.ul of silica fines suspended in TE were mixed in 
and the tube left for 10 minutes at RTP. The fines were pelleted by centrifugation in 
an MSE Microcentaur, washed by resuspension in 1ml 70% ethanol, pelleted again 
and taken up in 100.ul TE. After incubation at 37° C for 10 minutes the mixture was 
centrifuged in an MSE Microcentaur for 15 seconds and the DNA recovered in the 
supernatant. For higher yields the 37° C incubation and subsequent steps were 
repeated. 
2.6.3 Plasmid Maxi-Prep (Caesium chloride/Ethidium bromide Method). 
STE: sterile 0.1M NaCl, 10mM Tris-HCl, 1mM EDTA (Sambrook et al, 1989). 
This method yeilds high amounts ( > 1mg) of high purity DNA. A 5ml 
overnight culture grown with appropriate selection was used to inoculate 500ml 
liquid media supplemented with antibiotics. Cells grown overnight were harvested 
by centrifugation at 4000g for 10 minutes in an MSE 18. The bacterial pellet was 
washed in 20ml STE and spun at 4000g, 4 o C for 10 minutes. Cells were resuspended 
by pipetting in 10ml solution 1 supplemented with lysozyme to a final concentration 
of 5mg/ml. The mixture was split into 2 fresh Oakridge tubes before incubation at 
RTP for 10 minutes. 20ml of solution 2 were added and the tubes allowed to stand 
for a further 20 minutes. 15ml of solution 3 were shaken in and the tubes chilled on 
ice for 10 minutes. After a 55000g, 4 o C spin for 20 minutes in a Du Pont Instruments 
Sorvall RC5B Refrigerated Superspeed Centrifuge, the supernatant was transferred 
by pipette to 30ml Corex tubes and 0.6 volumes of isopropanol added. The contents 
of the tubes were mixed and allowed to stand at RTP for 15 minutes. The DNA was 
recovered as a pellet after a 30 minute, 20000g spin. Phenol chloroform extraction 
(see section 2.9.1) was performed until the solution cleared. The mixture was 
centrifuged at 15000g, 4 o C for 10 minutes and the DNA ethanol precipitated 
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(section 2.9.2). A 70% ethanol wash was followed by centrifugation and vacuum 
drying. 
The DNA was combined and taken up in 4ml sterile ddH20 in a Universal 
tube. 4g high purity CsCl were dissolved in the DNA solution and 5ml of the 
resulting mixture transferred to a fresh Universal. 400.ul of lOmg/ml ethidium 
bromide solution were added and the mixture transferred to a 5ml Beckman Quick 
Seal tube using a needle and syringe. The tube was balanced and heat sealed before 
centrifugation overnight at 250000g, 15 o C in a DuPont Instruments Sorvall OTD 
65B Ultracentrifuge, equipped with a VTi50 rotor. 
The following morning, the tube was carefully removed from the rotor and 
viewed under UV light. Two fluorescent bands of DNA corresponding to open 
circular plasmid and contaminating chromosomal DNA (upper band) and 
supercoiled plasmid (lower band) were seen. A hole was made in the top of the tube 
to allow entry of air, and the lower band collected in a syringe with a wide bore 
needle passing through the wall of the vessel. The DNA was transferred to an 
Eppendorf tube and 1 volume of butan-2-ol saturated in sterile ddH20 and CsCl 
added. After mixing the top layer was removed, and the procedure repeated until no 
ethidium bromide remained. 300.ul aliquots of the DNA solution were placed in 
Eppendorfs and 600.ul sterile 0.45M sodium acetate plus 540.ul isopropanol added. 
The mixture was stored at -20 o C for 1 hour and subsequently centrifuged for 5 
minutes in an MSE Microcentaur. The DNA was 70% ethanol washed, pelleted, 
vacuum dried and resuspended in TE. 
2.6.4 Isolation of Plasmid DNA By Anion Exchange Chromatography. 
In the later stages of research the use of Qiagen columns replaced the above 
midi and maxi prep protocols as the method of choice due to increased speed and 
facility. 
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Buffer Pl: 100,ug/ml lyophilized RNase A, 50mM Tris-HCl, 100mM EDTA, 
pH8.0 
I Buffer P2: 200mM NaOH, 1% SDS. 
I Buffer P3: 2.55M KAc, pH 4.8 
Buffer QBT: 750mM NaCI, 50mM MOPS, 15% EtOH, 0.15% Triton X-100, 
pH7.0 
Buffer QC: l.OM NaCl, 50mM MOPS, 15% EtOH, pH 7.0 
Buffer QF: 1.25M NaCl, 50mM MOPS, 15% EtOH, pH 7.0 
The protocols for the two scales of preparation are essentially the same. The 
figures in the text refer to the midi size prep (100ml culture, 100,ug average yield), 
with maxi prep (500ml culture, 500,ug average yeild) variations being shown in 
brackets. 
lOOml (500ml) of L-broth with appropriate selection were inoculated from a 
5ml stationary phase culture and the cells grown overnight. Bacteria were harvested 
by centrifugation at 4000g for 10 minutes in a MSE 18. The pellet was resuspended 
in 4ml (10ml) buffer Pl. One volume of buffer P2 was gently mixed in and the tube 
incubated at room temperature for 5 minutes to allow cell lysis. Following addition 
of 4ml (10ml) buffer P3 the mixture was vortexed and spun at 15000g, 4aC for 30 
minutes. The resultant supernatant was removed and subjected to an identical 
second spin. A Qiagen tip-100 (tip-500) was equilibrated by passing 3ml (10ml) 
buffer QBT down it. The supernatant from the spin was passed down the column to 
allow plasmid DNA to bind to the anion exchange resin. Contaminating, protein, 
RNA and chromosomal DNA were washed away with 10ml (30ml) buffer QC. The 
plasmid DNA was eluted at high salt concentration by the addition of buffer QF, (5 
or 15ml as appropriate). 0.7 volumes of isopropanol at RT were added to precipitate 
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the DNA which was recovered by centrifugation at 15000g for 30 minutes. The 
sample was washed with 70% ethanol, air dried and resuspended in TE. 
2.7 Introduction of DNA into Agrobacterium tumefaciens. 
2. 7.1 Conjugation. 
2.7.1.1 Triparental Mating (Ditta et al, 1980). 
This method allows mobilization of a plasmid from E.coli to Agrobacterium, I Q 
through conjugal pili formed by the helper strain HB101 (pRK 2013). Plasmid 
transfer is independent. Drawbacks include low efficiency and length of time taken 
to complete the protocol. 
5ml cultures of the helper, donor and recipient strains were grown to late log 
phase with antibiotic selection. The strains were then mixed in the ratio of 8 parts 
recipient, 1 part helper, 1 part donor and allowed to stand for 30 minutes. The 
bacteria were then incubated at 28 o C overnight on a 13mm nitrocellulose disc which 
had been placed on a non selective L-agar plate. The bacteria were harvested from 
the filter in lOmllOmM MgS04, pelleted in an MSE 18 centrifuge and resuspended 
in lOO.ul L-broth and before plating out on appropriate selection to allow growth of 
transconjugants. Donor, helper and recipient strains were plated out on the same 
selection as controls. Plasmid transfer was confirmed by restriction analysis of 
plasmid DNA. 
2.7.1.2 Two Step Mating. 
STAGE 1. 
5ml cultures of BM2KNaiR(pRN3) and the E.coli donor strain were grown 
overnight without antibiotics. The 2 cultures were mixed and 0.1ml of the mixture 
spread on an L-agar plate. As a control O.lml of donor and recipient strains were 
also plated out. The plates were incubated at 37° C for 4 hours. The cells were 
scraped off from the surface of the agar in 3ml w-2M MgS04. RN3 transconjugants 
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were selected by plating out w-4, w-5 and w-6 fold dilutions on appropriate 
selection. Controls were plated out on selection for transconjugants at 1 and w-1 
fold dilutions to ensure they did not grow. A few transconjugant colonies were 
checked for growth on unselected markers. 
STAGE2. 
Overnight cultures of the final recipient strain and the recombinant strain 
were grown without antibiotics. The cultures were mixed in a 3:1 ratio as above and 
0.1ml aliquots spread on to L-agar to be grown overnight at 28°C. 0.1ml aliquots of 
donor and recipient were also incubated under the same conditions. The cells were 
recovered in 3ml MgS04 as in stage 1 and plated out on appropriate selection to 
allow growth of recombinants. Control plates of donor and recipient cells on the 
selection for recombinants were also set up. Putative recombinants were screened on 
secondary selection and plasmid DNA extracted for analysis. 
2.7.1.3 Plate-Mate Conjugation. 
This simple method allowed the transfer of plasmids between competent 
E.coli strains and Agrobacterium, in addition it was used to transfer plasmids 
between E.coli strains. 5ml cultures of the donor and recipient strains were grown 
overnight. lOO,ul of each were mixed in a pool on a non selective L-agar plates and 
allowed to grow overnight (28 o C, E.coli/ Agrobacterium, 37° C E. coli/ E. coli). 
Loopfulls of transconjugants were harvested and streaked out on selection. As 
controls, the inability of donor and recipient to grow on the selection were 
confirmed. Plasmid content was confirmed by restriction analysis. 
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2. 7.2 Transformation. 
2.7.2.1 Freeze Thaw (Hofgen & Willmitzer, 1988). 
An overnight culture of Agrobacterium tumefaciens was diluted in 200ml L-
broth and grown until mid log. phase. Cells were harvested by spinning at 4000g for 
10 minutes in an MSE 18 centrifuge at 4 o C. The pellet was washed in lOml 
precooled TE buffer and resuspended in 10ml L-broth. 0.5ml aliquots were rapidly 
frozen in liquid nitrogen and stored in Eppendorfs at -70 o C until required. 
Stored cells were thawed on ice prior to transformation. Five hundred to 
lOOOng of DNA in TE buffer were added. Cells were incubated on ice for 5 minutes, 
in liquid nitrogen for 5 minutes and at 37° C for 5 minutes. This was repeated. After 
dilution with 1ml L-broth, cells were shaken at 28 o C for several hours before being 
plated on appropriate selection and incubated at 28 o C for 2 days. Single colonies 
were chosen for plasmid content analysis. Non transformed cells were grown on 
plasmid selection as a control. 
2. 7 .2.2 Electroporation. 
2.7.2.2.1 After Mattanovich et al (1989 ). 
A 300ml L-broth culture with antibiotic selection was inoculated and grown 
to an O.D.600nm of 0.5. Bacteria were chilled on ice and spun down at 4000g, 4 o C 
for 10 minutes in an MSE 18 High Speed Centrifuge. The cells were resuspended in 
10ml 1mM HEPES, pH7.0. Two further HEPES washes were followed by a lOml 
10% glycerol and 3ml 10% glycerol wash. 200,ul aliquots of cells were rapidly frozen 
in liquid nitrogen and stored at -80 o C until required. 
Prior to transformation, cells were thawed on ice and mixed with 200ng 
plasmid DNA. 40,ul of material were placed in a 0.2cm electrode gap electroporation 
cuvette and subjected to a 2.5KV pulse dissipated through 25,uF of capacitance 
using a Biorad Gene Pulser. Cells were immediately diluted with 1ml L-broth and 
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shaken for one hour at 28oC. Transformants and suitable controls were plated out 
on selective L-agar and plasmid presence verified by restriction analysis. 
2.7.2.2.2 After Nagel et al (1990). 
This protocol had the highest efficiency and greatest ease of use of the 
published Agrobacterium transformation protocols employed. 
250ml of cells were grown with plasmid selection to an absorbance of 0.5-1.0 
at 600 nanometres. Cells were harvested by centrifugation in an MSE 18 at 4000g for 
10 minutes and resuspended in 250ml ice cold 1mM HEPES/KOH buffer, pH7.0. 
Cells were sequentially pelleted at 4 a C and resupended in 125ml HEPES buffer, 
100ml 10% glycerol and 750.ul 10% glycerol, all solutions being ice cold. lOO.ul 
aliquots of competent cells were frozen in liquid nitrogen and stored at -80°C. 
Electroporation was conducted by mixing 40.ul of cells with 1.ul miniprep 
DNA dissolved in TE. The mixture was transferred to a 2mm electrode gap Biorad 
cuvette and exposed to a 12.5KV I em electrical pulse at 200 Q and 25 .uF in Gene 
Pulser apparatus. Transformed cells were grown in L-Broth for several generations 
to allow expression of anti-biotic resistance genes and plated out on selection. 
Plasmid content was demonstrated by restriction pattern analysis and control 
selective plates were inoculated with un-transformed cells. 
2. 7.2.2.3 After Wen- jun & For de (1989). 
lOOml agrobacterial cultures were grown to an O.D.600nm of 0.6. Cells were 
cooled on ice, pelleted in an MSE 18 centrifuge at 4000g, 4 o C for 10 minutes and 
resuspended in 1 volume ice cold 10% glycerol. Further washes followed, using 0.5, 
0.02 and 0.02 culture volumes of cold 10% glycerol. Competent cell storage was as 
above. 
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Electroporation conditions were 12.5KV /em, 600Q, 25,uF, 0.2cm cuvette. 
Cells were grown for several hours in L-broth before plating out on selection. 
Appropriate control were performed and transformation success confirmed. 
2.7.2.2.4 After Wirth et al (1989 ). 
Transformation buffer: sterile 300mM Sucrose, 7mM sodium phosphate, 1mM 
MgS04, pH 7.4. 
Bacteria were grown in liquid media with selection to an O.D.600nm of 0.3. 
Pelleting in an MSE 18, 4000g for 10 minutes was followed by washing in 1 volume 
transformation buffer. Cells were resuspended to 109 c.f.u. per mi. in transformation 
buffer and mixed with 200ng DNA per ml. After 30 minutes on ice 800,ul of mixture 
were transferred to a cooled 0.4cm electroporation cuvette and subjected to a 2.5KV 
pulse using 25,uF capacitance. The cells were kept on ice for 20 minutes and then 
allowed to grow for several generations before exposure to selection on solid plates. 
Plasmid presence was verified in putative transformants. Untreated host was 
verified as unable to survive plasmid selection. 
2.8 Transformation of Escherichia coli. 
2.8.1 Rubidium Chloride Method (Kushner). 
A 10ml culture of E.coli was grown to an O.D.680nm of 0.4-0.5. 1.4ml of 
culture were transferred to an Eppendorf tube and cells pelleted for 30 seconds in a 
MSE Microcentaur. The supernatant was discarded and the cells gently resuspended 
in 0.5ml fresh 10mM MOPS, 10mM RbCl, pH 7.0. The cells were pelleted for 15 
seconds as before and resuspended in 0.5ml lOOmM MOPS, lOmM RbCl, 50mM 
CaCl2, pH 6.5. After standing on ice for 90 minutes, the cells were centrifuged for 10 
seconds in an MSE Microcentaur and resuspended in 150,ul lOOmM MOPS, 10mM 
RbCl, 50mM CaCl2, pH 6.5. 3,ul of DMSO were added followed by 1-250ng DNA in 
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TE buffer. The mixture was held on ice for 1 hour. The contents of the tube were 
mixed and then heat shocked at 55°C for 30 seconds in a waterbath before being 
transferred to an ice bucket for 1 minute. 1ml of prewarmed L-broth was added and 
mixed in by inversion. The cells were incubated at 37° C for one hour without 
antibiotics. The suspension was mixed and the cells plated out on appropriate 
selection. Control reactions without DNA added were also set up. The plates were 
incubated at 37° C overnight. 
2.8.2 Electroporation after Wirth et al, 1989. 
As for Agrobacterium, see section 2.7.2.2.4. 
2.9 DNA Manipulations. 
All essentially as described by Sambrook et al, 1989. 
2.9.1 Phenol/Chloroform Extraction. 
Protein was removed from DNA samples due to differential solubility in 
organic solvent. DNA solutions were mixed with an equal volume of TE saturated 
redistilled phenol. The phases were mixed by vortexing and then reseparated by 
centrifugation for 3 minutes in an MSE Microcentaur. The upper aqueous layer was 
removed and the DNA similarly extracted with an equal volume of TE saturated 
phenol:chloroform:iso-amyl alcohol (25:24:1). 
2.9.2 Ethanol Precipitation. 
DNA was recovered from aqueous solution with high efficiency by 
precipitation in alcohol. One tenth volume of 3M sodium acetate, pH4.8 and 2 
volumes of ethanol were added to the DNA solution. The sample was vortexed and 
allowed to stand for a few minutes before chilling at -80 o C for at least 45 minutes. 
Centrifugation at greater than 12000g for 10 minutes yielded a DNA pellet. Salt was 
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removed from the sample due to its higher water solubility during a 70% ethanol 
wash. Mter 5 further minutes of centrifugation the DNA was dried under vacuum 
and resuspended in a suitable volume of TE. 
2.9.3 Restriction Digests. 
TBE: per litre: 121.1g Tris-HCl, 51.33g boric acid, 3,72g EDTA. 
6*Stop Dye: 0.25% w/v Bromophenol blue, 0.25% w/v xylene cynol, 40% 
sucrose, 1 * TBE. 
500ng of plasmid DNA were typically digested with 5 units of the desired 
restriction enzyme. The reaction was buffered with the recommended concentration 
of restriction enzyme buffer (as supplied with the endonuclease). Sufficient sterile 
distiled water to make the reaction volume up to 10~tl was added, the reaction mixed 
and incubated at the optimum temperature (usually 37°C) for 1-2 hours. Digestion 
was stopped by the addition of 0.2 volumes of stop dye. 
2.9.4 Agarose Gel Electrophoresis. 
2.9.4.1 Lambda-Pstl Size Markers. 
50~tg of phage lambda DNA were digested for 4 hours using 100 units of Pst I 
in 1ml of 1 *Pst I restriction buffer (as supplied with the enzyme). This yielded 
fragments of the following sizes (Kb): 
14, 11, 5(triple), 2.8, 2.5(double), 2.19, 1.99, 1.7, 1.16, 1.09, 0.8, 0.52, 0.47, 0.45, 0.34. 
50*TAE: per litre: 242g Tris, 57.1ml glacial acetic acid, 0.05M EDTA, pH8.0 
Unless otherwise stated 0.7% agarose gels were used, providing efficient 
separation of DNA between 0.8- 10 Kb. 
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2.9.4.2 Mini-Gels. 
Materials and Methods. 
Mini-gels were used for routine checks of plasmid presence in strains and for 
estimating DNA concentration. 500ml of 1 * TBE were prepared and supplemented 
with 10 ,ul 10mgmt 1 ethidium bromide. 40ml of agarose solution in 1 *TBE were 
made up for a small mini-gel, 70ml for a large one. The suspension was placed in an 
Electrolux Mealmaker microwave oven at power setting 9 for 2 minutes. The 
agarose solution was cooled and poured into a Pharmacia GNA 100 minigel former, 
air bubbles were removed and a comb placed in the gel before it was allowed to set. 
The gel and the former were placed in the electrophoresis tank and covered with 1 * 
TBE buffer. Samples were loaded into the gel wells. Phage lambda Pst I digest was 
run as a size marker. A p.d. (30-100V, 50-100 rnA) was applied along the length of 
the gel to allow adequate fragment separation. The gel was examined under a U.V.P. 
Incorporated U.V. transilluminator and photographed through a red filter with a 
Polaroid RP4 Land camera using Polaroid 667 Professional film. 
2.9.4.3 Maxi-Gels. 
Maxi-gels were run when a high quality record was required, when fragment 
isolation was being performed or when a large volume of solution was being 
electrophoresed. 
A glass plate was cleaned with ethanol and allowed to dry. A gel former was 
sealed to the glass using Dow Corning High Vacuum Grease, and a suitable comb 
placed in position. Sufficient molten agarose solution in 1 *TBE (with ethidium 
bromide added as above) to fill the mold was prepared. The solution was allowed to 
cool after being microwaved and then poured into the former. Air bubbles were 
removed, and once the gel had set it was placed in an electrophoresis tank. One 
times TBE containing 10,ul 10mg/ml ethidium bromide was placed in the tank, 
covering the gel. The comb was removed and the samples loaded. Size markers were 
run alongside the samples. Fragments were separated and photographed as above. 
88 
Chapter 2. Materials and Methods. 
2.9.5 Fragment Isolation. 
This method allows the purification of a DNA fragment suitable for cloning 
into a vector. The required band was cut from the gel with a scalpel while visualised 
under UV light. The band was trisected and transferred to a small Eppendorf with a 
hole in the base and a packing of glass wool. The tube was stored at -80 a C for 30 
minutes. The tube was placed inside a large Eppendorf and centrifuged in an MSE 
Microcentaur for 10 minutes. The volume of elutant was made up to lOO,ul. 
Phenol/Chloroform extraction and ethanol precipitation were performed, followed 
by a 70% ethanol wash, pelleting of DNA and resuspension in 5,ul of TE buffer. 
2.9.6 DNA Concentration Estimation. 
Prior to cloning attempts DNA concentration was estimated to allow usage of 
correct ratios of vector to fragment (1:3 moles of termini). 
2.9.6.1 U.V. Fluorescence Method. 
Five, 2.5, 2.0, 1.5, 1.0, 0.5, 0.25 0.1 and 0.05 ng/ ,ul solutions of phage lambda 
DNA were prepared in TE. 2,ul of each of these solutions were mixed with equal 
volumes of 2,ug/ml ethidium bromide and placed as discrete spots on a piece of 
Nescofilm. 2,ul of a 10, 50 and 100 fold dilutions of the DNA sample were treated in 
the same way. The nescofilm was photographed using Polaroid 667 Professional film 
and a Polaroid RP4 Land Camera equipped with a red filter. Illumination was from 
a UV transilluminator, UVP Inc. The DNA concentration was estimated by seeing 
which spot of known concentration most closely corresponded to the brightness of 
the unknown sample. 
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2.9.6.2 Spectrophotometric Method. 
Appropriate dilutions in TE were made of the DNA sample (typically 1:50 or 
1:100). Absorbance of the solution was measured at 260 and 280nm using a Beckman 
Instruments DU7500 spectrophotometer. Pure DNA has a O.D.260/280nm ratio of 
1.8 in solution, protein and RNA contamination altering this. An O.D.260nm of 1.0 
corresponds to a double stranded DNA concentration of 50,ug/ml 
2.9.7 Alkaline Phosphatase Treatment. 
Vector DNA was treated with alkaline phosphatase to limit self ligation. 
Restrictions of vector DNA were set up as usual and 1 unit calf intestinal 
phosphatase per 10,ul was added for the last 30 minutes of the digest. 4.8ml of NT A 
per 11,ul were added and the tube stored at 70 a C for 15 minutes to denature the 
enzymes. The DNA was phenol/ chloroform extracted and then ethanol precipitated. 
Following 70% ethanol washing and centrifugation in an MSE Microcentaur, the 
DNA was dried under vacuum and resuspended in TE. 
2.9.8 DNA Ligation. 
In a total volume of 20,ul, adjusted with ddH20, 2,ulligation buffer, 4 units of 
T4 DNA ligase and the fragment solutions were incubated overnight at l5°C and 
used to transform E. coli. 
2.9.9 Colony Hybridization. 
This technique, adapted from Sambook et al, 1989, is used to confirm the 
presence of a desired DNA sequence or fragment in a bacterial host. Protocols using 
digoxigenin labelled probes are safer to perform than older protocols using 
radiolabelled material, but sufficiently sensitive for this purpose. 
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2.9.9.1 Transferring Small Numbers of Colonies to Nitrocellulose Filters. 
A grided nitrocellulose filter was placed on a selective agar plate. Using 
sterile wooden toothpicks, individual colonies were transferred onto the filter and a 
. master selective agar plate, marked with a similar grid. Each colony was placed in an 
identical position on both plates. Colonies were streaked as diagonal lines, 2-3mm 
apart. As positive and negative controls, colonies with and without the desired 
sequence were included on the grid. The cells were grown until the streaks were 
approximately 1mm wide. The filter was marked in 3 places to allow its orientation 
to the determined relative to the master plate at a later time. The master plate was 
sealed with Nescofilm at kept at 4 a C until required. 
2.9.9.2Jn Situ Colony Lysis and Biding of DNA to Filters. 
I Denaturing Solution: 0.5M NaOH, 1.5M NaCl. 
Neutralizing Solution: 1.5M NaCl, 0.5M Tris-HCl, pH 7.4 
20*SSC: Dissolve 175.3g NaCl and 88.2g sodium citrate in 800rnl HzO. Adjust to 
pH 7.0 with NaOH. Make up to 11. Autoclave. 
The bottoms of 4 petri dishes were fitted with circles of Whatman 3MM 
paper. Each paper circle was saturated with one of the following: 10% SDS, 
denaturing solution, neutralising solution, 2*SSC. Excess liquid was poured off. 
Using blunt ended forceps, the nitrocellulose filter was transferred from the agar 
plate to the SDS soaked paper. The filter was placed with the colonies on the upper 
side, SDS soaking through the membrane to limit the diffusion of DNA during the 
following steps, resulting in a sharper eventual signal. After 3 minutes exposure to 
SDS, the filter was lightly dried and transferred to the denaturing solution dish for 5 
minutes. Similar 5 minute incubations with neutralising solution and 2*SSC were 
performed. The filter was then allowed to dry fully at RT before being sandwiched 
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between 2 dry sheets of 3MM paper and glass. DNA was fixed to the membrane by 
baking in a vacuum oven for 1.5 hours at 80 o C. 
2.9.9.3 Preparation of DNA Probes. 
Following the guide-lines of the Boehringer and Mannheim Nonradioactive 
DNA Labelling and Detection Kit, target DNA was labelled with digoxigenin 
labelled dUTP. The random priming technique of Feinberg and Vogelstein, 1983 
was employed. 
Between lOng and 3J.lg of linearized target DNA was prepared by restriction 
digest, agarose gel electrophoresis, fragment isolation, phenol/ chloroform extraction 
and ethanol precipitation. Double stranded plasmid was denatured at 95°C for 10 
minutes followed by rapid chilling. 2J.tl of a concentrated random hexanucleotide 
mixture, 2J.tl of dNTP labelling mix (1mM dATP, 1mM dCTP, 1mM dGTP, 0.65mM 
dTTP, 0.35mM Dig-UTP pH6.5) and sufficient ddH20 to make the reaction volume 
up to 19 J.ll were added. 1J.ll of labelling grade 2 units/ J.ll Klenow enzyme were 
introduced and the mixture incubated at 37°C for at least 1 hour. The labelling 
reaction was stopped by the introduction of 2J.ll 0.2M EDT A, pH8.0. Labelled DNA 
was precipitated with 2J.ll 4M LiCl and 60J.tl ethanol prechilled to -20°C. After at 
least 30 minutes at -80 o C, labelled DNA was pelleted in a MSE Microcentaur, 
washed in 70% ethanol and taken up in TE. 
2.9.9.4 Gel Filtration of Probes. 
To remove unincorporated label from the probe, a 1ml disposable syringe 
was filled with Sephadex G50 resuspended in TE. Glass wool was used to pack the 
base of the syringe to prevent the liquid flowing through. The column was placed in 
a plastic test tube, with the syringe finger grips preventing it from falling into the 
tube. A short 1800rpm spin in a Wifug Bench Top centrifuge forced excess liquid 
through the column. The syringe was refilled with Sephadex G50 suspension and 
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respun. This procedure was repeated 4 times. Fresh aliquots of TE buffer were spun 
through the column 4 times to wash it and the matrix dried by a 5 minute spin. The 
sample was added to the top of the column and spun through for 5 minutes, the 
purified probe being collected in an Eppendorf at the syringe lock. 
2.9.9.5 Hybridization of Probes. 
Hybridization solution: 5*SSC, 1% w/v Boehringer Mannheim blocking 
reagent, 0.1% w /v lauroylsarcosine, 0.2% w /v SDS. 
Nitrocellulose membranes with the DNA of interest bound to them were 
presoaked in water and then 20*SSC. Filters were prehybridized in a sealed plastic 
bag at 65°C for longer than 1 hour with 20ml Hybridization solution per 100cm2 of 
nitrocellulose. Prehyrbridization solution was replaced with 2.5ml/100cm2 filter of 
hybridization solution containing the freshly boiled labelled probe. The probe was 
hybridized to the bacterial DNA overnight at 65°C. Prior to signal detection, the 
unbound labelled probe was washed away by 2 incubations with each of the 
following: 50ml 2*SSC, 0.1% SDS, RT, 5 minutes, 0.1 *SSC, 0.1% SDS, 15 minutes, 
0 65 C. The membranes were allowed to dry. 
2.9.9.6lmmuno-Detection of Labelled Sequences. 
Buffer 1: lOOmM Tris-HCl, 150mM NaCI, pH 7.0. 
Buffer 2: 0.5% w/v Boehringer Mannheim blocking reagent in buffer 1. 
Buffer 3: lOOmM Tris-HCl, lOOmM EDTA, 50mM MgCl2, pH 9.5. 
I Buffer 4: 10mM Tris-HCl, 1mM EDTA, pH8.0. 
Colour Solution: 45,ul 75mg/ml nitroblue tetrazolium salt in 70% DMF, 35,ul 
50mg/ml 5-bromo-4-chloro-3-indoyl phosphate toluidinium salt in DMF, 10ml 
buffer 3. 
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Filters were washed for 1 minute m buffer 1 then for 30 minutes in 
100ml/ cm2 nitrocellulose buffer 2. This was followed by a brief wash in buffer 1. 
Sheep polyclonal anti-digoxigenin antibody Fab fragment conjugated to alkaline 
phosphatase was diluted to an activity of 150mU/ml in 20/cm2 ml buffer 1 and 
incubated with the filters. Unbound antibody conjugate was removed by washing 
twice for 15 minutes in 100ml/ cm2 buffer 1. The membranes were allowed to 
equilibrate with 20ml/ cm2 buffer 3 for 2 minutes. The filters were exposed to 
10ml/ cm2 of colour solution in the dark until purple precipitate started to appear. 
The reaction was stopped by the addition of 50ml/ cm2 buffer 4. All reactions except 
the colour development were performed with shaking at room temperature . The 
position of colouration on the filters was correlated with the position of colonies on 
the master plate to ascertain which bacteria were carrying the sequence of interest. 
2.9.9.7 Chemiluminescent Detection of Labelled Sequences. 
A theoretically more sensitive protocol using the Stratagene FLASH 
detection system was tested. The protocol was essentially the same as for the 
digoxigenin labelled probe, with the exception of the signal detection step. The 
bound alkaline phophatase conjugate was incubated with a substrate that produced 
light upon cleavage. This emission was detected using photographic film. Whilst 
promising, the technique was not routinely employed due to problems in reducing 
strong background signals. 
94 
Chapter 2. Materials and Methods. 
2.12.2 GUS Assays (Jefferson, 1987). 
GUS Extraction Buffer: 50mM Na2P04, 10mM 2-mercaptoethanol,10mM 
EDTA, 0.1% sodium lauryl sarcosine, O.T% Triton-X. 
Assay Buffer: 1mM 4-methyl umbelliferyl beta-D-glucuronide m extraction 
buffer. 
! Stop Buffer: 0.2M Na2C03. 
C58C1Rif (pVK 257) cells harbouring a virB::GUS fusion provided by Dr 
C.Garret were induced with varying concentrations of phenolic compounds, see 
previous section. Positive and negative controls were also as above, strains cured for 
the GUS plasmid were used to determine the background cleavage of substrate. 
1.5ml of cells were resuspended in 0.5ml extraction buffer and frozen in liquid 
nitrogen. The tubes were thawed at 37° C for 10 minutes, then transferred to the 
fridge for 2 hours. 0.5ml aliquots of assay buffer were incubated concurrently at 
37°C to pre-warm. 15,ul of extract were mixed into the prewarmed assay buffer. 
After 4 minutes incubation, 0.1ml of assay mixture was removed and added to 0.9ml 
stop buffer. Substrate cleavage was estimated visually by examination of U.V. 
fluorescent product (MU). 
2.12.3 6-Galactosidase Assays (Miller, 1972). 
Induction Media: Murashige Minimal Organics Media, 12.5mM potassium 
phosphate, antibiotics as appropriate (Rogowsky et al, 1987). 
Z-buffer: 0.06M Na2HP04.1H20, 0.04M NaH2P04.H20, 0.01M KCl, 1mM 
MgS04.1H20, 0.05M B-mercaptoethanol. pH7.0 
Overnight cultures of A348 (pSM30) were grown overnight with kanamycin 
selection. 1ml aliquots of cells were added to 10ml induction media, putative 
inducers added at the desired concentration and the cells allowed to incubate at 
27° C for exactly 12 hours. The contents of the tubes were chilled on ice for 30 
minutes to prevent further growth or induction before the addition of 0.5ml of cells 
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to 0.5ml Z-buffer. B,ul chloroform and 4,ul 0.1% SDS were added to each of the tubes 
and mixed in by vortex. 50,ul extract was removed and stored at -80°C with 10% 
glycerol for protein determination at a later stage (see section 2.10). 0.19ml 
prewarmed 4mg/ml ONPG (excess to maintain reaction linearity) in O.lM 
phosphate buffer, pH7.0 was mixed in and substrate cleavage allowed to proceed at 
28 a C for 440 minutes in the dark. 0.575ml of reaction mixture were then added to 
0.25ml 1M Na2C03, stopping the reaction and the sample spun down in a MSE 
Microcentaur for 10 minutes to clarify the solution of protein and cell debris. Optical 
density at 420nm was determined using a Phillips PU8700 Series UV /Visible 
Spectrophotometer, allowing the quantification of yellow product formation. Protein 
determination was performed, and specific B-galactosidase activity of the extract 
determined in terms of ,umoles o-nitrohenol/min/mg protein with reference toano-
nitrophenol O.D.420nm vs concentration calibration curve. Experiments were 
performed in duplicate. 
2.13 Chemotaxis Assays. 
2.13.1 Swarm Experiments. 
Chemotaxis Medium: O.lmM EDT A, 10mM KH2P04, pH7.0 (Adler, 1973). 
Initially swarm plates (Parkinson, 1976) comprised of chemotaxis medium 
supplemented with 0.17% agar and the desired concentration of filter sterilised 
attractant. Equal numbers of cells were inoculated into the centre of the plate and 
allowed to grow for 2 days. After incubation the diameters of the resulting swarms 
were measured. Treatments that produced large swarms were thought to be 
attractive to the bacteria since they metabolize the substance where they are growing 
and then move outwards towards the edge of the plate in response to a concentration 
gradient of unmetabolised material. Experiments were performed in triplicate. 
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2.13.2 Blind Well Assays. 
lsoton II: 7.9g/l NaCl, 1.9g/l Na2HP04, 0.4g/l EDTA, disodium salt, 0.4g/l KCl, 
0.2g/l NaH2P04, 0.3g/1NaF 
Motile populations of the strains to be tested were selected by 3 sequential 
rounds of swarming on selective rich media swarm plates. Bacteria from the 
outermost edge of the colony were used to inoculate the subsequent swarm plate. 
Followilfelection of motile bacteria plasmid presence was confirmed by restiction 
analysis of mini-prep DNA and culture purity was checked microscopically using a 
Nikon Optiphot microscope equipped with phase contrast optics and biochemically 
by the Agrobacterium plate test. 
Liquid cultures of the cells were grown overnight in 5ml aliquots of Min A + 
glucose contained in McCartney bottles. The bacteria were spun down in a Wifuge. 
500E centrifuge at lOOOg for 10 minutes and washed 3 times in equal volumes of 
chemotaxis medium. A cotton bud was used to grease the assay chamber of a Blind 
Well assembly (see figure 2.13.2.A adapted with permission from C.H. Shaw) with a 
very small amount of Dow Corning High Vacuum Grease. 200,ul of the culture was 
placed in the chamber and a 13mm diameter, 8,um pore size Nuclepore 
polycarbonate membrane introduced above it. The assembly's cap was screwed in 
and 480,ul of attractant solution placed in the attractant chamber. Parafilm was 
stretched over the top of the assembly, excluding air bubbles, the chambers inverted 
and air flicked to the top of the assay chamber. After 2 hours inverted incubation, 
the number of cells passing through the membrane in response to the attractant was 
enumerated by diluting 200,ul of the fluid from the attractant chamber with 20ml 
Isoton II and counting with a Coulter Electronics Multisizer II. 
Experiments were performed in triplicate and the average of 2 counts taken 
for each assembly. Initially results were expressed in terms of net number of cells 
attracted/ml (ie each experimental average number of cells counted - average 
control value). 
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Attractant solutions were carefully prepared so as to a maintain a constant 
and low concentration of solvent in all assays. Stock solutions of phenolic were 
prepared in decimal decrements from w-1 to w-5M using 1:1 ethyl acetate and 
methanol. Attractant solutions were prepared for assays by dilution of these stocks 
with 1000 volumes of chemotaxis medium. Control solutions consisted of chemotaxis 
medium with an equal concentration of solvent to that used in assay solutions, but no 
phenolic compound. 
2.14 Mutagenesis Protocols. 
2.14.1 Ultra-Violet Light Mutagenesis (Miller, 1972). 
To establish suitable conditions for mutagenesis, since none had been 
published, a killing curve was constructed. A single colony of A348 (pSM30) was 
grown to stationary phase overnight in 5ml selective L-broth. The cells were spun 
down in a Wifug 500E bench top centrifuge at lOOOg for 10 minutes. The bacteria 
were resuspended in an lOml of sterile ddH20 and chilled to prevent further 
division. Henceforth the procedure was conducted in the absence of direct 
illumination to minimize photoreactivation of DNA (Iasson, 1982). The cells were 
transferred to a 9cm radius petri dish and a sterile 4.5cm magnetic stirrer bar added. 
The dish was placed on a Gallenkamp Magnetic Stirrer Hotplate 400 and 
illuminated with a Camlab CAMAG Universal U.V. Lampe 254nm U.V. light 
source. At various times following the commencement of irradiation, 0.1ml samples 
were withdrawn from the dish and diluted. These samples were then plated out on 
L-agar at varying dilutions and incubated for 2 days at 28 o C. From these plates, the 
95% killing dose was calculated under these conditions. 
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2.14.1.1 Screening for Potential HV A and VMA Sensitive Agrobacterium Mutants. 
Colonies were exposed to the 95% killing dose of U.V. radiation and plated 
out at w-2, w-3 and w-4 fold dilutions on 9cm diameter plates of L-agar with 
following additions: 
1.4*1o-5M VMA 
2.4*1o-5M HVA 
0.04mg/ml X-GAL 
25 Jlg/ ml Kanamycin. 
The plates were incubated for 2 days at 28 o C and then 4 hours at room 
temperature. Representative colonies then streaked out under similar conditions, 
but without the addition of catecholamine to characterise constitutive mutants. 
2.14.2 Hydroxylamine, in vitro (Ankenbaur et al, 1991, Humphreys et al1976). 
Hydroxylamine solution: 1M hydroxylamine hydrochloride, lmM EDTA 
adjusted to pH6.0 with NaOH (Humphreys et al, 1976). 
Qiagen purified piB50 plasmid DNA was mutagenized as follows. DNA was 
added to 5 volumes of O.lM sodium phosphate buffer pH6, supplemented with lmM 
EDTA, and 4 volumes of hydroxylamine solution. Typically the reaction was 
conducted in a total volume of 200f.ll with 5Jlg DNA. The mixture was chilled on ice 
for 45 minutes followed by 2 hours incubation at 68 o C. Following this, the mutagen 
was extensively dialysed (Sam brook et al, 1989) against 3 21 volumes of sterile lOmM 
CaCl2 at 4 o C, ethanol precipitated and used to transform GMI9023(piB50) after 
Nagel et al, 1990. Electroporated cells were plated out to select for catecholamine 
sensitive mutants. 
2.14.3 Hydroxylamine, in vivo (Miller, 1972). 
C58CEryCm (piB50) was grown overnight in 5ml L-broth with kanamycin 
selection. The cells were spun down at 6000g for 10 minutes in an MSE 18 High 
Speed Centrifuge and washed and resuspended in 4ml1M NH20H.HCl previously 
adjusted to pH6.0 with lN NaOH. After 30 minutes incubation at 28°C, the bacteria 
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were spun down again, washed and resuspended in L-broth before plating out for 
selection of HV A and VMA sensitive mutants. 
2.14.4 EMS mutagenesis (Cangelosi et al, 1991). 
AB Salts: (Chilton et al, 1974.) 
Solution A: 3g/l K2HP04, 1g/l NaH2P04 
Solution B: 1g/l NH4Cl, 0.3g/l MgS04.1H20, 0.15g/l KCl, 0.01g/l CaCl2, 
2.5mg/l FeS04.1H20 0.2% glucose 
Autoclave 2 parts separately and mix when cool. 
C58C1EryCm (piB50) was grown overnight in minimal AB selective medium. 
The culture was diluted in 50ml fresh medium to an O.D.600nm of approximately 
0.25. Incubation continued for a further few hours until the culture achieved an 
O.D.600nm of 0.35. 4ml aliquots were transferred to sterile Universal tubes and 
EMS added to a final concentration of 4% w/v. The mixture was incubated at 28°C 
for a further 90 minutes before centrifugation at 6000g for 10 minutes in an MSE 18 
High Speed Centrifuge. The bacteria were washed twice in TE buffer before 
resuspension in 4ml AB media. After 2 hours incubation cells were plated out to 
select catecholamine sensitive mutants. 
2.14.5 NG mutagenesis (Pazour et al, 1991). 
ABMes: 1 * AB salts, 0.2% glucose, 25mM phosphate, 50mM Mes, pH5.5. 
A 50ml ABMes culture supplemented with 6.5mg NG was inoculated with 
C58C1EryCm (piB50) to an O.D.600nm of 0.22. Cells were grown for 75 minutes at 
30 o C, Mutagenesis was stopped by centrifugation at 6000g, for 10 minutes in an 
MSE 18 High Speed Centrifuge and washing in one volume of Min A + glucose, 
pH7.0. Cells were resupended in 1ml L-broth and plated out to select for 
catecholamine sensitive mutants. 
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2.14.6 Nitrous Acid Mutagenesis. (Miller, 1972). 
0.1M Acetate Buffer. pH4.6: 
Solution A: 11.5ml cone. glacial acetic acid, made up to 11 in ddH20 
Solution B: 27.29g NaAc.3H20 in per 1 
Add 25ml A to 24.5ml B and 50ml H20, adjust pH and autoclave. 
Nitrous Acid: Immediately before use dissolve sodium nitrite to a final cone. of 
0.05M in 0.1M acetate buffer, pH4.6, pH critical. 
A 5ml culture of C58C1Ery Cm (piB50) was grown overnight with kanamycin 
selection. The cells were spun down in an MSE 18 High Speed Centrifuge at 6000g 
for 10 minutes and washed in an equal volume of 0.1M acetate buffer, pH4.6. The 
bacteria were centrifuged again and resuspended in 0.3ml nitrous acid. After 10 
minutes incubation at 27° C, 5ml 1 *Min A (pH7.0) was added to stop the reaction. 
Cells were plated out to select catecholamine sensitive mutants. 
2.15 The Agrobacterium Plate Test (Bernaerts & De Ley. 1963). 
Benedicts Solution: 
Solution A: Dissolve with heating 173g sodium citrate and lOOg anhydrous 
sodium carbonate in 600 ml water. 
Solution B: 17.3g CuS04 in lOOml water. 
Slowly add B to A with constant stirring. Cool and make up to 1litre. 
Bacteria to be tested were grown for 2 days on Lactose media at 28 o C. 
Benedicts solution was poured onto the surface of the agar and allowed to stand for 
at least 10 minutes. The presence of yellow rings of Cu20 around streaked out 
colonies was taken as diagnostic of Agrobacterium species, since from 80 strains 
from various genera tested by Bernaerts & De Ley, only A.tumefaciens and A. 
radiobacter had the ability to produce 3-keto-lactose, a reducing sugar. 
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2.16 Carbon Source Assays. 
As necessary, the ability of bacteria to utilise certain carbon sources for 
growth was determined. This was generally done by using a minimal media 
supplemented with the compound of interest. 
2.16.1 Octopine Assays. 
The ability of Agrobacterium to metabolize opines is dependent on the 
presence of a Ti-plasmid (Bomhoff et al, 1976). This method was thus used to 
confirm tumour inducing plasmid presence. 
The Agrobacterium strain of interest was grown on octopine agar. Positive 
controls with a Ti-plasmid present and negative control cured strains were also 
streaked out. Growth of the experimental strain after 2 days incubation was taken to 
confirm Ti-plasmid presence. 
2.16.2 Inositol Assays. 
The ability of bacteria to metabolize inositol was checked by incubation for 2 
days on Min A supplemented with 1% agar and 200mM inositol. 
2.16.3 Phenolic Assays. 
Similarly the ability to metabolize HV A and VMA was determined using Min 
A supplemented with 1% agar and 10-2M to 10-9M phenolic. 
2.17 Effects of Urine on Agrobacterium tumefaciens. 
2.17.1 Bacterial Growth Assay. 
Samples of adult urine were collected and filter sterilized. 5ml aliquots were 
introduced into sterile Universal bottles and inoculated with 1 ml of C58C1Rif. 
Controls were set up with no bacteria added to ensure no growth of organisms 
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occurred without inoculation and a C58C1Rif culture was grown in L-broth for 
comparison. After overnight incubation, the culture density was assessed using a 
Coulter Electronics Multisizer II. To ensure freedom from contamination the 
resulting population of bacteria was checked using the Agrobacterium plate test 
(Bernaerts & De Ley, 1963) furthermore non-innoculated filter sterilised samples 
were incubated under the above conditions to ensure no organisms grew. The 
experiment was repeated several times with different urine samples to determine the 
overall effect. 
2.17 .2 vir Induction Assay. 
C58C1Rif (pVK257, pUCD1187) cultures were set up as described above. 
Positive controls of urine and L-broth supplemented with w-4M AS were included. 
An equal amount of solvent was added to experimental bottles. As a negative 
control bacteria were grown in L-broth + solvent. After overnight incubation cell 
density was determined as above and 1ml of bacteria added to 15ml induction media 
(Rogowsky et al, 1987). Photon production was measured using an ffiM PC linked 
Packard 2000 CA Tricarb Liquid Scintillation Analyser. Photon production per cell 
per minute was compared for the different treatments. This experiment was also 
repeated several times. 
2.18 The Synthesis of Bromo-Acetosyringone. 
With the assistance of Dr David O'Hagan, Department of Chemistry, 
Durham University, the protocol of Miksche, 1973 was followed. 
Equimolar amounts of Brz(l) (1.6ml, 31m moles) and AS (6g, 31m moles) 
were mixed with 50ml chloroform in a bulb fitted with a condenser and drier. The 
exothermic reaction between these reagents was allowed to run to completion 
(assayed by TLC) over a 40 minute period. Excess bromine was removed by 
partitioning in saturated aqueous sodium thiosulphate. The aqueous layer of this 
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mixture was separated in a funnel and discarded. Product was washed in ethyl 
acetate and then water. Anhydrous MgS04 was added to remove the water and then 
filtered off under vacuum. Solvent was boiled off using a rotary evaporator. The 
brominated sample was crystallized on ice and washed with 70% ethanol, giving a 
light brown solid. To purify the material it was taken up in a minimum volume of 
pre-warmed 100% ethanol, filtered and re-crystallized over a period of several 
hours. The product was harvested by vacuum filteration and desiccated overnight 
with PzOs. The sample's melting point was determined and a N.M.R. 250nm proton 
spectrum performed using a Broker instrument. 
2.18.1 Assaying Reaction Completeness. 
Small quantities of AS and reaction mixture were strongly diluted in ethyl 
acetate and spotted onto a foil backed TLC plate. The chromatogram was run in a 
mixture of chloroform and ethyl acetate (approximately 3:1) and viewed under U.V. 
light. 
2.19 Generation of Molecular Models. 
'Ball and stick' and 3 dimensional space filling molecular models were 
generated by the application of the requisite algorithms of the IBM PC2 based 
program 'Desktop Molecular Modeller', version 1.2 (Oxford University Press 
Electronic Publications), to fully energy minimised structures of AS, ASOH, HV A 
and VMA. The resultant images were photographed from the computer display and 
are shown in figures 1.3.2.A-B. 
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3. Virulence Gene Induction by Catecholamine Metabolites. 
3.1 Introduction. 
As already mentioned (section 1.3) one of the main reasearch aims was to 
investigate the effect of the catecholamine metabolites HV A and VMA on 
Agrobacterium. It was initially proposed that the use of a reporter gene construct, 
induced by the presence of these compounds would be the most amenable method 
for implementing a bacterial screening test. 
3.2 Reporter Genes. 
Reporter gene fusions are a particularly useful tool for studying gene 
expression, allowing relatively simple estimation of promoter activity. The coding 
region is removed from the gene to be analysed and the promoter of interest fused 
to the coding region of a gene whose expression is easily quantifable. Ideally, 
expression of the reporter gene should not normally take place in the cell, nor should 
it be deleterious to normal cell behaviour. The fusion gene is re-inserted into the 
organism and its expression under the control of its novel promoter assessed. 
Fusions are of two types, with much variation within the types. Transcriptional 
fusions are defined as fusions in which all protein coding sequence is derived from 
the reporter, whereas translational fusions produce a polypeptide as a result of 
coding information from the reporter and the controlling gene (Jefferson, 1987). The 
reporter gene systems used in this study were as follows: 
3.2.1 Lac Z: 
The coding region of the E. coli B-galactosidase gene was fused to various vir 
promoters. When expressed this gene has the ability to degrade the colourless dye X-
GAL to a vivid blue product. Activity is then easily monitored visually or by 
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colourimetry. Additionally the colourless substrate ONPG can be cleaved to yellow 
o-nitrophenol and galactose (Miller, 1972). 
3.2.2 Lux: 
In this system a self contained luciferase cassette produces visible light which 
can be detected visually, by film or in a scintillation counter, depending on the 
degree of sensitivity required (Shaw and Kado, 1986, Rogowsky et al, 1987). This 
method has the advantage that no external substrate is required. 
3.2.3 GUS: 
The expression of B-glucuronidase under the control of the subject promoter 
can be assayed via a number of spectrophotometric, colourimetric and fluorimetric 
means, depending on the substrate chosen. Common substrate's include 4-methyl 
umbelliferyl B-D-glucuronide (4-MUG), a non-fluorescent compound which, when 
enzymatically cleaved produces a fluorescent product. This is highly desirable since a 
high signal to noise ratio is available in the assay, which is also relatively easy to 
perform. Sensitivity is reported as being 2 to 4 orders of magnitude higher than for 
spectrophotometric and colourimetric assays. A colourless substrate for 
colourimetric assay, X-GLUC is also available which cleaves to a blue product 
(Jefferson, 1987). 
Qualitative assays of gene expression can be made quantitative by reference 
to calibration curves. 
3.3 Stock Phenolic Solutions. 
Initially solutions of AS, HV A and VMA were maintained in 75% methanol. 
However addition of large amounts of methanol (even though almost saturated with 
phenolic) to bacterial cultures in order to achieve the final concentrations of 
phenolics required, proved most deleterious to bacterial growth. Ethyl acetate was 
then tested as a solvent. However, although allowing higher phenolic stock 
concentrations this was still not a sufficiently good solvent. Following the suggestion 
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of Dr D. O'Hagan (University of Durham, Department of Chemistry) a 1 : 1 mixture 
of ethyl acetate and methanol was used. This provided excellent results, with 1M 
stock solutions of phenolics being readily achievable. The resultant decrease in 
volume of solvent addition required to produce high final attractant concentrations 
greatly aided culture maintenance. 
3.4 vir Gene Expression Studies. 
It had been hypothesized that HV A and VMA would interact with the 
Agrobacterium vir AI G system to induce vir gene expression. This hypothesis was 
tested using a number of reporter gene constructs as there is no readily applicable 
direct assay for the expression of these genes on an individual basis. virB and virE 
promotors were chosen for the majority of these studies as they regulate the most 
highly inducible vir genes (Rogowsky et al, 1987). 
3.4.llux. 
Plasmid miniprep pUCD1187 DNA (virB::lux) was introduced into strain 
C58C1Rif (pVK257) by the freeze/thaw method of (Hofgen & Willmitzer, 1988). 
Similarly strain C58C1Rif (pVK257, pUCD1194) (virE::lux) was also constructed. 
Strain C58C 1 Rif (p VK257) was chosen as the background since this readily allowed 
selection of transformants and carried vir A and G functions on the cosmid clone. 
Plasmid content was confirmed by restriction analysis of plasmid mini-prep DNA. 
lux inducibility was tested by exposing test strains to 10-4M AS as described in 
Materials and Methods. Fold induction was calculated as a ratio of this figure to the 
negative control. pUCD1187 gave a 8.5 fold increase in photon emission whilst 
pUCD1194 gave a 7.23 fold induction when exposed to 10-4M AS (concentration 
chosen for strong induction qualities). The virB::lux fusion was thus selected for 
future work due to its higher inducibility. 
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Figure 3.4.l.A shows the results of vir gene expression assays (see section 
2.12.1) following exposure of C58C1Rif (pVK257, pUCD1187) to a range of 
concentrations of AS, HV A and VMA between w-9 and w-4M. This range of 
concentrations was employed since it was reasoned that Agrobacterium was not 
likely to respond to unnatural ligands at lower concentrations than the threshold of 
response to AS (1o-9M) and because it was practically difficult to acheive 
concentrations higher than w-4M without adversely affecting the bacterial cells. vir 
gene expression is strongly induced by w-4M AS, comparing well to the results of 
Rogowsky et al (1987). Other acetosyringone concentrations do not illicit light 
production greater than the solvent control. No significant vir gene induction above 
the control level was detected on exposure to HV A and VMA, indicating that these 
compounds do not act as vir inducers within the range of concentrations tested. 
w-4M AS was chosen as a positive control for future experiments. 
To assay for possible synergism or repression of induction, the test strains 
were exposed to the same range of concentrations of HV A and VMA supplemented 
with w-4M AS. (see figure 3.4.l.B). However, once again no significant variation 
was noted between the experimental and control treatments, indicating an inability 
of these compounds to interact with the bacterial induction system. The photon 
production is slightly lower than in the previous experiment, despite the inclusion of 
w-4M AS presumably because of the greater volume of solvent introduced into the 
bacterial cultures. In an attempt to improve vir induction by HV A and VMA, the 
assay protocol was modified such that the conditions for induction were optimised. A 
number of "induction media" have been devised by various groups for this purpose, 
see section 2.5, (Rogowsky et al, 1987, Vernade et al, 1988, Winans et al, 1988). 5ml 
aliquots of cells were grown up overnight and the cells spun down in an MSE18 High 
Speed centrifuge at 7000g for 10 minutes. The bacterial pellet was resuspended in an 
equal volume of the induction media supplemented with phenolics as desired. 
Appropriate controls were included and after overnight shaking at 27° C 
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measurements made, allowing calculation of light emission as before. Experiments 
were performed in duplicate. Data from these experiments are presented in figure 
3.4.1.C and indicate the medium devised by Rogowsky et al (1987) produces the 
highest levels of reporter activity. These results compare well to those of the 
previous experiments and indicate that the use of the modified protocol leads to 
slightly higher levels of induction. 
Concurrently with these experiments the effect of these phenolic compounds 
on bacterial growth was studied by plotting the stationary phase culture densities of 
the different treatments as determined during the experiments. This data is 
presented in figure 3.4.1.D and illustrates the toxic nature of HV A and VMA to 
Agrobacterium cells, as increasing phenolic concentrations are more and more 
deleterious to cell growth. Repression of induction or competition between 
catecholamine metabolites and acetosyringone for a phenolic receptor site is 
discounted as there is no alteration of effect with concentration. 
3.4.2 GUS. 
A virB::GUS fusion in a C58C1Rif (pVK257) background was kindly 
provided by C.S. Garrett. To test the strain and assay procedure, 5ml aliquots of cells 
were grown overnight in L-broth supplemented with w-4M AS or an equal volume 
of solvent. The cultures were assayed for cleavage of 4-MUG as in section 2.12.2 
with various reaction times being employed. Longer reaction (60min) durations 
produced higher substrate cleavage leading to increased fluorescence, but shorter 
reaction periods (2min) gave a much lower background (control) signal (see figure 
3.4.2.A). As result of these experiments a 4 minute period was decided upon for all 
future experiments. 
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When performing more detailed experiments the assay procedure was 
modified as follows. 200ml selective L-broth cultures of the GUS strain and 
C58C1Rif (pVK257) were grown overnight. The cells were spun down at 10000g for 
10 minutes in an MSE 18 High Speed Centrifuge and resuspended in an equal 
volume of induction media (Rogowsky et al, 1987). 5ml aliquots of cell suspension 
were incubated overnight at 27° C with the desired concentrations of phenolics. 
Controls with an equal amount of solvent but no phenolic were included. C58C 1 Rif 
(pVK257) provided a cured strain control with no inducible GUS activity. This 
allowed comparison of any reporter induction against the cellular background level. 
When assayed visually, no significant background activity was detected upon 
exposure to solvent controls or inducing levels (10-4M) of AS. Moreover, the range 
of HV A and VMA concentrations used did not lead to significantlty higher 
fluorescence than noted in the solvent control. This suggests these compounds did 
not interact with Agrobacterium to induce the vir promotors (see figure 3.4.2.B). The 
acetosyringone positive controls shown in this figure indicate the inducibility of the 
GUS fussion under assay conditions. 
Since the GUS system is reported as being a highly sensitive measure of gene 
expression (Jefferson, 1987) it was decided to try and improve upon this qualitative 
assay. Possible errors were thought to come from the visual estimation of enzyme 
activity and from differences in the extraction procedure including possible toxicity 
of phenolics to the cells. To overcome these problems and make the assay 
quantitative, fluorescence was measured in a Baird Atomic Fluoripoint 
Spectrofluorimeter set to 365nm excitation and 455nm emission, blanked against the 
solvent control preparation. Induced substrate cleavage was calculated relative to a 
calibration curve of cleavage product ( 4 MU) dissolved in stop buffer. To control for 
differences in efficiency of extraction of specific activity, the total protein 
concentration in all GUS extracts was estimated as in section 2.10. This allowed the 
calculation of vir gene induction in terms of MU production/ f.J-M/ f.J,g total 
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protein/min. The results of this experiment, shown in figure 3.4.2.C, net activity 
being calculated by the subtraction of solvent control activity from experimental 
figures. These results illustrate that acetosyringone is a strong inducer at w-4M 
concentration, other AS concentrations are less potent. The range of HV A and 
VMA concentrations tested do not lead to significant vir induction above that of the 
control. Once again, to detect possible synergism or repression of induction by 
catecholamine metabolites, assays were performed against a range of HV A and 
VMA concentrations with and without supplementary w-4M AS. This graph shows 
that within the sensitivity of the assay employed the concentrations of HV A and 
VMA used do not interact with the Agrobacterium vir gene induction regulatory 
elements to cause any response when compared to the solvent controls (see figure 
3.4.2.D). For each catecholamine concentration an appropriate solvent control was 
included, allowing calculation of net activity as before. The lack of detected 
synergysm or competition between the catecholamine metabolites and 
acetosyringone is comparable to the lux experiment, as are the slightly lower overall 
results due to the increased volume of solvent. 
3.4.3/acZ. 
The plasmid pSM30 encodes a virB::lacZ fusion. The lacZ gene encodes an 
E.coli B-galactosidase enzyme. Miller (1972) describes an ultra-sensitive assay forB-
galactosidase. With long incubation times this protocol is accurate enough to detect 
differences in enzyme activity caused by as few as 10's of enzyme molecules (M.D. 
Watson, personal communication). 
Assays were performed as in section 2.12.3. C58 was used as a cured strain 
control, having no inducible lacZ contruct but providing an estimate of background 
uninduced B-galactosidase activity. A348 (pSM30) was incubated with the same 
concentration of solvent as in experimental assays but no phenolic as a negative 
control for induction by assay conditions.A similar negative control was set up with 
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the cured strain C58. As positive controls the cured strain and A348 (pSM30) were 
incubated with inducing concentrations of acetosyringone (1o-4M). The results of 
these assays are presented in figure 3.4.3.A and indicate that treatment with 
catecholamine metabolites does not cause an induction response above that of the 
solvent control (bar A). In comparison with the positive control (bar D) substrate 
cleavage in experimental assays is small, but somewhat higher than that of the cured 
strain (bars B +C). This small but detectable cleavge is probably due to a low 
background level of reporter expression by the non induced vir promotor since it 
does not appear to vary significantly with either concentration or the phenolic used. 
3.4.4 Expression Studies in Urine. 
One of the objections to the proposal of an Agrobacterial screening test for 
neuroblastoma is that compounds present in urine other than HV A or VMA would 
be likely to induce vir gene expression. Candidate molecules would include 
phenolics and sugars. A further possibility would be that compounds which suppress 
vir induction would alter test reliability. To test these arguments the experiments 
described in section 2.17.2 were performed using the lux reporter gene system for 
ease of assay. The results presented in figure 3.4.4.A show that the procedure 
provided an aseptic sample and that Agrobacterium is capable of growing almost as 
well in urine as in rich media. Furthermore urine appears not to contain compounds 
which induce vir gene expression although conditions may repress induction by 
acetosyringone (figure 3.4.4.B), this may simply be a pH effect however (vir 
induction pH optimum 5.25). The organisms recovered at the end of the experiments 
were confirmed to be Agrobacterium by the plate test. 
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4. Agrobacterium's Chemotactic Response to Phenolic 
Compounds. 
4.1 Introduction. 
As previously mentioned, Agrobacterium responds to phenolic compounds in 
2 ways, by gene induction and by chemotaxis - the nature of the response depending 
on the perceived phenolic concentration. Chemotaxis is the movement of organisms 
toward or away from a chemical (Adler, 1966). Having failed to detect agrobacterial 
vir induction as a result of the action of catecholamine metabolites, it was decided to 
see if the bacterium responded chemotactically to HV A and VMA. Positive 
attraction of Agrobacterium to AS has been demonstrated by Ashby et al (1987, 
1988) and a number of compounds with similar structures have been shown to act as 
chemoattractants (Ashby et al, 1988). 
4.2 Chemotaxis in Bacteria. 
The majority of chemotaxis related genes are involved in flagella production 
and assembly (MacNab, 1987a). The rotation of helical flagella provides the impetus 
for most bacterial motion (MacNab, 1987a). The flagella itself is a complex 
structure, composed of many different proteins. Essentially however, there are 
motor and switching regions, a transmembrane basal body which incorporates 
structures allowing rotation and a 50-lOO.um filament on the outside of the cell 
joined to the basal body by a hook (Shaw, 1991, Armitage, 1992). In the best studied 
example, E.coli, counter clockwise proton driven flagella rotation causes the flagella 
filaments to wrap into a bundle, driving the bacterium (MacNab, 1987b, Armitage, 
1992). However, if the perceived conditions change, cytoplasmic components 
interact with the flagella switch (FliG,M,N) (Stock and Lukat, 1991), altering the 
direction of flagella rotation (Armitage, 1992). Clockwise rotation causes the 
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filament bundle to fly apart and the bacterium is induced to tumble, randomly 
reorientating itself (Armitage, 1992, MacNab and Ornston, 1977). Counter-clockwise 
rotation is resumed and the bacterium sets off in a new direction. Environmental 
conditions change the frequency of tumbling, making it less likely if the direction of 
movement is favourable, more frequent if the cell travels along an unfavourable 
gradient (Armitage, 1992). The result of this is a tactic movement towards 
favourable stimuli or away from repellents (Armitage, 1992, Stock et al, 1989). In 
Agrobacterium the flagella are only capable of clockwise rotation, driving the cells at 
speeds of up to 60,um/s in runs as long as 500,um (Shaw, 1991). In this case simple 
stops of flagella rotation allow re-orientation (Armitage, 1992). As already 
mentioned Agrobacterium is envisaged to be chemotactically attracted towards plant 
wound sites prior to vir gene induction (Ashby et al, 1987, 1988). The observations of 
Hawes and Smith (1989) and Hawes et al (1988) that mutants deficient m 
chemotaxis are less virulent under certain conditions supports this hypothesis. 
Agrobacterium has been shown to be attracted to 3 classes of plant wound 
exudates. Loake et al (1988) reported a highly sensitive attraction of the bacterium 
towards a range of sugars. Sucrose, an abundant plant saccharide evokes the 
strongest response, with an optimum concentration of w-6M. Other sugars exhibit 
equally low attraction thresholds (1o-9M) but provoke a smaller aggregation (Loake 
et al, 1988). In addition the amino acids arginine and valine act as chemoattractants 
(Loake et al, 1988). The majority of genes involved in chemotaxis are 
chromosomally encoded (Shaw et al, 1991) and Agrobacterium's response to these 2 
classes of molecule is independent of Ti plasmid presence (Loake et al, 1988). This 
may explain the prevalence of both virulent and avirulent strains in the rhizosphere 
(Kerr et al, 1969). Attraction towards the third class of molecules, phenolics, 
however requires the presence of the Ti-plasmid (Ashby et al, 1987) and more 
specifically VirA and G (Shaw et al, 1988). This smaller response is thought to 
operate only in close proximity to the wound site (Shaw et al, 1989, Shaw, 1991) and 
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is therefore probably more important in guiding virulent cells to a suitable infection 
site once they are close to the plant roots. The strong response to sugars and amino 
acids benefits both virulent and avirulent cells by directing them to nutrient sources 
and additionally aids tumourigenesis by bringing virulent cells nearer to the wound 
site. The results of Parke et al ( 1987) indicate that the importance of phenolic 
chemotaxis appears to show some strain specificity whilst Hawes et al (1988) and 
Hawes and Smith (1989) emphasise the importance of chemotaxis in general during 
virulence. 
4.3 Chemotaxis Information Signal Transduction and Flagella Rotation 
Switching. 
The events associated with the perception and transduction of information, 
its integration and mode of action in Agrobacterium are not as well studied as the 
model systems E.coli and Bacillus subtillis. There is however a degree of similarity 
between Agrobacterium and especially E.coli (Shaw, 1991). 
Bacteria are too small to perceive spatial gradients, thus they sample their 
environment temporally. Implicit and essential for this behaviour is an ability to 
'remember' and adapt to conditions (Schnitzer et al, 1990). Furthermore since 
bacteria are simultaneously subjected to a wide range of varying stimuli that may be 
contradictory, there must be a facility for signal integration allowing a consensus 
response (Borkovich and Simon, 1990, Armitage, 1992). 
4.3.1 Methyl-Accepting Chemotaxis Proteins. 
In 1969 Adler demonstrated that chemoeffectors exerted their effect without 
being transported (Adler, 1969). This indirectly implied the existence of surface 
receptors (Armitage, 1992). In E.coli and closely related Salmonella typhimurium 4 
such receptors (see table 4.3.1.A) have been identified (MacNab, 1987b) although 
there is also scope for receptor independent signalling (Armitage, 1992). 
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Receptor 
Tsr 
Tar 
Trg 
Tap 
Table 4.3.1.A. 
Mediates Response to: 
Serine, temperature, pH 
Aspartate, ribose 
Maltose, galactose 
Dipeptides 
Chemotaxis. 
These surface receptors are known as methyl accepting chemotaxis proteins 
or MCP's. The response to sugars is indirect and occurs through the periplasmic 
sugar binding proteins of the sugar transport system (Armitage, 1992). For example 
Tar can interact directly with aspartate or can respond to direct binding of an 
occupied ribose periplasmic binding protein. The MCP's act as both receptors and 
signal transducers. 
From sequence analysis many predictions have been made about the 
structure and possible mechanism of action of the MCP's (Hazelbauer et al, 1990) 
(see figure 4.3.1.B). There is strong sequence homology between the proteins and 
interspecific antibody cross reactivity, suggesting a common evolutionary heritage 
(Bollinger et al, 1984, Krikos et al, 1983). As would be expected, this homology is 
strongest in the cytoplasmic signalling region whilst there is greater variation in the 
ligand binding domains (Armitage, 1992). Each transducer has 2 membrane 
spanning regions, a periplasmic loop involved in response to the signal and a 
cytoplasmic loop which incorporates the signalling and methylation domains 
(Armitage, 1992). This is very reminiscent of the Agrobacterium VirA structure 
(Leroux et al, 1987) as already described and moreover there is a degree of sequence 
conservation between vir A and cheA of E. coli, a protein in the signal transduction 
cascade (Stock et al, 1989). Furthermore there is strong homology between the 
cytoplasmic signalling regions of MCP's and 2 component regulator system 
receptors. Functional regions associated with methylation and adaption and flagella 
signalling/ switching are to be found in both groups (Armitage et al, 1992). The 
transducers exists as dimers in the membrane (Milligan and Koshland, 1988). Vir A is 
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therefore especially interesting since it acts both as an MCP and a 2 component 
regulator receptor. 
4.3.2 Dynamic Protein Phosphorylation. 
Four E.coli cytoplasmic proteins are involved in the transmission of sensory 
information from the MCP's to the flagella motors, namely: CheA, CheW, Che Y and 
CheZ (Wolfe et at, 1987). Sensory adaptation (Goy et al, 1977) is mediated by two 
cytoplasmic enzymes, CheR and CheB which covalently modify the MCP's, thus 
modulating signalling (Borkovich and Simon, 1990, Parkinson, 1988) (see figure 
4.3.1.B). Although this diagram is useful as a model there is evidence for the 
existence of MCP-CheA-CheW complexes (Liu and Parkinson, 1989, McNally and 
Matsumura, 1991) and it must also be remembered that MCP's form dimers in vivo 
(Milligan and Koshland, 1988). 
Phosphate fluxes through a pathway involving, CheA, CheB and Che Y 
(Borkovich and Simon, 1990, Parkinson, 1988, Shaw, 1991). CheA, an 
autophosphorylating protein kinase receives the gamma phosphate from A TP 
(Shaw, 1992, Borkovich and Simon, 1990, Bourret et al, 1991) and covalently binds it 
to histidine residue 48 (Hess et al, 1988c). Phospho-CheA passes phosphate to CheB 
and Che Y aspartate 57 (Sanders et at, 1989), converting them to their active forms 
(Borkovich and Simon, 1990, Stock et at, 1989). The rate of CheB and Che Y 
phosphorylation is dependent on ligand binding at the MCP's (Borkovich et al, 
1989). Che Y phosphate acts at the flagella switch to induce clockwise rotation and is 
thus known as the 'tumble factor' (Stock et at, 1989). CheB phosphate acts to 
remove methyl groups from the MCP's (Borkovich and Simon, 1990). CheZ 
constitutively dephosphorylates Che Y (Hess et al, 1988a,b ). CheR constitutively 
methylates the MCP's at specific glutamate residues (Springer and Koshland, 1977). 
Regulation of CheA kinase activity thus indirectly alters the net amount of 'tumble 
factor' present in the cytoplasm and the net methylation state of the MCP's. CheW is 
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necessary for the transfer of information concerning ligand binding from the MCP's 
to CheA (Borkovich et al, 1989). 
The binding of attractant to the periplasmic receptor region of an MCP 
causes a conformational change which is propagated to the membrane spanning and 
signalling domains of the same polypeptide (Milligan and Koshland, 1991). In the 
presence of CheW, the rate of CheA autophosphorylation decelerates, causing 
decreases in CheB and Che Y activation (Borkovich et ak, 1989, Stock et al, 1989). 
Constitutive CheZ activity lowers the net concentration of Che Y phosphate, 
decreasing the probability of a tumble (Shaw, 1991). Concurrently constitutive CheR 
activity competes more effectively with lowered CheB methylesterase activity 
leading to greater MCP methylation allowing adaptation to prevailing conditions 
and restoring the conformational change (Shaw, 1991, Armitage, 1992). Each MCP 
has 4 (5 in some cases) methylatable glutamate residues, 2 of which are usually filled 
(Park et al, 1990). Acquisition of these residues alters MCP conformation and 
favours smooth swimming (Armitage, 1992). 
A more recent model proposed by Armitage (1992) allows for the existence 
of an MCP-CheA-CheW complex from which CheA-CheW is released following 
similar conformational changes resultant from less ligand binding. Released CheA-
Che W is more capable of autophosphorylation and subsequentlty more Che Y 
phosphate is produced, promoting tumbling. CheZ subsequently dephosporylates the 
'tumble factor'. 
In Bacillus subtillis the situation has been demonstrated to be slightly more 
complex (Bischoff and Ordal, 1992) with the main chemotaxis proteins from E.coli 
being present but playing slightly different roles. In B.subtillis additional 
intermediates are also present and MCP methylation does bring about adaptation. 
There is also a possibility of signal transduction by methylated intermediates 
although the exact differences between the 2 models are not yet clear. 
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The role of dynamic phosphorylation in mediating vir induction has been 
demonstrated (Huang et al, 1990, Jin et al 1990a,b,c). In these papers, the authors 
demonstrate that the C terminus of VirA can be autophosphorylated at histidine 
residue 474 and can transfer this phosphate to aspartate 52 in the N terminus of 
VirG, rendering it a sequence specific DNA binding protein and transcriptional 
activator through its C terminus (Huang et al, 1990, Jin et al 1990a,b,c, Pazour and 
Das, 1990a, Powell et al, 1989). It was thus thought interesting to investigate the role 
of VirA/G phosphorylation in mediating chemotaxis since it is not clear how the 
VirA/G system is capable of mediating both chemotaxis and vir induction at 
different concentrations of the same ligand. This is especially interesting in the light 
of Lukat et al's 1991 paper which describes the conservation of an acidic pocket 
containing a phosphate receiving aspartate residue amongst response regulators 
(Asp57 in Che Y (Sanders et al, 1989), Asp52in VirG (Jin et al 1990a)). This 
structural similarity amongst regulators makes 'cross talk' or interaction with sensor 
proteins other than their normal partner possible (Aoyama et al, 1991, Wanner, 
1992). It is also of note that CheB has a DNA binding domain although no 
transcriptional activation has yet been attributed to this protein (Stock et al, 1989). 
In addition little is known about the role of dynamic phosphorylation in bacterial 
signal transduction pathways other than in the model systems described above. 
4.4 Agrobacterium 's Chemotactic Response to HV A and VMA. 
Initially, attempts to measure Agrobacterium chemotaxis towards phenolic 
compounds relied upon the use of attractant supplemented swarm plates (see section 
2.13.1 ). The results were however very disappointing, and this was suspected to be 
because the bacteria were incapable of metabolising the compounds under study (a 
requisite for this tyoe of assay). Metabolism of the agar used to solidify the plates, 
resulting in decreased medium viscosity was taken as evidence of this (Lippincott 
J.A. et al). 
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Ashby et al (1987, 1988) and Shaw et al, 1988 had shown that the attractant 
metabolism-independent Blind Well assay was applicable to the study of 
Agrobacterium chemotaxis towards phenolic compounds. Strain C58C 1 (p VK 257) 
was made motile and used to test the assay, chemotaxis experiments towards 
acetosyringone being performed as in section 2.13.2. This strain was chosen as 
suitable since it harboured essential vir A and G functions and because it has 
previously been demonstrated to be attracted towards acetosyringone (Shaw et al, 
1988). The results of this work are shown in figure 4.4.A and illustrate a peak of 
positive attraction to acetosyringone at w-7M. Other AS concentrations are 
markedly less attractive to the bacteria, and these results correspond well to those of 
Ashby et al (1987, 1988) and Shaw et al (1988) who report similar response. 
In a similar manner positive reproducible attraction to HV A and VMA was 
also demonstrated (see figures 4.4.B and 4.4.C). The most attractive concentrations 
of HV A and VMA attraction were w-6M and w-7M respectively. As with 
chemotaxis to AS other attractant concentrations were caused markedly smaller 
changes in bacterial behaviour. Significance should not be attatched to the actual 
numbers of bacteria attracted since no account of the number of cells initially 
introduced into the assay chambers has been taken. It is however of note that VMA 
causes strongest attraction at the same concentration as AS (within the sensitivity of 
these assays) and that a 10 fold higher concentration of HV A is required to provoke 
a similar response This could be taken to indicate a weaker interaction with the 
bacterial chemosensory system. 
To test the mechanism of attraction these experiments were repeated using 
motile strains C58C1 (211MxCb), C58C1 (226MxCb) and C58C1 (19MxCb), 
respectively vir A, vir A and virG Tn3HoHo transposon disrupted mutants. This data 
is presented in figures 4.4.E and 4.4.F (AS data shown for comparison, figure 4.4.D). 
Comparison of the chemotactic response of C58C1 (211MxCb) and C58C1 
(226MxCb ), carrying non functional Vir A molecules to C58C 1 (p VK257) with a wild 
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type clone indicate loss of chemotactic competancy. Similarly transposon insertion 
into virG causes a reduction in the chemotactic ability of essel (19Mxeb) 
compared to essel (pVK257). It should be noted that these graphs are plotted to 
different scales and as before, the density of cells attracted is not significant in these 
experiments. The shapes of the graphs are however important, and the reader is 
encouraged to note the lack of a chemotactic peak in the data produced in 
experiments using transposon disrupted mutants when compared to the esse 1 Rif 
(pVK257) graphs. 
These results imply that VirA and G function are essential in the mediation 
of Agrobacterium's chemotactic response to catecholamine metabolites. This 
indicates that the nature of the response is strongly reminiscent of that to 
acetosyringone. Furthermore this data was interesting since it demonstrates that the 
vir AI G system is capable of mediating chemotaxis but not vir gene induction in 
response to HV A and VMA. The latter response presumably requires greater 
stimulation of the bacterial response mechanisms than the former since vir induction 
has an AS concentration peak some 1000 fold higher than that of chemotaxis toward 
the same ligand (see earlier). It was decided to study the role of dynamic protein 
phosphorylation in mediating the chemotactic response, as alteration of 
phosphorylation patterns has been implicated in both vir induction and bacterial 
chemotaxis (see above). In addition it is not clear how the vir AI G system is capable 
of mediating both chemotaxis and vir induction in response to different 
concentrations of AS and it was felt these experiments might illuminate the subject. 
4.4.1 Chemotaxis Towards Infants' Urine. 
Using filter sterilized children's urine adjusted to neutral pH, response of 
motile Agrobacterium to 3 healthy childrens' and 1 neuroblastoma patient's urine 
was compared (see figure 4.4.1.A). All samples acted as agrobacterial attractants. 
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Nothing distinguished the response to the urine of the patient, suggesting that the 
bacterium was responding to some stimulii other than HV A or VMA concentration. 
This is largely as expected since the predominant chemotactic response of 
Agrobacterium is to sugars and amino acids rather than phenolic compounds (Loake 
et al, 1988). Samples were generously donated by J.Seviour of Newcastle General 
Hospital. 
4.5 The Role of Dynamic Phosphorylation in vir AI G Mediated Phenolic 
Chemotaxis. 
4.5.1 Micro-electroporation (Palmer and Shaw, 1992). 
To allow construction of the large number of strains required for these 
experiments a new transformation protocol was devised. Tri-parental (section 
2.7.1.1) and 2 step matings (section 2.7.1.2) had proved very inefficient and time 
consuming to perform. Freeze thaw (section 2.7.2.1) allowed greater ease of 
introduction of DNA into Agrobacterium but the most promising method had been 
shown to be electroporation, especially the protocol published by Nagel et al (1990). 
This method however, was still relatively slow although it provided almost certain 
success. A modified version of this protocol was devised that maintained the success 
rate of Nagel et al's work whilst cutting the time required for transformation down to 
around 10 minutes. 
Plasmids were purified from 100ml overnight cultures of E.coli C2110 using 
Qiagen plasmid midi columns. Plasmids carrying copies of vir A and virG were 
electroporated into Agrobacterium backgrounds carrying cosmid clones. 5ml cultures 
of the recipient strain were grown overnight with antibiotic selection. 2 successive 
1.5ml aliquots of cells were pelleted in the same Eppendorf tube by centrifugation 
for 10 seconds in an MSE Microcentaur bench top centrifuge. The sample was 
washed 3 times in ice cold 1mM HEPES buffer, pH7.0 and once in 1ml chilled sterile 
10% glycerol. The cells were resuspended in 40,ul 10% glycerol ( 4 a C) and 3,ul 
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plasmid miniprep DNA mixed in. The mixture was transferred to an ice cold Biorad 
0.2cm electroporation cuvette and subjected to a 2.5kV pulse dissipated at 200Q, 
25.uF using a Biorad Gene Pulser. Successful transformations were associated with a 
time constant in the order of 4.7 milliseconds. Immediately after transformation, 1ml 
nutrient broth was added to the cuvette and the cells incubated with shaking at 27° C 
for 2 hours. Following pelleting and resuspension in 100.ul nutrient broth, the cells 
were plated out and grown with appropriate selection for transformants. Prior to use 
plasmid content and culture purity was confirmed as before. 
4.5.2 Modifications to the Blind Well Assay (Palmer and Shaw, 1992). 
The nature and complexity of the Blind Well assay made it impossible to 
perform all the desired experiments concurrently. It was thus felt that an attempt 
should be made improve the comparibilty of data gathered on different days. A new 
estimate of chemotaxis, the Chemotactic Index (CI) (Palmer and Shaw, 1992) was 
derived which corrects for differing numbers of cells being added to the chamber 
and for attraction/repulsion by factors other than the compound of interest. To 
these ends the assay procedure was modified somewhat from section 2.13.2 and 
would now allow comparison of the strength of responses to different treatements. 
For later experiments greater numbers of cells were used. 50ml Min A + 
glucose cultures were grown overnight with shaking at 27° C. The cells were 
harvested by centrifugation for 10 minutes at 7000g in an MSE 18 High Speed 
Centrifuge and washed in 40, 30, 20 and 15ml chemotaxis medium before final 
resuspension in 10ml of the same. The density of the preparation introduced into the 
bacterial chamber was ascertained using a Coulter Electronics Multisizer ll. 
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4.5.2.1 The Chemotactic Index (Palmer and Shaw, 1992). 
The chemotactic index is a measure of the proportion of cells in the bacterial 
population attracted towards (or repelled by) a particular concentration of 
attractant. The CI corrects for differing initial cell density, and arises from the 
observation that for a given strain, the proportion of cells attracted to a particular 
attractant concentration is a constant, over the range of cell densities used 
experimentally (see figure 4.5.2.1.A). 
To calculate the CI, Multisizer II readings were converted to number of 
cells/mi. Control figures were subtracted from each point, to give a figure for 
number of cells attracted solely by the phenolic compound. To correct for 
differences in original culture density, the data were then divided by the cell density 
of the suspension initially introduced into the chambers. Averaged figures were then 
converted to percentages of cells attracted by the compound (the CI). The CI is thus 
a reproducible value which permits comparison from one experiment to the next. 
4.5.3 Chemotaxis Assays Using Phosphorylation Deficient VirA and G 
Mutants. 
pSG687 and pRS0824 encode mutant VirG and VirA proteins, respectively, 
in which the phosphorylated residue has been altered by site specific mutation to a 
similar but non-phosphorylatable amino acid (see section 2.3). Neither protein can 
mediate vir-induction (Jin, et al, 1990a; Jin, et al, 1990b). pTB108 and pSG689 
express wild-type Vir A and VirG respectively. 
To investigate the pathway effecting acetosyringone chemotaxis, the ability of 
these mutant proteins to confer this phenotype upon A.tumefaciens was investigated. 
Due to plasmid incompatibility, it was necessary to analyse the wild-type and 
mutated virA and virG (on IncW plasmids) in A.tumefaciens backgrounds carrying 
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vir-gene combinations on the IncP cosmids pVK219 (virA, B) pVK225 (virG, C, D, 
E) and pVK257 (vir A, B, G, C). Plasmids were introduced into these backgrounds by 
micro-electroporation. Motile populations of bacteria were then selected by swarm 
plate, and assayed for chemotaxis by modified Blind Well Assay against several 
acetosyringone concentrations. 
4.5.3.1 The Requirement for VirG Phosphorylation in Mediating Chemotaxis. 
Figure 4.5.3.l.A depicts the results of acetosyringone chemotaxis 
experiments, utilising A.tumefaciens harbouring either pVK219 (virAB) or pVK257 
(virABGC) alone, and strains harbouring both pVK219 and pSG687 (virGD52N) or 
pVK219 and pSG689 (virG). In this and the following figures, error bars indicate one 
standard deviation from the mean. As before pVK257 could confer chemotaxis to 
acetosyringone, with a peak of attraction at 10·7M. The fact that pVK219-harbouring 
cells lack this response, shows that vir A alone is insufficient to mediate chemotaxis 
to acetosyringone. However, the introduction into pVK219-harbouring cells of 
pSG687, demonstrates that the non-phosphorylatable mutant of VirG, is not able to 
complement this deficit, when compared to the wild-type VirG encoded by pSG689. 
This indicates that phosphorylation of VirG is necessary for acetosyringone 
chemotaxis. 
4.5.3.2 The Requirement for Vir A Phosphorylation in Mediating Chemotaxis. 
Figure 4.5.3.2.A illustrates chemotaxis assays in which the test strains all 
harboured pVK225 (virGCDE) either alone, or in combination with pRS0824 
(virAH474Q), or pTB108 (vir A). pVK257 data from figure 4.5.3.1.A is shown by way 
of comparison. In accordance with previous results (Shaw et al, 1988) pVK225 is 
incapable of conferring chemotaxis towards acetosyringone, demonstrating that virG 
alone is insufficient for this response. Addition of the non-phosphorylatable VirA 
(encoded by pRS0824) provides very marginal chemotactic competency compared to 
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the wild-type situation conferred by pVK257 or pVK225 and pTB108 in 
combination. The non-phosphorylatable derivative of vir A is thus incapable of 
complementing for the wild-type protein, suggesting that phosphorylation of Vir A is 
required for acetosyringone chemotaxis. 
In addition, the method of Dunnett (1955) was used to show that the peaks of 
attraction observed at 10-7M AS were statistically significant (within 95% 
confidence limits) increases in the CI whilst the same could not be said of other 
treatments. Using motile C58C1Rif with and without piB100 attraction to HVA and 
VMA was also shown to be statistically significant (see figures 4.5.3.2.B and 
4.5.3.2.C) and further confirming that the vir A and G functions encoded by pVK257 
were sufficient to mediate chemotaxis as described by Shaw et al (1988). It is also of 
note that HVA provokes a stronger chemotactic response (max. C.I. 1.2) than VMA 
( max. C.I. 0.45) but that the most atractive concentration of the former is 10 times 
higher than that of the latter. 
4.5.3.3 The Interaction Between Wild Type and Mutant 2 Component Requlatory 
System Molecules. 
From figure 4.5.3.3.A it is apparent that the addition of mutant copies of Vir A 
and VirG (encoded by pRS0824 and pSG687 respectively) to a background 
harbouring their wild-type counterparts (encoded by pVK257) decreases 
chemotactic competency. Using half-logarithmic increments, it appears that the 
addition of mutant copies of VirA and VirGin a wild-type background cause a shift 
in the chemotaxis optimum towards higher attractant concentrations (see figure 
4.5.3.3.B). This figure determines the optimum AS concentration for Agrobactrium 
chemotaxis more accurately than previosly published estimates (Ashby et al, 1988, 
Shaw et al, 1988) at 3.16*10-8M. As the vir genes on these plasmids are expressed 
from their normal promoters, it is to be expected that wild-type and mutant proteins 
would be transcribed at equivalent levels. This suggests 
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Figure 4.5.3.3.A 
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Figure 4.5.3.3.B 
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that the mutant copies of Vir A and VirG interfere with normal signalling in a wild-
type background. 
4.6 The Effects of vzr Induction Inhibitors and Saccharides on Phenolic 
Chemotaxis. 
Bromo-acetosyringone is a potent and specific inhibitor of vir induction at 
micromolar concentrations (Hess et al, 1991). The molecule is thought to bind 
covalently and irreversibly to the AS receptor site (Hess et al, 1991, D.O'Hagan, 
personal communication). 2.4g of AS-Br was synthesized as in section (2.18). This is 
equivalent to a 34% yield. TLC showed the reaction had gone to completion, the 
halogenated phenolic being more polar and thus more mobile when run on a 
chromatogram than the starting material. The melting point of the compound 
produced was 125°C, somewhat higher than the 118-120°C reported by Miksche 
implying the sample produced in this study was either purer than that reported by 
the previous author or that the wrong product had been produced. A small quantity 
of the sample was taken up in chloroform and subjected to NMR spectroscopy as in 
section 2.18. This spectrum (figure 4.6.A) shows that the reaction had gone to 
completion as there is no evidence of -H bonding at 2ppm. The presence of CH3H, 
H-Br, C-H bonds in a 6:2:2 ratio confirms that the product is indeed bromo-
acetosyringone. The sample was run relative to a TMS standard (0 ppm). 
Inositol interacts synergistically with AS and AS-OH to induce vzr gene 
expression (Song et al, 1991a). These authors proposed that the sugar relieved some 
form of inhibition to gene induction, with maximal activity at a concentration of 
50mM. It was thought worthwhile to study the effects of AS-Br and inositol both 
singly and in combination on Agrobacterium chemotaxis and to compare this data 
with the published studies on vir gene induction. The nature of the chemotactic 
response with and without piBlOO (virA, G), to a range of inositol concentrations 
was first investigated (figure 4.6.B) and indicate a C.I. of around 1.1 at 50mM 
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concentration for both strains. There appears not to be a significant difference in the 
response of cells that expressing and not expressing VirA and G since a peak of 
attraction of similar size is noted at 200mM in both cases. This implies that 
Agrobacterium does not respond chemotactically to inositol via the vir A/ G system 
and the sugar is probably sensed by the chromosomal system reported by Loake et al 
(1988). Studies on the effect of inositol on bacterial growth followed (section 2.16.2) 
and indicated that Agrobacterium was unable to metabolize insositol. This was taken 
to show that any aggregation of bacteria noted in assays was a result of taxis rather 
than increased nutrients allowing greater cell division or random motility. 
The action of ASBr was investigated, see figure (4.6.C+ key following). 
These results show that the nature of the bacterium's response to this molecule is 
strongly dependent upon the concentration. At 10-5M concentration, (a 
concentration reported as strongly inhibiting vir gene induction (Hess et al, 1991) 
ASBr acts a Agrobacterium repellant (C.I. -0.6, bar A), whilst at lower concentration 
(1o-7M) it exhibits attractant behaviour (C.I. 0.85, bar B). When 10-7M AS (strong 
attractant) and 10-5M ASBr (repellent) are simultaneously exposed to the bacteria, 
replusion is observed (bar C). This is in contrast to the control situation when 10-
7M+ 10-5M (1.01 *10-5M) AS was tested for its reaction on the bacteria (bar D). In 
this case mild attraction (marginally less than for 10-5M AS, bar E) was noted. When 
studying the AS and inositol together, no synergysm of response is indicated by the 
combination of 10-7M AS and 50mM Inositol (C.I. 1.9 (bar H)), compared to 
separate treatments (1o-7M AS, 1.8 (bar F), 50mM inositol, 1.1 (bar G)). This is in 
contrast to the improved induction responce when optimally inducing AS is 
coincubated with 50mM inositiol. Furthermore 50mM inositol does not counter the 
repulsive nature of 10-5M ASBr (bar I, 50mM inositol + 10-5M ASBr), reinforcing 
the idea that inositol does not interact with the VirA/G system's chemotaxis 
mediating functions. A possible mechanism for this effect is proposed in the 
discussion. 
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4. 7 The Role of the Periplasmic Region of Vir A in Mediating Chemotaxis. 
The ligand binding site of MCP's and most 2 component regulator system 
sensors has been localised to the periplasmic region (Armitage, 1992). Whilst this 
region is essential for VirA pH, sugar and temperature responsiveness, deletion of 
this region does not abolish the ability to detect phenolic compounds (Winans, 1991) 
and respond by vir gene induction (Cangelosi et al, 1990). As it has been shown that 
virA is necessary for AS chemotaxis (Shaw et al, 1988) and for sensitivity to HVA 
and VMA (this work) it was thought interesting to investigate the role of the 
periplasmic region of Vir A in mediating chemotaxis. Plasmid piB415 (virA•63/240) 
expresses a mutant Vir A protein, in which residues 63-240 (essentially the whole 
periplasmic domain) have been deleted. In figure 4.7.A (10/8/92), the effect of the 
peri plasmic deletion of vir A upon chemotaxis is shown in comparison with the data 
for pVK257. piB415 is able to only partially restore chemotactic ability in concert 
with wild-type virG carried by pSG689. The peak is substantially smaller and shifted 
to a higher concentration, relative to the wild-type situation. This suggests that while 
the periplasmic domain of Vir A is non-essential for vir-induction by acetosyringone, 
it is important in acetosyringone chemotaxis. 
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5. Improving the Sensitivity of the Bacterium's Response. 
5.1 Introduction. 
The results of previous experiments had shown that the Agrobacterium 
vir AI G two component regulatory system was capable of detecting and responding 
to the phenolic compounds HV A and VMA. Unlike the 'natural' ligand, AS, 
exposure to catecholamine metabolites only provoked positive .chemoattraction, and 
not vir gene induction (even at higher phenolic concentrations). Experiments were 
thus undertaken to attempt to improve the sensitivity of response to HV A and 
VMA, in the hope that a catecholamine metabolite inducible strain could be 
produced. 
5.2 Two Component Regulatory Systems. 
As already mentioned, Vir A and G are part of a family of proteins, known as 
2 component regulators (Winans et al, 1986). Most members of this group encode 
positive regulatory elements (Winans et al, 1986), although CheA and Che Y which 
regulate chemotaxis and not gene expression are also strongly homologous to this 
group (Bourret et al, 1989). DNA sequence analysis has shown an extremely high 
level of conservation amongst this family (Ronson et al, 1987). This homology 
extends to the secondary and tertiary structures of gene products (Ronson et al, 
1987). These authors suggest that during bacterial evolution the 2 component system 
has been adapted many times for sensing and responding to different environmental 
changes (Ronson et al, 1987). One component acts as a sensor and signal transducer, 
interacting with the second, responsive component. Response time can vary from 
milliseconds in the case of chemotaxis to hours required for sporulation in Bacillus 
subtillis (Bourret et al, 1991). Members of the family include the E.coli proteins 
EnvZ/OmpR responding to osmolarity, NtrB/C responding to nitrogen limitation, 
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PhoR/B, phosphate limitation, CpxA/SfrA, toxic compounds and in Rhizobium 
Zeguminosarum, DctB/D which regulates expression of a transport protein (Ronson 
et al, 1987, Bourret et al, 1991). Stock et al (1990) expect about 50 such systems to 
operate in E.coli alone. 
Approximately 200-250 amino acids in the C terminal region of the sensor 
molecules show strong conservation amongst all members of the family. The greatest 
sequence variation is in the regions that have the least conserved roles ie the ligand 
binding domains (Armitage, 1992). Hydropathy data suggest that the sensors 
generally have 2 hydrophobic transmembrane regions bordering a positively charged 
N terminal periplasmic domain (Ronson et al, 1987, Winans, 1991). In addition there 
is a highly conserved C terminal cytoplasmic domain, making the structure 
manifestly reminiscent of that of MCP's (Ronson et al, 1987, Bourret et al, 1991). 
Furthermore the requirement of ChvE for Agrobacterium Vir A response to sugars is 
mirrored by the interaction of sugar binding proteins with E.coli MCP's. The sensor 
component is an autophosphorylating protein kinase that receives gamma phosphate 
from ATP and transfers it to a histidine residue (Bourret et al, 1991) (see above). 
Ligand binding is thought to occur at the N terminal periplasmic domain and result 
in a conformational change which is propagated to the C terminus allowing the 
signal to be transmitted further via regulator phosphorylation. Interestingly, deletion 
of the periplasmic region of VirA does not abolish Agrobacterium's vir induction 
response to acetosyringone (Melchers et al, 1989) and a number of workers have 
suggested the second transmembrane region as being involved in phenolic binding 
(Melchers et al, 1989). Winans (1991) casts doubt on this assumption however, 
considering this stretch of amino acids to be too short and of the wrong shape to 
constitute a ligand binding receptor site. Alternative binding sites could be formed 
by a pocket between the 2 halves of VirA dimers or on the cytoplasmic side of the 
molecule, accessibility being aided by as yet unidentified permeases. Another 
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attractive possibility would be an acetosyringone binding protein that interacts with 
the transmembrane or cytoplasmic portion of VirA to mediate its effect. 
The regulator class also shows strong homology between its elements 
(Ronson et al, 1987). All proteins in this group have a conserved region of around 
120 residues in their N terminus, including an aspartate residue in an acidic pocket 
which together are responsible for receiving phosphate from the sensor (Bourret et 
al, 1991, Lukat et al, 1991, Albright et al, 1989) (see above). In addition there is a 
conserved C terminus that falls into one of two groups which show strong homology 
between themselves and also DNA binding proteins and transcriptional activators. 
This region is thought to interact with RNA polymerase or its a factors (Ronson et 
al, 1987). It is suggested that response regulator phosphorylation stabilises a 
conformational change and thus indirectly mediates the increase in transcriptional 
activity (Bourret et al, 1991). 
5.3 Mutagenic Agents. 
The range of mutations commonly encountered include: deletions, 
frameshifts by both deletion and addition and base substitutions (Miller, 1972). 
Base substitutions include transitions (the substitution of a purine for a purine 
or a pyrimidine for a pyrimidine) and transversions, the substitution of a pyrimidine 
for a purine or vice-versa (Miller, 1972). 
Most mutagens are toxic. A calibration of mutagenic activity is thus required 
to allow a suitable compromise between survival whilst maximising chances of 
mutagenesis in the gene of interest. 
5.3.1 Spontaneous Mutation. 
Bacterial populations are subject to spontaneous random mutation. The 
frequency of specific events is generally less than w-5 in E.coli (Miller, 1972). This 
161 
Chapter 5. Mutagenesis. 
necessitates the study of large numbers of colonies. Spontaneous transitions, 
transversions, insertions, deletions and frameshifts are reported by Miller (1972). 
5.3.2 U.V. Light. 
Ultra violet radiation induces both subsitutions and deletions of bacterial 
genetic material (Yanofsky et al, 1966, Schwartz and Beckwith, 1969). Berger et al 
(1966) report the weak induction of frameshifts. Other effects may include insertions 
and internal chromosome rearrangements (Miller, 1972). Mutations are thought to 
arise due to errors in the repair of photochemical damage caused by UV exposure 
and the procedure is best carried out in the dark to prevent efficient DNA repair 
(Miller, 1972). 
5.3.3 Hydroxylamine. 
In vitro HA is specific for the transition of G:C to A:T (Freese et al, 1961a,b). 
However, in vivo both G:C to A:T and A:T to G:C transitions are found, stemming 
from side reactions with different cellular compounds (Tessman et al, 1967). In some 
cases the mutagenic effect is only weak (Miller, 1972). 
5.3.4 EMS. 
EMS is an alkylating agent that modifies DNA bases by the addition of alkyl 
groups to ring nitrogens (Lawly, 1966). It acts powerfully in vivo to induce transitions 
and transversions (Yanofsky et al, 1966, Miller, 1972). 
5.3.5 Nitro-S-Guanidine. 
This potent mutagen induces high frequency mutations whilst causing little 
killing. The agent primarily causes base substitutions, although deletions are also 
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found. Mutagenic activity is thought to stem from the production of diazomethane, 
which acts mainly at the site of replication, leading to clustering of mutations and 
high frequencies of multiple mutations (Miller, 1972). 
5.3.6 Nitrous Acid. 
Nitrous acid deaminates nucleic acids and results in transitions in vitro, but in 
vivo, transversions and deletions are also caused (Schwartz and Beckwith, 1966, 
Yanofsky et al, 1966, Freese, 1959, Bautz-Freese and Freese, 1961). High killing is 
required for good mutagenesis (Miller, 1972). 
5.4 Attempts to Increase Responsiveness to HV A and VMA. 
The rationale behind these experiments was to expose Agrobacterium cells 
carrying clones of vir A and G (with reporter gene constructs under their control) to 
conditions which it was hoped would prove inducing. Cells that were induced under 
these conditions would be selected for further analysis. The conditions selected were 
the "cutoff" values for diagnosis of neuroblastoma employed by workers in 
Newcastle-upon-Tyne (Cropper, 1989). It was thus hoped that mutant bacteria that 
were induced by low HV A and VMA concentrations could be selected. 
Catecholamine metabolite concentrations of 2.4*1o-5M HVA and 1.4*10-5M 
VMA were derived from the cutoffs of 39,ug/mg creatinine and 25,ug/mg creatinine 
respectively, assuming 1,uM creatinine (typically 0.5-3.0 ,uM, J.Seviour, personal 
communication, comparible with findings of Tuchman et al (1989), molecular weight 
creatinine: 113 (Varley, 1967)) and HV A and VMA molecular weights of 182.2 and 
198.2. Appropriate concentrations of antibiotic for selection were used and plates X-
Gal supplemented, so lacZ expression could be readily assayed. 
The U.V. calibration curve (figure 5.4.A) gave a 95% killing time of 2'30" for 
the strain used (A348 (pSM30) (virB::lacZ)). This length of exposure was used for 
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future experiments but whilst giving suitable numbers of survivors only generated 
constitutive (promoter) mutants although the experiment was repeated several 
times. To test the inducibility of blue colonies by HV A and VMA, seleted cells were 
plated out on similar media that only contained solvent and not catecholamine 
metabolites, in the expectation that truly inducible cells would appear white, whilst 
constitutive lacZ expressing cells would remain blue. 
Since the U.V. mutagenic approach provided poor results, it was proposed to 
try and employ the natural variation in the bacterial population to select a suitable 
mutant cell line. In several experiments, hundreds of thousands of cells were plated 
out under mutant selection conditions on 22cm sided phage plates. In these 
experiments, no mutagenic agent was employed. No suitable colonies were detected. 
It had become clear that the desired mutation would occur at extremely low 
frequency. A method for screening very large numbers of bacteria was thus needed 
to isolate the desired clone. It was thought that using a vir inducible antibiotic 
resistance reporter gene construct could be a feasible method of fulfilling this 
requirement. Exposure of very large numbers of mutagenised cells to low 
catecholamine metabolite concentrations in the presence of antibiotic would then 
only allow growth of induced and constitutive cells. Constitutive mutants could then 
be screened out of the mutant enriched population. To this end a vir inducible CAT 
fusion was constructed. 
The Sail vir B promoter fragment of V21 (see section 2.3) was purified by 
fragment isolation (section 2.9.5) from an agarose gel (section 2.9.4) that had been 
used to separate plasmid restriction products (section 2.9.3). Following DNA 
concentration estimation (section 2.9.6) of both vector and insert, the insert was 
ligated (section 2.9.8) to alkaline phosphatase (section 2.9.7) treated piJ3100 Sail 
digest (see table in section 2.3) in the appropriate ratio. Sail was used as piJ3100 has 
a suitable restriction site upstream of its CAT coding region and because the virB 
promotor can be most conveniently exised from V21 on a Sail fragment. The 
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resultant mixture was used to transform E.coli DH5a (section 2.8.1). Since no 
selection was available for inserts, recombinants were selected by colony 
hydridisation using the Boehringer Mannheim non radioactive detection kit and 
DNA bound to solid support membranes (sections 2.9.9). Insert orientation was 
determined in a number of independent isolates by restriction analysis. This line of 
research was abandoned before implementation due to the availability of a more 
elegant approach. 
The piB50/piB100 system was employed. piB50 encodes a dual reporter 
gene construct with lacZ and CAT fusions under the control of different vir 
promoters (see section 2.3). Induced piB50 harbouring cells will thus grow on 
chloramphenicol and cleave XGal to a blue product. This ability was used to screen 
for undesired promoter mutations since a constitutive mutation in either promoter 
would not affect the other and so the desired phenotype (CmR, blue cells on X-
GAL) would not be expressed. The probability of 2 independent promoter 
mutations was thought to be extremely low. Plasmid piB100 encodes wild type virA 
and G clones. This plasmid was mutagenised in vitro with HA (section 2.14.2), 
purified and electroporated (section 2.7.2.2) into GMI9023(piB100) before exposure 
to screen conditions. This strategy was favoured since the only material to be 
exposed to mutagenesis was piB100, theoretically decreasing the chances of 
unwanted mutations, increasing the chance of desired changes and aiding 
characterisation of selected mutants. 
In 2 separate experiments, 11 possible independent mutants were isolated. 
These were confirmed to be Agrobacterium by the Agrobacterium plate test (section 
2.15) and then grown on mutant selection media that lacked HV A and VMA but 
contained an equal concentration of solvent to previous experiments. An absence of 
resultant blue colonies was initially encouraging and it was decided to test the 
mutants inducibility using the pUCD1187 (virB::lux). In these and following 
experiments mutant selection plates were supplemented with 50mM inositol 
166 
Chapter 5. Mutagenesis. 
following the report of Song et al (1991a) that this treatment improved induction 
response to phenolics. 
It was not possible to electroporate pUCD1187 into the mutant Agrobacteria 
directly as it would not be possible to select for novel KmR pUCD1187 
transformants due to the kanamycin resistance marker of piB50. piB50 (IncP) was 
however dispensable for these experiments and thus it was decided that plasmid 
incompatibility should be used to cure the mutants of this plasmid. To this end RPI-
85 (AmpR, TcR,Kms, IncP) was introduced into W3110 using a plate mate 
conjugation technique (section 2.7.1.3), transconjugants being selected by ability to 
grow on thiamine supplimented M9 minimal media and Amp+Tc. Using a second 
plate mate conjugation RPI-85 was transferred to the mutant Agrobacterium strains 
and selected for by Amp(Cb)+Tc resistance. Resultant transconjugants were cured 
for piB50 due to IncP incompatibility and thus no longer KmR. This allowed the 
introduction of pUCD1187 by micro-electroporation (section 4.5.1). Vir induction of 
mutant lux transformants by HV A and VMA was tested as before and 
dissapointingly showed no improvement. 
The results of previous experiments (see Discussion), Cangelosi et al (1990) 
and Winans (1991) have suggested the existence of an acetosyringone binding 
protein which interacts directly with the ligand and VirA. In light of the failure to 
generate the required mutants by the above procedures, it was decided to alter the 
strategy. Virulent Ti plasmid harbouring Agrobacterium were considered to be the 
organism of choice for further mutagenesis experiments. A putative AS binding 
protein would in all probability be chromosomally encoded since the entire Ti 
plasmid has been analysed (Rogowsky et al, 1990). Furthermore this location is 
consistent with the work of Ashby et al (1988) who reported a chromosomally 
encoded phenolic sensing ability. For future mutagenesis experiments strain C58C1 
Ery Cm(pDUB1003•31, piB50) was constructed by micro-electroporation, allowing 
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mutagenesis of wild type cells with marked Ti plasmid and selection with 
discrimination against promoter mutants as above. 
It was decided that the nature of the mutagen should be altered and several 
additional mutants were isolated following exposure of C58Cl Ery 
Cm(pDUB1003delta31, piB50) to U.V.light, HA in vivo, EMS, NG and nitrous acid 
(see section 2.14). However, none had the desired phenotype. 
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6.1 Introduction and Project Aims. 
This project set out to test the hypothysis that the common soil prokaryote 
Agrobacterium tumefaciens would sense and respond to the catecholamine 
metabolites HV A and VMA via the VirA/G two component regulatory system. This 
hypothesis is based on the marked structural similarity between HV A, VMA and AS, 
a phenolic compound to which the bacterium naturally responds (see figures 1.3.2.A 
and 1.3.2.B). Two main classes of potential response were tested, vir gene induction 
and chemotaxis, and it was hoped that these would form the basis of a bacterial test 
for neuroblastoma. This test would be based upon the observation that a high 
proportion of neuroblastoma patients excrete elevated urinary concentrations of 
HV A and VMA. A cheap, reliable and reproducible bacterial screening test was 
thought to be of great benefit in improving the prognosis of neuroblastoma patients, 
whose age at time of diagnosis is strongly correlated with their clinical outlook. 
During the period of research, the initial optimism aroused by pilot 
neuroblastoma screening projects has settled to a reserved caution. It is felt that such 
programmes may not be as beneficial as first thought, and the results of more 
carefully conducted studies are eagerly awaited. There is growing evidence that 
suggests that mass neuroblastoma screening should not be recomended for countries 
not already involved in such research. 
Likewise much has been discovered about the biology of Agrobacterium 
tumefaciens in the last few years. Research illuminating the control of virulence has 
been especially interesting, and the role of dynamic protein phosphorylation and 
sugar binding proteins that interact with VirA, the two component sensor have been 
described. The role of VirG as a sequence specific DNA binding protein and 
transcriptional activator has also been elucidated. Most recently it has been 
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suggested that a phenolic binding protein may exist and this has clear implications 
for a bacterial neuroblastoma screening test. 
6.2 Consequences of Neuroblastoma Screening. 
Since the implementation of the Japanese national neuroblastoma screening 
programme in 1985 it has detected over 250 cases (Sawada et al, 1991). In the 
fourteen years between 1974 and 1988 Dr Sawada and collegues have recorded 55 
neuroblastoma cases in the Kyoto Prefecture. 22 of these cases were detected by 6 
month VMA testing and HPLC screening (Sawada et al, 1991). Data from this study 
has shown that VMA testing increased the number of patients diagnosed under 1 
year of age and decreased the number of patients older than 2 years at the time of 
diagnosis (Sawada et al, 1991). Concurrent with these changes was an increase in the 
proportion of cases diagnosed during favourable stages (I,II and IVS) and a 
reduction in stage III and IV presentations (Sawada et al, 1991). The implementation 
of the screening is considered by its proponents to have halved the annual number of 
neuroblastoma deaths in Kyoto (Sawada et al, 1991). 
Implementation of HPLC screening in the same prefecture caused an 
apparent 1.5 fold increase in the annual diagnosis of neuroblastoma and raised the 
number of patients detected before 1 year of age to 5.5 times that of the same 
population before screening (Sawada et al, 1991). A similar trend towards earlier 
diagnosis due to screening is noted by Nishi et al (1990c) in Sapporo City. The 
number of cases diagnosed after 2 years of age had fallen to half the pre-screening 
figure (Sawada et al, 1991). Sawada and collegues (1991) expect the annual rate of 
neuroblastoma deaths in an HPLC screened population to be half that of the 
population before screening. Summarising their experiences, these authors describe 
mass neuroblatoma screening as leading to an increase of neuroblastoma incidence 
in children under 1 year of age, a shift to diagnosis at earlier ages and stages, and a 
decrease in the number of deaths. These authors however concede that HPLC 
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screemng may detect the small proportion of cases that would otherwise 
spontaneously regress and feel that this explains the higher observed incidence of 
neuroblastoma in screened populations compared to untested ones. lshimoto et al 
(1990) and Matsumura et al (1991) have observed spontaneous remission in patients 
detected by mass screening. Parker et al (1992) and Nishi et al (1990c) also feel 
screening will detect benign tumours and Hanawa et al (1990) and Goodman (1991) 
point out that the detection of cases with good prognosis may improve the apparent 
effectiveness of screening in improving prognosis. An additional explanation for the 
increased neuroblastoma incidence rates observed after the introduction of 
screening would be a greater awareness of the disease in the medical profession and 
a consequent increase in neuroblastoma diagnosis (Sawada et al, 1991, Tuchman, 
1991a). Nishi et al (1990c) however claim that screening has not increased the 
recorded incidence of neuroblastoma in Sapporo City. 
Japanese workers claim their most important acheivement has been the 
reduction of annual neuroblastoma deaths following the introduction of screening 
(Sawada et al, 1991). However, the significance of this figure is debated by several 
authors (Goodman, 1991, Parker et al, 1992) who feel that this is a misleading 
comparison. Sawada et al (1991) contrast contempory annual death rate in the Kyoto 
prefecture with the same population many years ago, thus ignoring improvements in 
therapy during this period (Sawaguchi et al, 1990). The Japanese study would thus 
be of far greater significance if data could be compared to a similar unscreened 
population during the same period (Goodman, 1991, Parker et al, 1992) and there is 
little convincing evidence of a fall in neuroblastoma death rate as a result of 
screening (Hanawa et al, 1990). This initial report (Hanawa et al, 1990) of reduction 
in Japanese neuroblastoma mortality attributed to screening by the authors, 
produces little evidence for optimism since an equivalent fall is noted in the UK 
unscreened population (Cole et al, 1992). 
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Further complications in the interpretation of the Japanese studies arise due 
to the lack of proper controls. Length time bias derives from the observed increase 
in survival due to the higher proportion of good prognosis cases in screened 
populations. This can be as a result of the sensitivity of the test or its timing, if poor 
prognosis cases present clinically before screening (Goodman, 1991, Parker et al, 
1992, Prorok, 1992). Lead time bias originates however due to the earlier detection 
of screened cases giving rise to a longer surival period compared to clinical cases, 
even though death may occur at the same age (Goodman, 1991, Parker et al, 1992, 
Prorok, 1992). To assess the feasibilty of GC-MS screening for a properly controlled 
UK study, workers in Newcastle-upon-Tyne undertook a more carefully designed 
trial (Parker et al, 1992). 
This GC-MS study has detected 2 cases of neuroblastoma with good 
prognosis both of whom have been sucessfully treated. However, 3 false negative 
cases with poor prognosis were missed despite the use of HV A and VMA cut off 
values biased for sex and creatinine concentration. One of these patients succumbed 
to disease whilst the other 2 responded positively to treatment. In addition 8 false 
positive cases were noted from the 20829 babies screened. Employment of more 
recent practises would have reduced the number of false positives to 3 (Parker et al, 
1992). This and other studies (Hanawa et al, 1990, Tuchmann et al, 1990, Sawada et 
al, 1990) have shown that neuroblastoma screening is technically feasible but it 
remains to be seen whether screening per se improves the long term survival and 
mortality of neuroblastoma patients (Murphy et al, 1991 ). Indeed it is suggested that 
the overall neuroblastoma mortality rate may not be significantly different in the 
Japanese screened and UK unscreened populations (Murphy et al, 1991, Cole et al, 
1992). 
Furthermore it has been demonstrated that neuroblastoma cases detected by 
mass screening frequently have good prognosis markers (Tuchman et al, 1990b, 
Kaneko et al, 1990, Lavalotte, 1991, Bessho et al, 1991, Parker et al, 1992) and 
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indeed screening detected cases are reported to have a 97% survival rate (Bessho et 
al, 1991). Conversely poor prognosis markers are often associated with clinically 
diagnosed tumours that thave been missed by screening (Woods et al, 1992, 
Tuchman et al, 1990b ). This further questions the effectiveness of screening by 
suggesting that the cases detected as a result of screening are probably amenable to 
therapy even if detected clinically, and that those missed are less so (Woods et al, 
1992). Implicit in this observation is evidence to refute the claim that patients 
diagnosed by screening fare better than clinically discovered patients in the same 
poulation. This means that a potential screening test may not fulfill the requirement 
of Prorok (1992) that individuals identified as true positives should benefit from a 
more favourable prognosis. It has been suggested (Kankeo et al, 1990, Parker, 1991, 
Ishimoto et al, 1990) that screening at 6 months of age is thus too young and that a 12 
or 18 month screen would be more appropriate. Later screening would aim to detect 
a higher proportion of poor prognosis cases and reduce false negatives whilst not 
adversly affecting the outlook for the group of patients currently diagnosed by 6 
month screening. Reduction in the false positive rate would occur by allowing small 
tumours time to develop sufficient volume to produce detectable HV A and VMA 
levels (Ishimoto et al, 1990) and becuase poor prognosis tumours missed by 
screening are more strongly associated with older children (Kaneko et al, 1990). 
Norman et al (1987) question whether subsequently diagnosed tumours missed at 6 
months are actually present at the time of screening, although as already mentioned 
the general assumption is that neuroblastomas are congenital. A further explanation 
would be that aggrressive tumours are congenital, but have the ability to remain 
quiescent for several years (Weinblatt, 1988) perhaps awaiting a second mutation in 
genes controlling cell division. 
The progression of poor prognosis neuroblastomas to aggrressive disease has 
yet to be demonstrated and contary to this, it appears that N-myc amplification and 
DNA ploidy levels are temporally constant (Brodeur et al, 1987, Taylor et al, 1988). 
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This inability to detect poor prognosis cases and stable heterogeneity of the tumours 
accounts for the unchanged mortality rate in screened poulations (Carlsen, 1992) 
when compared to controls. About 50% of the Japanese tumours missed by 
screening have been diagnosed at later than 1 year of age and were poor prognosis 
tumours that killed the patients (Kaneko et al, 1990, Ishimoto et al, 1990, Murphy et 
al, 1991 ). It has yet to be demonstrated that the target group of tumours that later 
screening would aim to detect would benefit from earlier detection (Murphy et al, 
1991), once again violating the guidelines of Prorok (1992). Indeed it has been 
demonstrated that once N-myc amplification and DNA ploidy have been subjected 
to multivariate analysis, age no longer has an independent effect on prognosis 
(Bourhis et al, 1990). A further alternative would be to screen only high risk infants, 
such as those whose parents have had assisted conceptions or who have been 
exposed to strong electromagnetic fields (Toren et al, 1992). 
In conclusion the early optimism aroused by the Japanese screening 
programmes may have been premature. Whilst it has been demonstrated that 
neuroblastoma mass screening is technically and logistically practical and that the 
cost is acceptable (Scriver et al, 1987, Takeda, 1989, Parker et al, 1992, Nishi et al, 
1991, Sawada et al, 1991), it is not clear that screening for neuroblastoma in 6 month 
old infants can significantly decrease mortality resulting from the disease. In spite of 
this, further study may prove fruitful ( esp the results of the cooperative study 
undertaken in Canada and North America with population based controls) although 
it will be essential to consider the design of further trials more carefully to include 
essential controls and refine the timing of testing. Ideally screening methodology 
should be improved to detect patients with a poor prognosis. Additionally, important 
questions concerning the progression of disease associated with good prognosis 
markers to aggressive neuroblastoma need to be answered, before further national 
scereening could be wholeheartedly recomended. If disease progression is 
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discounted as currently seems possible, improvements in therapy for advanced 
patients will be of paramount importance in improving overall prognosis. 
6.3 Evaluation of the Agrobacterium Virulence Gene System as a Potential 
Diagnostic Test for Neuroblastoma. 
6.3.1 vir Gene Induction. 
The National Catalogue of Industrial and Marine Bacteria (1990) lists no 
organisms capable of metabolising HV A or VMA. This coupled with the presence of 
many other metabolites in urine and its solvent extracts precludes the use of 
bacterial growth utilizing catecholamine metabolites as the basis for a screening test. 
Likewise the observed supression of Agrobacterium growth by HV A and VMA 
(figure 3.4.1.D) would not be sufficiently reliable to form the foundation of such 
work due to the presence of interfering compounds. 
A study based upon the use of vir promotor controlled reporter genes would 
be the most suitable way of developing a bacterial neuroblastoma screening test. 
Agrobacterium was shown to grow well in filter sterilised urine (figure 3.4.4.A) and 
not to be induced in normal samples (figure 3.4.4.B). A potential screening scenario 
would have the test bacterium grown in either fresh liquid sample or in aqueous 
resuspension of dried urine collected on filter paper. If necessary to improve the test 
specificity, bacteria could be exposed to aqueous solutions of solvent extracted 
sample, thus removing some inhibitory impurities (figure 3.4.4.B). It was hoped that 
the bacterium would be induced by catecholamine metabolites in positive samples 
and that this induction could easily be detected using a colourimetric or light 
production assay dependent on lux, GUS or lacZ reporter activity. 
However, studies with these reporter genes failed to show any induction 
response by the bacterium on exposure to HV A and VMA (see figures 3.4.1.A, 
3.4.2.C and 3.4.3.A) when compared to controls. Furthermore HV A and VMA did 
not interfere with the biological activity of acetosyringone (figures 3.4.1.B and 
3.4.2.D). It had been thought that catecholamine metabolites might supress induction 
175 
Chapter 6. Discussion. 
in cells exposed to inducing concentrations of AS due to competition between 
HV A/VMA and AS for phenolic receptor sites. Alternatively these experiments 
could have detected possible synergism of response between HV A and VMA and 
AS in cells sensitised to phenolic presence by the 'natural' ligand. 
These results were disappointing despite the optimisation of vir induction 
conditions (figure 3.4.1.C) and the use of quantitative assays of reporter expression 
in all cases. However, the extremely sensitive lacZ assay was taken to indicate that 
the wild type VirA/G system was incapable of mediating a vir induction response to 
catecholamine metabolites (figure 3.4.3.A). These results could be a result of the 
inability of HV A and VMA to interact with the phenolic sensing functions of 
Agrobacterium to elicit a res ponce. 
Such an inability could arise because the sensor does not recognise the 
catecholamine metabolites. Alternatively the shape of the catecholamine 
metabolites or their larger size when compared to AS could prevent access to the 
active moiety of the receptor. On the basis of these results alone it would also be 
possible that the bacterial outer membrane presents a physical barrier to HV A and 
VMA, through which they are not able to pass. AS would however be actively or 
passively able to transverse the outer membrane and gain access to the phenolic 
receptor site - traditional associated with the inner membrane. This last suggestion is 
however the least attrractive since a chemotactic response to catecholamine 
metabolites was later demonstrated. 
6.3.2 Chemotaxis. 
These experiments confirm the previously reported observations of 
Agrobacterium chemotaxis towards phenolic compounds (Ashby et al, 1987, 1988, 
Shaw et al, 1988), see figure 4.4.A. In addition the optimvfY"\ acetosyringone 
concentration for taxis was determined more precisely than in previously published 
reports (3.16* w-8M as compared to w-7M). HVA and VMA were reproducibly 
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shown to be positive chemoattractants in a number of experiments (figures 4.4.B, 
4.4.C, 4.5.3.2.B, 4.5.3.2.C). In addition transposon disruption and the use of cured 
strains (figures 4.4.E, 4.4.F, 4.5.3.2.B, 4.5.3.2.C) showed that this response was 
mediated by the vir AI G system suggesting a strong similarity with the response to 
AS. A further experiment designed to test this assumption would have been to 
synthesise brominated HV A and VMA which it was hoped would covalently bind to 
their sites of action and block them. If these sites were the same as for 
acetosyringone, chemotaxis and vir induction would be expected to be suppressed in 
response to the 'natural' ligand. However, consultation with Dr D. O'Hagan 
(University of Durham, Chemistry Department) lead to the abandonment of this 
idea since it was felt that the differing chemistry of these molecules would mean that 
halogenated forms would not bind covalently to their receptor sites. 
The non phosphorylatable versions of VirA and VirG proteins are not 
competent to mediate chemotaxis towards acetosyringone. This deficiency when 
compared to their wild-type counterparts implies a requirement for phosphorylation 
if chemotaxis is to occur efficiently (see figs 4.5.3.1.A and 4.5.3.2.A). The implicit 
suggestion that phospho-VirA and phospho-VirG are required for chemotaxis is 
consistent with the previously reported phosphorylation of VirG by phospho-VirA 
during the induction of vir-gene expression (Jin et al, 1990a,b). It would appear that 
VirA, the sensor, is capable of sensing a broad band of acetosyringone 
concentrations, and effecting two responses, depending upon the sensed 
concentration. Phospho-VirG is the active, stable, transcriptional activator, capable 
of sequence specific, high affinity DNA binding (Jin et al, 1990a,c, Pazour & Das, 
1990a,b, Powell et al, 1989, Powell & Kado, 1990). How it can fulfil this role at high 
concentrations of acetosyringone and mediate chemotaxis at lower concentrations is 
not clear. 
A possible explanation for the ability of VirA and VirG to mediate two 
effects, in response to differing concentrations of the ligand would be that phospho-
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VirG has a high affinity for a component of the cytoplasmic chemotaxis signalling 
pathway (possibly a CheA homologue) and a somewhat lower affinity for vir-box 
DNA. Thus at low concentrations of the ligand ( < < 1 molecule/receptor) the small 
amounts of phospho-VirG produced would preferentially interact with the 
chemotaxis pathway. At higher concentrations(> 10 molecules/receptor) sufficient 
phospho-VirG is produced to participate in significant vir-box binding, and hence 
vir-induction. 
The periplasmic region of VirA has been shown to be essential for vir-
induction by sugars through the ChvE pathway (Cangelosi, et al, 1990). It has also 
been shown not to be involved in chemotaxis towards sugars, where a mechanism 
involving ChvE and a putative Trg analogue are thought to effect the response. The 
role of this region of the molecule in the cell's response to acetosyringone is unclear. 
The putative acetosyringone binding site of Vir A is thought to be associated with the 
transmembrane regions of the molecule (Cangelosi, et al, 1990, Melchers, et al, 
1989). Deletion of the periplasmic region is reported to have a variety of effects on 
vir-induction, with one report of no change (Melchers, et al, 1989) and another 
describing increasing sensitivity of response (Cangelosi, et al, 1990). The reported 
increased sensitivity to acetosyringone is thought to be because the molecule adopts 
a non-wild type conformation in the membrane. The peri plasmic deletion appears to 
severely curtail chemotaxis towards acetosyringone (figure 4.7.A), which may be 
simply an effect of the altered conformation. However, the data does indicate that 
the periplasmic domain, while inessential for vir-induction, is required for 
chemotaxis. Most recently Chang and Winans (1992) have suggested that the 
periplasmic region whilst being dispensable for induction is essential for virulence. 
This coupled with the absolute requirement for chemotaxis in virulence in certain 
soils (Hawes and Smith, 1989) lends weight to the requirement for this region of the 
molecule in mediation of chemotaxis. This suggests that Vir A may possess more than 
one site with differing affinities for acetosyringone. It is also possible, and perhaps 
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more likely that acetosyringone does not interact directly with Vir A, but rather with 
one or more binding proteins in the periplasm, with different ligand affinities. 
Differential concentration effects would then be achievable by these proteins 
interacting with different domains of Vir A (see next section). 
The addition of mutant copies of VirA and VirG to the wild-type chemotaxis 
system encoded by pVK257 decrease its effectiveness (figure 4.5.3.3.A). The ability 
to respond to the stimulus is reduced, with a shift in the chemotaxis peak towards 
higher ligand concentrations (figure 4.5.3.3.B). In the case of virA mutants it is 
hypothesized that of the relatively small number of acetosyringone molecules 
interacting with cell surfaces, a proportion interact with mutant molecules to no 
effect and a proportion elicit a chemotaxis inducing signal through the wild-type. 
This decreases the number of cells attracted. The explanation of the results 
following the addition of mutant virG is thought to be that the cells ability to respond 
to acetosyringone is depleted because its proportion of competent signal 
intermediates is lessened. Mutant non-phoshorylatable VirG molecules compete 
with wild-type intermediates for association with VirA, meaning that although 
acetosyringone presence is detected by Vir A the chemotactic signal is transmitted at 
lower levels. 
6.3.3 A New Model for Agrobacterium Phenolic Sensing. 
The result of experiments with the specific vir induction inhibitor, ASBr 
suggest a new model for the interaction of phenolics with the virA/G system. This 
model proposes that AS interacts indirectly with VirA to bring about its effects. This 
new model takes account of the suggestion that there may be more than one 
phenolic receptor site and seeks to provide a further hypothetical explanation for the 
ability of VirA and G to mediate two responses to different concentrations of the 
same ligand. 
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Bromo-acetosyringone is interesting because it acts as a chemoattractant at 
low (1o-7M) concentration whilst, at higher levels (10-5M) it is a repellent or chemo-
suppresant (see figure 4.6.C). The new model is in keeping with previous reports 
(see earlier) and attributes pH and temperature sensing functions to the periplasmic 
domain of VirA. As before sugars bring about their response through ChvE and 
indirect association with the periplasmic loop. The new model however differs from 
previous suggestions (Melchers et al, 1989, Cangelosi et al, 1990) by attributing the 
phenolic binding ability to separate and as yet unidentified binding proteins rather 
than to Vir A itself. This is similar to the requirement of analagous proteins involved 
in MCP and Vir A sugar responsiveness. It is proposed that Agrobacterium has 2 such 
proteins, a high affinity, possibly relatively highly expressed periplasmic binding 
protein that is responsible for mediating chemotaxis and a lower affinity, inner 
membrane protein that controls induction response (see figure 6.3.3.A). 
The periplasmicprotein would either as a result of its higher affinity for the 
ligand, its higher copy number or its mobility in the periplasmic space be able to 
detect lower concentrations of phenolics than the inner membrane protein. This 
would account for the lower ligand concentration required for optimum chemotactic 
response compared with that of induction. This molecule would when complexed 
with ligand interact with the periplasmic domain of VirA to mediate a chemotactic 
response, explaining the requirement of this portion of the 2 component regulatory 
sensor in phenolic chemotaxis. The possibility of this being a higher affinity receptor 
than its membrane bound counterpart could explain the ability of Agrobacterium to 
respond to catecholamine metabolites chemotactically but not by vir induction. 
In contrast the association of the vir responsive binding protein with the inner 
bacterial membrane and a possible lower level of expression would lower its ability 
to bind available ligand. This lower affinity could also be a function of the receptor 
site itself. The lower affinity for ligand would explain the 1000 fold higher AS 
concentration required for vir induction compared to chemotaxis. This protein would 
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be expected to interact with the second transmembrane region of Vir A in traditional 
dogma, but after the observations of Chang and Winans (1992), an association with 
the cytoplasmic portion of the molecule is to be expected. There would be no 
requirement for interaction with the periplasmic domain of Vir A in the new model. 
If such a model is true then its goes someway to explaining the results of Parke et al 
(1987) who report that a compounds capacity to cause a chemotactic response is not 
always proportional to its vir inducing abilities. This could be explained if the 2 
binding proteins had slightly different specificities, perhaps as a result of responding 
to different functional groups or portions of the ligand. This in turn offers another 
explanation for the observed chemotactic response of Agrobacterium to HV A and 
VMA whilst induction can not be detected. 
ASBr is proposed under the new model to interact at low (1o-7M) 
concentration in much the same way as the non-halogenated ligand, thereby 
inducing chemotaxis. However, at higher concentration (10-5M) it also interacts with 
the inner membrane binding protein. This causes specific inhibition of vir gene 
induction (Hess et al, 1991) and would also alter the ability of VirA to mediate 
chemotaxis, thus causing the observed suppression of response (figure 4.6.C). 
Supression of chemotaxis by 'high' phenolic concentrations has been observed 
before (Shaw et al, 1988). ASBr, is thought to bind covalently and irreversibly to its 
receptor (D.O'Hagan, personal communication). There is scope in this new model 
for hypothetical phenolic binding proteins to interact with signal transducers other 
than VirA, in a similar way to that in which ChvE interacts with both VirA and a Trg 
analogue. 
The results of the chemotaxis experiments to urine (figure 4.4.1.A) indicate 
that other compounds in samples make this an unsuitable basis for a screening test. 
The time consuming nature and practical difficulty of such assays mean they also do 
not lend themselves to a mass screening programme. 
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6.3.4 Mutagenesis. 
Non of the mutagenic treatments employed gave rise to the desired 
mutations. The mutants isolated in early experiments were most likely to be 
promoter mutants that lead to constitutive expression of the reporter genes under 
their control. In the experiments using, piB50, the dual reporter construct, the 
mutants generated could have possibly been of a similar type, but this is thought to 
be most unlikely as the frequency of a single cell obtaining 2 independent 
constitutive promotors mutations would be expected to be very low. An alternative 
explanation is that mutations arose in the genes encoding the RNA polymerase 
sigma factors involved in transcription of the reporter genes. This could possibly lead 
to constitutive expression without promotor mutation. 
The inability of piBlOO (virA, G) mutagenesis to generate the desired 
phenotype is not contradictory to the new model for phenolic sensing. As this 
plasmid cannot encode any putative phenolic binding protein, its mutagenesis and 
consequently virA/G mutagenesis would not be expected to improve the ability of 
the bacterium to sense HV A and VMA (if the receptor site is elsewhere). 
Furthermore there is no reason to suppose that binding proteins should be subject to 
a high rate of turnover if ligand binding is irreversible. This would suggest that in a 
bacterial culture not undergoing rapid division the rate of binding protein gene 
expression would be relatively low. Depending upon the gene's proximity to other 
highly expressed regions of DNA this could suggest that the DNA encoding putative 
binding proteins would be in a highly condensed state and thus less accessible to 
mutagenic agents. This coupled with the highly specific nature of mutation required 
to improve sensitivity to HV A and VMA could go part way to explaining the lack of 
these strategies success. 
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6.4 Conclusions and Future Prospects. 
In summary Agrobacterium has been shown to be unable to respond to the 
catecholamine metabolites HV A and VMA by vir gene induction. However, the 
bacterium can respond chemotactically to these compounds, and the mechanism of 
this response has been elucidated to some extent. This response is not thought to be 
amenable to the development of a neuroblastoma screening test, the need for which 
is becoming increasingly uncertain. Attempts to improve the ability of 
Agrobacterium to sense HV A and VMA failed, and explanations for this have been 
suggested. In light of experiments which have shown flaws in the accepted model of 
Agrobacterium's phenolic sensing functions, a radical new hypothetical model has 
been suggested. 
If further reseach time and funds were available it would be interesting to try 
and gain evidence to reinforce or disprove these suggestions. One key experiment 
could be to attempt isolation and purification of acetosyringone binding proteins. A 
possible method for doing this would be to disrupt and fractionate Agrobacterium 
cells and to incubate these fractions with tritiated or 14c labelled bromo-
acetosyringone. Using protein purification techniques it should be possible to purify 
the AS binding functions, identified by means of the covalently bound radiolabelled 
ligand. If sufficient sample could be obtained, it should be possible to sequence the 
proteins and isolate the genes encoding them using deduced degenerate sequence. 
Cloned binding proteins could then be subjected to mutagenesis in a similar way to 
that which piBlOO was, in the hope of isolating HVA and VMA sensitive mutants. If 
insufficient protein to sequence was available, and alternative strategy would be to 
screen and Agrobacterium expression library with mouse antibody raised to the 
binding protein and to isolate the gene from this. 
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